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« If you talk to God, you are praying; if God talks to you, you have 
schizophrenia. If the dead talk to you, you are a spiritualist; if you talk to 
the dead, you are a schizophrenic. »   Thomas Szasz 
    Extract from: Schizophrenia: The Sacred Symbol of Psychiatry 
 
 
 
 
 
A date to remember by Loran Speck 
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- ABSTRACT - 
In schizophrenia impaired episodic memory is a debilitating cognitive 
symptom but is poorly controlled by currently available antipsychotic 
drugs. Episodic memory is the capacity to recall an event in time and 
place (what-where-when) and can be dissociated between 
remembering (autonoetic awareness) and knowing (noetic awareness). 
Withdrawal from subchronic treatment with the NMDA receptor 
antagonist phencyclidine (PCP) and rearing rats in isolation are widely 
used as animal models relevant to the pathophysiological origins of 
schizophrenia. Both PCP withdrawal and isolation rearing produce 
deficits in a variety of memory paradigms such as object recognition 
that are reversed by antipsychotic drugs. It is not known whether these 
treatments produce deficits in tasks that recapitulate the what-where-
when aspects that characterise human episodic memory. In this thesis, 
it has been investigated whether withdrawal from subchronic PCP 
(5mg/kg i.p. twice daily for 7 days followed by 7 days withdrawal period) 
and isolation rearing disrupt memory in a task that requires 
simultaneous integration of memory for object (what), place (where) 
and context (when) (OPC recognition task). Rats learned to 
discriminate objects under specific spatial and contextual conditions 
(two sample phases). The effects of PCP withdrawal and isolation 
rearing were also examined in an object in place (OP) recognition task 
in which the context was kept constant (one sample phase). PCP 
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withdrawal but not isolation rearing rats impaired episodic-like memory 
in both recognition tasks. However, both PCP withdrawal and isolated 
rats unexpectedly showed impaired delay dependent reduction in total 
object exploration in the OPC task but not in the OP task, an index 
interpreted as being reflective of autonoetic awareness. On the basis of 
these experiments pharmacological studies with PCP withdrawal 
induced impairment in the OPC task had been investigated further. The 
antipsychotic drug clozapine (5 mg/kg) did not reverse PCP withdrawal 
effects in the OPC task. However the acetyl cholinesterase inhibitor 
(AChEI) donepezil (0.3 mg/kg), which has been shown to improve 
episodic memory in humans, did reverse the PCP withdrawal-induced 
impairment in OPC recognition, suggesting a potential role for AChEIs 
in treatment of memory impairment in schizophrenia. However, neither 
clozapine nor donepezil restored the total object exploration index of 
autonoetic awareness which could suggest that potential beneficial 
effects of AChEIs may be limited to noetic aspects of memory. In 
summary, these studies have shown that OPC recognition in rats may 
have some potential as a behavioural measure for animal models of 
episodic memory in schizophrenia. 
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- CHAPTER 1 - 
 
GENERAL INTRODUCTION 
 
 
1.1 What is schizophrenia? 
 
1.1.1 Definition 
 
Schizophrenia is a psychotic disorder with a prevalence around 0.7% of 
the adult population in the world. Though the annual incidence is low, 
between 0.016% and 0.042% in the world population, the prevalence is 
high due to chronicity (World Health Organisation 2009).  
 
Schizophrenia was first described as dementia praecox (early 
dementia) by Emil Kraepelin but the term schizophrenia was used by a 
Swiss psychiatrist, Eugen Bleuler. It is derived from the Greek 
terminology: ³sNKL]HLQ´ which means split and ³SKUrQ´ meaning mind. 
The mind split in schizophrenia refers to a division between thinking 
and affect resulting in an inappropriate expression of affect. 
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1.1.2 Symptomatology of schizophrenia 
 
The hallmark features of this mental illness are hallucinations and 
delusions which induce impaired judgement and loss of contact with 
reality. Symptoms are typically manifest between the ages of 16 and 
30. It is found more frequently and more severely in men (Nicole et al., 
1992, Post, 2001). Men also develop schizophrenia slightly earlier than 
women around 18 years of age in men and around 25 years of age in 
women. However, women have a higher incidence after 30 (Sham et 
al., 1994). 
 Symptoms can be divided into three main categories: psychotic 
RU ³SRVLWLYH´ V\PSWRPV GHILFLW RU ³QHJDWLYH´ V\PSWRPV DQG FRJQLWLYH
impairments (Crow, 1980, Andreasen, 1982 , Liddle, 2002). 
 
- Positive symptoms are additional behaviours and thoughts not 
seen in the general population resulting in hallucination, delusions, 
bizarre behaviour and positive formal thought disorder (Kay, 1990, 
Mitchell et al., 2001).  
- Negative symptoms are lack of drive and behaviour seen in the 
general population such as affective flattening, alogia, avolition-apathy 
and anhedonia asociality (Kay, 1990, Ananth et al., 1991, Mitchell et 
al., 2001).   
- Cognitive dysfunctions in attention, language, memory and 
executive functions have been reported (Gold et al., 1992, Clare et al., 
1993, Milner et al., 1998). These cognitive impairments are of particular 
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significance for the disease as they are more closely associated with 
poor outcome in patients than are the other symptoms such as 
hallucinations or delusions (Green et al., 2004, Berenbaum et al., 
2008). 
 
All these deficits have a strong impact on daily social life, education 
and employment. The negative and cognitive symptoms tend to be 
more persistent and chronic (Breier et al., 1991), However, although 
the psychotic symptoms have an episodic pattern they are usually the 
impetus for hospitalization when active (Andreasen, 1995). 
 
1.1.3 Cause of schizophrenia 
 
The cause is still unknown. Although, hypotheses suggest that genetic 
(Guidry and Kent, 1999), viral such as influenza virus (Pearce, 2001) or 
pre-natal environmental (Weissman et al., 2006) factors are important. 
 Alternatively, these factors could create a vulnerability to develop 
schizophrenia in adulthood. Exogenous factors (e.g. drugs, social 
LVRODWLRQ VWUHVV« PD\ LQFUHDVH YXOQHUDELOLW\ DQG FRXOG EH cause of 
schizophrenic symptom expression which appears when young adults 
are at their most vulnerable (beginning of independence) and finding 
their identity (Asarnow and Goldstein, 1986, Harris et al., 1986) (see 
Figure 1.1). 
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It is also generally accepted by researchers that schizophrenic 
symptoms can be induced by disturbance in neurochemical and/or 
structural brain architecture. 
 
Figure 1.1: The developmental origins of schizophrenia (From Howes et al., 
2004). 
 
1.1.4 Neurochemical dysfunction in schizophrenic patients 
 
1.1.4.1 Structural brain abnormalities 
 
A number of studies have shown abnormal cerebral morphologies in 
schizophrenic patients (Ward et al., 1996, Velakoulis et al., 2000). 
Schizophrenic patients have been shown to have a significant reduction 
of brain and intracranial size compared to a control group. These have 
been suggested to result from genetic and environmental factors which 
can be progressive (Ward et al., 1996, Velakoulis et al., 2000). 
Furthermore there is ventricular enlargement, notably the third ventricle 
and lateral ventricles which affect the adjacent brain regions such as 
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temporal cortex and HPC (hippocampus) (Weinberger et al., 1979, 
Weinberger et al., 1980, Shenton et al., 2001). The prefrontal cortex 
(PFC) of schizophrenic patients, which is implicated in organisation of 
action and memory, shows a reduced volume and a progressive 
decrease of gray matter volume (Gur et al., 2000, Thompson et al., 
2001).  
 
1.1.4.2 Dopamine hypothesis 
 
The dopaminergic system consists of four main pathways, 
dopaminergic neurons project from the ventral tegmental area (VTA) to 
the limbic system (mesolimbic pathway) and to the PFC (mesocortical 
pathway), the nigrostriatal pathway involved in the control of motivity 
DQGZKLFKLVGHSOHWHGLQ3DUNLQVRQ¶VGLVHDVH(Kim et al., 2003), and the 
tuberoinfundibular pathway which transmits dopamine from the 
hypothalamus to the pituitary gland and influences the secretion of the 
hormone prolactine (Gonzalez et al. 2004). 
 The effect of dopamine is mediated through activation of 
dopamine receptors. There are two main families of dopamine 
receptors: D1-like (D1 and D5) and D2-like (D2, D3 and D4). The 
division is based on their inhibitory or excitatory function effect on 
adenyl cyclase. D1-like (D1 and D5) linked to Gs-protein (s=stimulant) 
and D2-like (D2, D3 and D4) linked to Gi-protein (i=inhibitory) 
(Contreras et al., 2002, Nieoullon, 2002).  
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Three pharmacological lines of evidence support the dopamine 
hypothesis: 
 The first line of evidence comes from amphetamine users and 
postulates an abnormal release of dopamine by dopaminergic neurons. 
Amphetamine is an indirect dopamine agonist that induces an 
increased release of dopamine by an action through the dopamine 
transporter (DAT) (Schmitz et al., 2001) and inhibits dopamine 
reuptake. Amphetamine, also disrupts vesicular monoamine transporter 
inducing an increasing released of dopamine into the neuronal 
cytoplasm (Feldman et al., 1997) Amphetamine abuse induces and 
exacerbates schizophrenic symptoms respectively of non-psychotic 
individuals and schizophrenic patients (Bell, 1973, Crow, 1980). 
 The second line of evidence comes from the efficacy, on the 
positive symptoms of schizophrenia, of traditional antipsychotic drugs 
such as haloperidol and chlorpromazine which are dopamine D2 
receptor antagonists (Carllson and Lindqvist, 1963, Carlsson, 1978, 
Seeman et al., 1987, Talbot and Laruelle, 2002). The dopamine D2 
receptor antagonist effect of antipsychotics and their efficacy in 
regulating symptoms suggests dopaminergic hyperactivity in 
schizophrenia (Carlsson, 1978). 
  Third line of evidence comes from post mortem studies which 
describe an abnormal elevated level of dopamine D2 receptors in 
schizophrenic brain striatum (Seeman et al., 1987).  Neuroimaging 
studies in psychotic patient (e.g. positron emission tomography (PET) 
and single photon emission computed tomography (SPECT)) 
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highlighted an abnormal level of dopamine release with an 
exacerbation during psychosis (Abi-Dargham et al., 1998, Abi 
Dargham, 2002). 
 
According to the dopaminergic hypothesis the dopamine hyperactivity 
in mesolimbic regions of the brain is leading to the positive symptoms 
of the disease (treated by antipsychotic) while hypoactivity in prefrontal 
cortical regions is leading to negative and or cognitive symptoms of the 
disease (which are antipsychotics resistant) (Weinberger, 1988, Ananth 
et al., 1991, Gold and Weinberger, 1995). 
   
An analysis of dopamine receptors in schizophrenic brain using PET 
and SPECT has shown less dopamine D1 receptor expression in PFC 
in schizophrenia confirming the dopamine hypoactivity in PFC (Okubo 
et al., 1997). On the other hand, the majority of the studies fail to show 
a difference in dopamine D2 receptor density in schizophrenic patients 
in PFC (Martinot et al., 1990, Hietala et al., 1994, Nordstrom et al., 
1995). However, higher occupancy of dopamine D2 receptor is 
observed in patients with schizophrenia experiencing an episode of 
illness exacerbation compared with healthy controls. This could be a 
consequence of  higher levels of free dopamine in the vicinity of D2 
receptors or/and higher affinity of D2 receptors for dopamine (Abi-
Dargham et al., 2000).  A complementary study by Laruelle et al. 
(2000) has focused on the role of dopamine transporter (DAT) which 
controls dopamine concentration in the synaptic cleft (Laruelle et al., 
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2000). There is no increase of DAT density between schizophrenic 
patients and control. Furthermore, there is no relationship between 
amphetamine induced dopamine release and DAT density suggesting 
dopamine hyperactivity is associated with a deregulation of dopamine 
neurons rather than an increase in the number of these neurons 
(Laruelle et al., 2000). 
 
Further evidence suggests that the dopaminergic deregulation 
observed in schizophrenia  could be the result of the dysconnectivity of 
cortico-subcortical and intracortical networks, with a main deregulation 
in PFC (Nieoullon, 2002). This postulate suggests a subcortical 
hyperactivity of dopaminergic neurons to compensate for cortical 
hypoactive dopaminergic neurons (Weinberger et al., 1994, Marsden, 
2006) (Figure 1.2). 
 
Figure 1.2: Dopaminergic imbalance in schizophrenia. Alteration in cortical DA 
transmission may contribute to a reactional process increasing striatal DA 
transmission. Such hyperactivity of subcortical DA transmission could likely 
compensate for deficits related to cortical DA depletion and consequent frontal 
hypoactivity, but could also contribute to behavioural impairment (From Abi-
Dargham, 2002).  
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The activity of midbrain dopaminergic neurons is under the control of 
PFC, via an activating pathway involving direct glutamatergic 
projections into dopaminergic cells and an indirect inhibitory pathway 
LQYROYLQJ Ȗ-aminobutyric acid (GABA)ergic interneurons via the 
striatum. The indirect inhibitory GABAergic pathway is also under the 
control of the glutamatergic system from the PFC (Marsden, 2006). 
After amphetamine administration, dopaminergic cells are inhibited via 
the inhibitory pathway and by their presynaptic D2 autoreceptors, to 
reduce the dopamine released. Ketamine, an N-methyl-D-aspartate 
receptor (NMDA receptor) antagonist, potentiates the DA release 
produced by amphetamine showing similar response seen in 
schizophrenic patients (Kegeles et al., 2000). These data indicate that 
dopaminergic dysfunction in schizophrenia could result from a 
disruption of the glutamatergic and GABAergic neuronal systems 
(Figure 1.3). 
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Figure 1.3: Simplified diagram showing the neural pathways linking the 
prefrontal cortex, the nucleus acumens and the ventral tegmental area (VTA) 
(From Marsden, 2006).  
 
As previously mentioned D2 receptor antagonists can reduce the 
positive symptoms of schizophrenia (Abi-Dargham et al., 2000, Abi 
Dargham, 2002), while the negative symptoms are associated with 
reduced dopamine function in the PFC (Brozoski et al., 1979, Lynch, 
1992). It has been shown that the D1 receptor agonist SKF38393 
reduces extracellular concentration of glutamate and GABA in mPFC 
which can be reversed by the D1 receptors antagonist SCH23390 
(Abekawa et al., 2007) and that D2/D3 antagonism increases glutamate 
function via an inhibition of the GABAergic system (Hatzipetros and 
Yamamoto, 2006). 
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 1.1.4.3 Glutamatergic hypothesis 
   
Glutamate is one of principal excitatory neurotransmitters of the central 
nervous system (CNS). Two groups of receptors mediate glutamatergic 
transmission: ligand-gated ion channels (NMDA, AMPA and kainate) 
and G-protein linked receptors (mGluRs) (Pin and Duvoisin, 1995). 
 At present, eight mGluR subtypes have been identified by molecular 
cloning (mGluR1-8) (Pin and Duvoisin, 1995). They are classified into 
three groups according to their sequence homology, mechanisms of 
signal transduction and pharmacology. MGluRs regulate glutamate 
activity. Glutamate is implicated in diverse processes such as: synaptic 
plasticity, neuronal death or control of cardiac activity (Pin and 
Duvoisin, 1995). 
 The NMDA receptor is responsible for the early and the late 
phases of Long Term Potentiation (LTP) that define the adaptive 
plasticity. NMDA receptor can also contribute to the excitatory 
postsynaptic currents (EPSCs) and dendritic spikes (Squire, 1992, 
Coyle, 2006). It has been consistently demonstrated that glutamatergic 
hypoactivity induced by glutamatergic antagonists mimic 
VFKL]RSKUHQLF¶V V\PSWRPV (Luby et al., 1959, Javitt and Zukin, 1991, 
Coyle and Tsai, 2004, Coyle, 2006, Javitt, 2007).  
 The NMDA receptor is a tetramer containing two subunits: NR1, 
which is required for channel function and NR2A-D, which affects the 
biophysical and pharmacological characteristics of the NMDA receptor. 
To be activated, the NMDA receptor requires both glutamate and 
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glycine binding at two distinct sites, the NR2A-' DQG ³JO\FLQH
PRGXODWRU\VLWH´ *06RQ WKH15VXEXQLW (Coyle et al., 2002). This 
co-binding will release Mg2+ from the channel and allow the Ca2+ entry 
into in the post-synaptic neuron (Lynch and Guttmann, 2001)  
(Figure 1.4.). 
 
Figure 1.4: Schematic model of the NMDA receptor complex showing the 
binding sites for glutamate, glycine and D-serine (From Javitt et al., 2007). 
 
Synaptic glutamate is synthesized from glutamine supplied by 
astrocytes. Another process to synthesize glutamate involves N-acetyl-
aspartyl glutamate (NAAG), an abundant neuropeptide in the 
mammalian nervous system. NAAG is catabolised to N-acetylaspartate 
(NAA) and glutamate by glutamate carboxypeptidase II (GCP II) and 
possesses a glycine reversible antagonist effect on the NMDA receptor 
as well as an agonist effect at the mGluR3 receptor which both induce 
negative NMDA receptor modulation (Bergeron et al., 2005). 
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 To regulate this system, the astrocytes play a central role by 
providing lactate for oxidative metabolism and glutamine. They are 
involved in the control of NMDA receptor activity by expressing 
glutamate (excitatory amino acid transporters: EAAT 1 and 2) and 
glycine transporters (GlyT1); by synthesizing and / or catabolising D-
serine via two enzymes located in the astrocyte racemase and D-amino 
acid oxidase (DAAO) respectively (Coyle, 2006); and by expressing 
GCP II which controls the NAAG concentration (Bergeron et al., 2005). 
 
The NMDA receptor hypofunction hypothesis for schizophrenia comes 
from three main different types of investigation: NMDA receptor 
antagonist studies, post-mortem studies and genetic studies with 
schizophrenic patients compared to control groups. 
 
1.1.4.3.1 The glutamate hypothesis: NMDA receptor antagonist studies 
 
Phencyclidine (PCP) was first synthesised in 1926. In mid 1950s the 
pharmaceutical organisation Parke-Davis developed PCP (sernyl, 
QDPHZKLFKGHULYHGIURP³VHUHQLW\´DVDKuman anaesthetic. In 1957, 
there were problems during the first test on human subjects, when 
studies showed PCP could induce psychotic effects which mimic 
schizophrenic symptoms (Luby et al., 1959).  
 The emerging pharmacology understanding of NMDA receptors 
revealed that  PCP was an NMDA antagonist thereby suggesting an 
endogenous dysfunction of NMDA receptor in psychosis (Javitt and 
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Zukin, 1991). Ketamine, another NMDA receptor antagonist, in healthy 
humans and schizophrenic patient also consistently evokes negative 
symptoms and cognitive symptoms of schizophrenia, as well as 
positive symptoms (Krystal et al., 1994, Newcomer et al., 1999, Curran 
and Morgan, 2000, Krystal et al., 2005, Javitt, 2007). This idea 
suggests that dopaminergic deregulation observed in striatal and 
prefrontal systems in schizophrenia results from a NMDA receptor 
dysfunction (Javitt, 2007).  
 
1.1.4.3.2 The glutamate hypothesis: Post Mortem studies 
 
Post mortem studies indicate significant changes in glutamate receptor 
binding, transcription and subunit protein expression in the PFC, 
thalamus and HPC of subjects with schizophrenia. There is a decrease 
of NR1 subunits of the NMDA receptor in HPC and PFC (Bergeron et 
al., 2005, Lewis and Moghaddam, 2006).  In schizophrenic subjects, 
GCP II, which catabolises NAAG into glutamate and NAA, is reduced in 
frontal cortex, HPC and temporal cortex in a comparison of to suitable 
controls (Coyle, 2006). The NAAG over expression implicates a hypo-
glutamatergic activity via its action of MGluR3 agonist and glycine 
reversible antagonist of the NMDA receptor. It was additionally show 
that there is an over expression of the glutamate transporters EAAT 1 
and 2 in thalamus which compromises glutamatergic transmission 
(Meador-Woodruff et al., 2003). 
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1.1.4.3.3 The glutamate hypothesis: Genetic studies 
 
Several genetic studies demonstrate an association with different 
genes and the risk for schizophrenia. The gene G72 is over expressed 
in PFC (Coyle and Tsai, 2004, Coyle, 2006). G72 gene codes for a 
protein that activates DAAO, the enzyme that catabolises D-serine. A 
reduction of D-serine would lead to NMDA receptor hypofunction 
(Stevens et al., 2003). The genes GRM3 or 7 which code for 
metabotropic glutamate receptorsb (Fuji et al., 2003; Ganda et al., 
2009), as well as SLC1A1, A2 and A3 which code for glutamate 
transporters (EAAT1, 2 and 3) (Deng et al., 2004; Deng et al., 2007) 
have been shown to be linked to schizophrenia. 
 
To conclude, the glutamatergic hypofunctionality in schizophrenia is 
thought to cause an indirect down regulation of GABAergic function, of 
mesolimbic dopamine hyperactivity and via a direct pathway of cortical 
dopaminergic hypoactivity (Kegeles et al., 2000, Lewis and 
Moghaddam, 2006, Marsden, 2006). 
 
1.2 Animal models relevant to schizophrenia 
 
Animal models are important both for the identification of novel 
therapeutic strategies and for the understanding the pathophysiology of 
symptoms. At the present time, there are no animal models that 
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capture all the features of schizophrenia, or indeed any psychiatric 
illness (Geyer and Moghaddam, 2002, Wong and Van Tol, 2003). 
The validity of a model consists of three levels of validity: 
predictive, face and construct validity (Willner, 1991). Predictive validity 
concerns predictions of pharmacological manipulations, these should 
replicate clinical findings. A good predictive model should include no 
false positive or false negative results. For example animal model 
relevant to schizophrenia should respond positively toward typical (e.g. 
haloperidol) and atypical (e.g. clozapine) antipsychotic on behavioural 
tasks that assess the positive symptoms and negative symptoms but 
not the cognitive symptoms. Face validity concerns the 
phenomenological similarities between the model and the disease such 
as similarities of symptoms. There should be as many similarities 
between the disease and the model with a minimum of dissimilarities. 
Construct validity is considered the highest level of validity and refers to 
the underlying pathological state of the disease. In the sense that 
biochemical changes should reflect those observed in the disease and 
induce a change in behavioural experiments. The combination of all 
different models of schizophrenia allows the understanding of 
pathophysiological mechanisms and neurobiology of the disease 
(Willner, 1991). In rats there are three main types of model: Lesion, 
developmental and pharmacological models. Table 1.1 below 
recapitulates the advantages and the disadvantages of those models. 
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Type  
 
Model in 
rats 
 
Positive aspect 
 
Negative aspect 
 
 
Pharmacological  
model 
 
PCP 
model 
 
Based on the 
glutamatergic 
hypothesis 
 
 
different routes 
and dosages 
induce different 
symptoms  
 
Amphetamine 
model 
 
Based on the 
dopaminergic 
hypothesis 
 
Developmental 
model 
 
Isolation-
rearing 
 
 
 
Developmental 
model rather drug 
administration or 
lesion 
 
reversibility of re-
socialization 
 
long time before 
using this model 
 
 
 
 
Lesion models 
 
 
NVH 
 
 
Particular interest 
because of the 
relation between 
striatum and HPC 
DA innervations 
and the core 
feature of 
schizophrenia 
 
 
 
 
 
Size of the lesion 
and invasive 
effect can induce 
different results  
 
 
mPFC 
 
Represent the 
structural 
abnormalities seen 
in schizophrenia 
and disturb striatal 
DA regulation 
 
Table 1.1: Overview of advantages and disadvantages of the three animal 
models relevant to schizophrenia in rats: pharmacological, developmental and 
lesion model. 
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1.2.1 Lesion models 
 
Historically, lesion studies have contributed to our understanding of the 
pathophysiology of various brain regions in different diseases, and this 
is also the case in schizophrenia (Geyer and Moghaddam, 2002, Wong 
and Van Tol, 2003). 
 Psychosis lesion models include: neonatal ventral hippocampal 
(NVH) or medial PFC (mPFC) lesions. There is a close structural 
interconnection between these two structures (e.g. glutamatergic 
pathways from the HPC to the PCF), lesions of one region affects 
function of the other one (Jay et al., 1992). This must be taken into 
consideration in lesion studies (Lipska, 2004). However, Neonatal 
ventral hippocampal lesion results in prepulse inhibition (Béracochéa et 
al.), latent inhibition, delayed alternation and social contact deficit which 
are representative tasks of schizophrenic positive and negative 
symptoms in animals (Lipska and Weinberger, 2000). 
 
 
1.2.2 Developmental models 
 
As previously mentioned, early life events influence brain development 
and subsequent adult behaviour and play an important role in the 
causation of certain psychiatric disorders including schizophrenia. With 
the aim of understanding these early environmental factors, some 
developmental based models of central nervous system disorders in rat 
have been proposed. These models focus on environmental 
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manipulations like isolation rearing, maternal malnutrition or hypoxia, 
which induce psychotic like disorder and furthermore are associated 
with neurochemical changes in the dopamine system (Geyer and 
Moghaddam, 2002, Wong and Van Tol, 2003). 
Geyer (Geyer et al., 1993) was the first to show PPI impairment 
in the developmental model of rat pups reared in isolation when tested 
in adulthood (Geyer et al., 1993). Furthermore, the main disadvantage 
of the developmental model is the difficulty to reproduce the model and 
the long delay before use; however the etiological validity of the model 
is not negligible (Geyer et al., 2001). The postweaning social isolation 
rearing model is used in the Chapter 4 of the thesis. 
 
1.2.2.1 Postweaning social isolation rearing 
 
Isolation rearing model in rats is a neurodevelopmental model of 
schizophrenia. Early social isolation mimics the early environmental 
stress which will induces an alteration of brain development resulting in 
behavioural deficits. Isolated rats develop long-term changes relevant 
to schizophrenia symptoms and it is used as a model relevant to 
schizophrenia in rats (Lapiz et al., 2003, Day-Wilson et al., 2006, Fone 
and Porkess, 2008). 
 
Isolation rearing induces long term neurobiological, neurochemical and 
behavioural changes in rats. Isolated rats show a hyperfunction of 
mesolimbic dopaminergic systems (Jones et al., 1992, Hall, 1998), a 
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hypofunction of mesocortical dopaminergic systems (Heidbreder et al., 
2000, Peters and O'Donnell, 2005), and glutamatergic hypofunction in 
the PFC (Melendez et al., 2004, Levine et al., 2007) as well as a 
decrease of dopamine turnover in the mPFC (Heidbreder et al., 2000), 
which all mimic neurobiological dysfunctions observed in 
schizophrenia. Post mortem analysis of isolated rats compared with 
group housed rats revealed alterations in dopamine level, 5-
hydroxytryptamine (5-HT) in the nucleus accumbens and striatum 
(Jones et al., 1992, Leng et al., 2004). These abnormalities lead to 
behavioural impairment such as hyper-reactivity to novel environment 
(Gentsch et al., 1982), reduced PPI of startle (Geyer et al., 1993) and 
some cognitive deficits such as object recognition (Bianchi et al., 2006, 
McLean et al., 2008). The schematic overview designed by Fone and 
Porkess (Fone and Porkess, 2008) represents the behavioural and 
neurochemical changes after social isolation compared to group 
housed rats (Figure 1.5). 
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Figure 1.5: Schematic overview designed by Fone and Porkess (Fone and 
Porkess, 2008) of behavioural and neurochemical changes after social isolation 
compared to group housed rats. Single headed lines reflect a decrease (dotted 
lines) or and increase (solid bold) in the neurotransmitter function identified. 
DA: dopamine; 5-HT: 5-hydroxytryptamine; Glu: glutamate; BDNF: brain derived 
neurotrophic factor; a2 ADR: a2 adrenoreceptor; HPA: hypothalamic pituitary 
adrenal axis and 5-HT receptors are named according to the IUPHAR 
nomenclature. *Impairment in recognition memory may involve deficits in the 
entorhinal and perirhinal cortex and HPC not represented on this figure (from 
Fone and Porkess, 2008). 
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1.2.3 Pharmacological animal models 
 
Pharmacological models include acute challenge and chronic 
treatments with DA agonists (amphetamine, apomorphine), 
hallucinogens such as PCP or LSD, dizocilpine maleate (MK-801), 
ketamine and neurotoxins. The drugs may be given to adult animals or 
targeted to specific periods in development (Geyer and Moghaddam, 
2002, Wong and Van Tol, 2003). 
 In humans, amphetamine produces a transient psychotic 
disorder which is defined as a thought disorder and induces positive 
symptoms. In contrast PCP induced positive, cognitive and negative 
symptoms of schizophrenia (Krystal et al., 2005). A retrospective study 
found that amphetamine abuse is associated with paranoia and PCP 
with bizarre delusions and alters sensory experiences (Rosse et al., 
1994). 
 Compared to the amphetamine model, glutamatergic models 
show higher predictive and face validity (Rung et al., 2005). Indeed, if 
both models induce positive symptoms, glutamatergic antagonists also 
mimics negative and cognitive dysfunction (Javitt and Zukin, 1991) and 
furthermore shows better response to the atypical antipsychotic 
clozapine compared to dopaminergic models (Aultman and 
Moghaddam, 2001, Geyer and Moghaddam, 2002). Also, typical 
antipsychotics such as haloperidol which are antagonist D2 receptors, 
in general, do not treat the negative symptoms in schizophrenic patient 
(Blin, 1999, Abdul-Monim et al., 2006), in contrast partial dopamine 
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agonists (e.g. terguride) ameliorate these symptoms (Davis et al., 1991, 
Olbrich and Schanz, 1991) which taken together these results 
demonstrate that hyperdopaminergia is not directly linked with negative 
symptoms of schizophrenia (Davis et al., 1991). On the other hand 
glutamatergic model induces negative, positive and cognitive 
symptoms (Bakshi et al., 1994, Abdul-Monim et al., 2007, Grayson et 
al., 2007). Thus the glutamatergic model appears to be a more 
complete model to mimic schizophrenia in animals than the 
dopaminergic agonist model. 
  
1.2.3.1 Glutamatergic Model  
  
1.2.3.1.1 Mk-801 model 
 
Compared to ketamine or PCP, MK-801 is the most potent NMDA 
receptor antagonist and has more selective effects than for example 
PCP (Seeman et al., 2005). Behavioural effects induced by acute 
injection MK-801 or PCP do not seem to differ for example both 
produce hyperactivity, PPI deficit, social withdrawal and impairment in 
various cognitive tasks (Zajaczkowski et al., 2003, Chartoff et al., 2005, 
Rung et al., 2005). However, when animals are tested after withdrawal 
from chronic administration the effects produced by PCP are different 
compared to those produced by MK-801. Withdrawal from subchronic 
administration induces working memory deficits, decrease social 
interaction and d-amphetamine-induced motor activity; while after 
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subchronic MK-801, there is only a slight decrease in social interaction 
(Seillier and Giuffrida, 2009). 
 
1.2.3.1.2 Ketamine model 
 
Ketamine is also often used as a model relevant to the symptoms of 
schizophrenia in rodent. As well as PCP ketamine has affinity at the D2 
receptor (Seeman et al., 2005). Even if ketamine and PCP have 
structurally similarity and were both used as intravenous anaesthetics, 
ketamine but not PCP is still used as anaesthetics in animals.  This is 
due to a less potent effect of ketamine than PCP on dopamine released  
in the amygdala, pyriform and prefrontal cortices (Bagchi, 1981, Rao et 
al., 1989). In contrast, ketamine decrease the DA release in striatum 
which is not affected by PCP (Rao et al., 1989).  Furthermore, ketamine 
is acting faster than PCP but has a less persistent effect (Byrd et al., 
1987).  
 
1.2.3.1.3 Subchronic PCP model 
 
PCP and PCP withdrawal -induced learning and memory deficits in 
rodents are consequently widely used to attempt to model the 
abnormalities in memory and other cognitive functions in schizophrenia 
(Jentsch and Roth, 1999, Wong and Van Tol, 2003, Mouri et al., 2007). 
This model is based on the hypoglutamatergic state observed in 
schizophrenia, which directly or indirectly affects the dopamine system. 
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In humans, there are multiple lines of evidence that NMDA receptor 
antagonists (e.g. ketamine and PCP) in healthy volunteers mimic 
schizophrenic-like symptoms such as positive and negative symptoms 
and cognitive deficits including episodic memory impairment (Luby et 
al., 1959, Javitt and Zukin, 1991, Krystal et al., 1994, Jentsch and Roth, 
1999, Curran and Morgan, 2000, Hetem et al., 2000, Javitt, 2007). 
These drugs have also been shown to exacerbate psychosis in 
schizophrenic patients (Lahti et al., 1995). In addition to its antagonist 
effect on the NMDA receptors, PCP but not ketamine has affinity for the 
dopamine transporter (Tangui et al., 1991, Seeman et al., 2005) as well 
as sigma receptors which have been implicated in PCP-induced motor 
sensitization (Vignon et al., 1988, Xu and Domino, 1999).  
 
Acute or chronic PCP (withdrawal) administration produces qualitatively 
different effects on neurochemical and behaviour changes, with a 
closer isomorphic symptomatology of schizophrenia after chronic PCP 
use. In humans and rodents symptoms are more relevant (social 
incompetence, poor attention and concentration) and recurrent with 
long term PCP treatment than acute (delusion and hallucination) 
(Jentsch and Roth, 1999). The behavioural effects of PCP in humans 
have been shown to persist for several weeks after drug 
discontinuation which is why withdrawal from repeated PCP 
administration is widely used as a pharmacological model relevant to 
schizophrenia (Jentsch and Roth, 1999, Enomoto et al., 2007, Mouri et 
al., 2007, Seillier and Giuffrida, 2009).  In PCP withdrawal models 
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animals are free from the considerable sedative effects of acute PCP 
that may confound interpretation of impairments in memory tasks. In 
addition withdrawal models have an advantage in that they circumvent 
WKH ³UHFHSWRU WDXWRORJ\´ FRQIRXQG LQ SKDUPDFRORJLFDO WUDQVODWLRQDO
studies, namely,  that reversal of drug induced effects can simply reflect 
a pharmacological interaction and may not necessarily predict clinical 
efficacy  (Young et al., 2009) (Table 1.2). 
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ĹĹĹHQKDQFLQJK\SHUDFWLYLW\ĻLPSDLUPHQWĺQRQ 
Table 1.2: Positive symptoms, negative symptoms and cognitive dysfunction in the PCP model animal (from Mouri et al., 2007). 
Positive symptoms 
 
Negative symptoms 
 
Sensorimotor gating 
deficit 
Cognitive dysfunction 
Acute PCP treatment 
Locomotor activity 
Ĺ 
 
Sturgeon et al. (1979) 
Nabeshima et al. (1983) 
Nagai et al. (2003) 
Social behavior in a 
social interaction test 
Ļ 
 
Sams-Dodd (1995) 
Sams-Dodd (1996) 
 
Prepulse inhibition 
Ļ 
 
Geyer et al. (2001) 
Bakshi et al. (1994) 
Bakshi and Geyer (1995) 
Keith et al. (1991) 
Memory impairment in a passive avoidance test 
Ļ 
 
Nabeshima et al. (1986) 
Attention/latent learning in a water finding test 
Ļ 
 
Noda et al. (2001) 
Immobility in a forced 
swimming test 
ĺ 
 
Noda et al. (1995) 
Attentional set shifting in a ID/ED test 
Ļ 
 
Egerton et al. (2005) 
Reversal learning in an operant test 
Ļ 
 
Abdul-Monim et al. (2003) 
 Idris et al. (2005) 
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ĹĹĹHQKDQFLQJK\SHUDFWLYLW\ĻLPSDLUPHQWĺQRQ 
 Table 1.2: Positive symptoms, negative symptoms and cognitive dysfunction in the PCP model animal (from Mouri et al., 2007) (continued). 
  
Positive symptoms 
 
Negative symptoms 
 
Sensorimotor gating deficit 
 
Cognitive dysfunction 
 
Repeated PCP treatment 
Locomotor activity 
ĹĹHQKDQFLQJ 
 
Nabeshima  
et al. (1987) 
Kitaichi et al. (1995) 
Nagai et al. (2003) 
Jentsch et al. (1998) 
Social behavior in a 
social interaction test 
ĻHQGXULQJ 
 
Sams-Dodd (1995) 
Sams-Dodd (1996) 
Qiao et al. (2001) 
Prepulse inhibition 
Ļ 
 
Martinez et al. (1999) 
Working memory in a T-maze/radial arm maze test 
ĻHQGXULQJ 
 
Jentsch et al. (1997b); Stefani and Moghaddam (2002) 
Li et al. (2003); Marquis et al. (2003) 
Spatial or non-spatial learning in an object recognition test 
ĻHQGXULQJ 
 
Mandillo et al. (2003) 
Hashimoto et al. (2005) 
Attention/latent learning in a water finding test 
ĻHQGXULQJ 
 
Mouri et al. (2007) 
Motivation in a forced 
swimming test 
ĻHQGXULQJ 
 
Noda et al. (1995) 
Noda et al. (1997) 
Corbett et al. (1999) 
Noda and Nabeshima 
(2000) 
Guan et al. (2000) 
Noda et al. (2001) 
Nagai et al. (2003) 
Murai et al. (2007) 
Attentional set shifting in a ID/ED test 
ĻHQGXULQJ 
Rodefer et al. (2005) 
ĺ 
Fletcher et al. (2005); Deschenes et al. (2006) 
Associative learning in a fear conditioning test 
ĻHQGXULQJ 
 
Enomoto et al. (2005) 
Reversal learning in an operant test 
ĻHQGXULQJ 
 
Abdul-Monim et al. (2006a); Abdul-Monim et al. (2006b) 
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ĹĹĹHQKDQFLQJK\SHUDFWLYLW\ĻLPSDLUPHQWĺQRQ 
Table 1.2: Positive symptoms, negative symptoms and cognitive dysfunction in the PCP model animal (from Mouri et al., 2007) (continued).
Positive symptoms 
 
Negative symptoms 
 
Sensorimotor gating deficit 
 
Cognitive dysfunction 
 
Perinatal PCP treatment 
Locomotor activity 
ĹĹHQKDQFLQJ 
Wang et al. (2001) 
Depoortere et al. (2005) 
No data Prepulse inhibition 
ĻHQGXULng) 
Wang et al. (2001) 
Wang et al. (2003) 
Takahashi et al. (2006) 
Acquisition of delayed spatial alternation task 
ĻHQGXULQJ 
 
Wiley et al. (2003) 
Reference memory in a Morris water maze test 
ĻHQGXULQJ 
 
Sircar (2003) 
Andersen and Pouzet (2004) 
Working memory in a Morris water maze test 
ĻHQGXULQJ 
 
Andersen and Pouzet (2004) 
Recognition in social novelty discrimination 
ĻHQGXULQJ 
 
Depoortere et al. (2005) 
Harich et al. (2007) 
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Repeated PCP administration induces functional impairments in the 
HPC, amygdala, PFCand nucleus accumbens (Shirayama et al., 2007). 
Chronic PCP administration in rodents induces behavioural deficits 
(e.g. radial maze, reversal learning, attentional set-shifting) (Li et al., 
2003, Rodefer et al., 2005, McLean et al., 2009) that are selectively 
reversed by antipsychotic drugs, including memory tasks, (Bakshi et al., 
1994, Verma and Moghaddam, 1996, Schwabe et al., 2005, Turgeon 
and Hulick, 2007) such as object recognition (Hashimoto et al., 2005, 
Grayson et al., 2007, McLean et al., 2009). However, chronic PCP 
treatment in rodent has not been tested in tasks that simultaneously 
HYDOXDWH³ZKDW´³ZKHUH´³ZKHQ´DVSHFWVRIHSLVRGLFPHPRU\ 
 Below a table recapitulates rodent studies which used different 
regimens of subchronic PCP model in object recognition task (Table 
1.3). This table shows that the subchronic PCP treatment used in 
different studies do not change the result of the PCP-induced deficit in 
object recognition and that PCP induces a robust deficit in rodents 
(mice, female and male rats).  
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Table 1.3: Different model of subchronic PCP treatment in rodent and their impact in object recognition paradigm.  
','LVFULPLQDWLRQ,QGH[QRQHIIHFWĻLPSDLUHGĹLPSURYHG  
Rodent PCP Treatment Other Treatments Object recognition Results Conclusion References 
 
 
Mice 
Male 
 
 
S.C. 
10 mg/kg - 
10days 
 
(Day:1-5, 8-12) 
Other treatment: 
Day 15 
Donepezil cholinesterase inhibitor 
(i.p.): 
 1 or 0.1 mg/kg -14 days 
 
Physostigmine, Cholinesterase 
Inhibitor (i.p.): 
0.25 mg/kg -14 days 
 
NE-100, Sigma-1 receptor antagonist 
(i.p.): 
1 mg/kg -14 days 
3 days of  habituation 
 
Object recognition  
(5 min) 
 
A-B      24 h        A-A 
- 3&3Ļ 
 
- PCP +donepezil 0.1mg/kg:  
Ø 
-PCP +Physostigmine:  Ø 
 
- 3&3GRQHSH]LOPJNJĹ 
- PCP +donepezil 1 mg/kg + 
NE-100:   Ø 
Only DI 
 
Interaction 
between 
donepezil and 
sigma-1 receptors 
mechanism in 
cognitive deficit 
in schizophrenia 
 
 
(Kunitachi et 
al., 2009) 
 
 
Mice 
Male 
 
 
S.C. 
10 mg/kg - 
10days 
 
(Day:1-5, 8-12) 
Other treatment: 
Day 15 
Clozapine atypical antipsychotic (i.p.): 
 5  mg/kg -1h before test -acute 
5  mg/kg -14 days 
 
Haloperidol (i.p.): 
0.1  mg/kg -1h before test -acute 
0.1  mg/kg  -14 days 
 
3 days of  habituation 
 
Object recognition  
(5 min) 
 
A-B      24 h        A-A 
- 3&3Ļ 
 
- PCP +clozapine  
(acute): Ø 
-PCP +haloperidol 
(acute): Ø 
 
- PCP +clozapine (chronic): 
Ĺ 
- PCP +haloperidol 
(chronic): Ø 
 
Only DI 
 
Subchronic 
clozapine 
improved PCP-
induced deficit 
but not 
haloperidol nor 
acute clozapine  
 
(Hashimoto et 
al., 2005) 
 
Rat 
Female 
hooded-
lister 
I.P. 
2 mg/kg x2             
-7 days/7days out 
SCH-23390, D1-like receptor 
antagonist (i.p.) 
0.025 or 0.05 mg/kg 
 
SKF-38393, D1-like receptor agonist 
(i.p.): 
6 mg/kg 
3 days of  habituation 
(1 h) 
 
Object recognition  
(3 min) 
 
A-B      1 min        A-A 
 
- 3&3Ļ 
 
-3&36.)Ĺ 
- PCP +SCH 0.025:  Ø 
-PCP +SCH 0.025 or 0.05 
+SKF:  Ø 
 
DI and new vs old 
 
Role of D1-like 
receptor in 
cognitive deficit 
in schizophrenia 
 
(McLean et al., 
2009) 
  
3
9
|
 
 
 
 
 
Table 1.3: Different model of subchronic PCP treatment in rodent and their impact in object recognition paradigm (continued).  
DI: DiVFULPLQDWLRQ,QGH[QRQHIIHFWĻLPSDLUHGĹLPSURYHG 
Rodent PCP Treatment Other Treatments Object recognition Results Conclusion References 
Rat 
Female 
hooded-
lister 
I.P. 
2 mg/kg x2             
-7 days/7days out 
Haloperidol (i.p.): 
 0.05 or 0.075 mg/kg -30 min before task 
 
Clozapine (i.p.) a week later: 
1 or 5 mg/kg -30 min before task 
 
Risperidone (i.p.): 
0.05 or 0.1 or 0.2 mg/kg -30 min before 
task 
3 days of  habituation 
(1 h) 
 
Object recognition  
(3 min) 
 
A-B      1 min        A-A 
 
- 3&3Ļ 
 
-PCP +haloperidol:Ø 
- 3&3FOR]DSLQHĹ 
-PCP +risperidone only 
PJNJĹ 
  
DI and new vs old 
 
Clozapine and 
risperidone but not 
haloperidol reversed 
the deficit induced by 
subchronic PCP 
treatment 
 
(Grayson et al., 
2007) 
Rat 
Male 
Wistar 
han 
I.P. 
10 mg/kg 
-5 days/ 6days 
out 
PCP (acute) (i.p.): 
1 mg/kg -90 min before task (after 
sample) 
 
SSR103800 glycine transporter-1 
inhibitor (p.o.): 
3 mg/kg -90 min before  task (after 
sample) 
1  habituation  
 
Object recognition  
(Sample: 20sec on two 
objects or 5min total) Test: 3 
min 
 
A-B      90 min        A-A 
- 3&3Ļ 
 
-3&3665Ĺ 
 
DI and new vs old 
 
SSR103800 restored 
PCP deficit in object 
recognition 
 
(Boulay et al., 
2008) 
Rat 
Male 
Wistar 
han 
I.P. 
10 mg/kg 
-5 days/ 6days 
out 
PCP (acute) (i.p.): 
1 mg/kg -90 min before task (after 
sample) 
 
665Įnicotinic partial agonist 
(p.o.): 
3 mg/kg -90 min before  task (after 
sample) 
1  habituation (same day 
than test) 
 
Object recognition  
(Sample: 20 sec on two 
objects or 5 min total) Test: 
3 min 
 
A-B      90 min        A-A 
- 3&3Ļ 
 
-3&3665Ĺ 
 
DI and new vs old 
 
SSR180711improved 
PCP deficit in object 
recognition 
 
(Pichat et al., 
2006) 
Rat 
Male 
Sprague-
dawley 
I.P. 
5 mg/kg x2             
-7 days/7days out 
MKC-231 choline uptake enhancer  
(i.p.): 
3 mg/kg x2 -8 days (test day:9) 
 
Object recognition  
(15 min) 
 
A-B      24 h          A-A 
- 3&3Ļ 
 
- PCP +MKC-Ĺ 
  
Only DI 
 
PCP induced 
impairment which 
was antagonized by 
MKC-231 
 
(Shirayama et 
al., 2007) 
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In rats, PCP challenge after repeated PCP administration increase 
locomotor activity (LMA) (Xu and Domino, 1994, Johnson et al., 1998). 
7KLVVSHFLILFSKHQRPHQRQLVFDOOHG³UHYHUVHWROHUDQFH´RUVHQVLWL]DWLRQ
and it is correlated with apoptotic neuronal degeneration in different 
brain regions (Phillips et al., 2001). Increased locomotor activity 
induced by PCP is associated with dopamaniergic hyperactivity and is 
supposed to be related to clinical manifestations of schizophrenia 
(Steinpreis et al., 1994, Adams and Moghaddam, 1998). Dysfunctions 
in the dopaminergic and glutamatergic systems are the origin of 
behavioural sensitization due to neural adaptations in the 
mesocorticolimbic regions (Pierce and Kalivas, 1997, Cornish and 
Kalivas, 2001). Neural adaptations involve the nucleus accumbens 
which received dopaminergic projections from the VTA and 
glutamatergic excitatory inputs from the PFC (Cornish and Kalivas, 
2001, Kalivas et al., 2005). Furthermore, clozapine, an atypical 
antipsychotic, prevents apoptotic degeneration of cortical neurons and 
reduces locomotor sensitization after chronic PCP treatment (Johnson 
et al., 1998, Phillips et al., 2001).  
 
At the behavioural level, tasks currently used to assess episodic 
memory such as novel object recognition following PCP withdrawal 
may be limited for two reasons. First, PCP withdrawal induces object 
recognition deficits in rodents that are reversed by antipsychotic drugs 
(Hashimoto et al., 2005, Grayson et al., 2007). However, antipsychotic 
drugs appears to be ineffective at reversing memory impairments in 
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patients (Goldberg et al., 1993) representing what has been termed a 
µIDOVHSRVLWLYH¶(Young et al., 2009). Second, there is evidence that the 
brain circuitry that underpins performance in tasks that assess memory 
foU³ZKDW´ (which object is new?) may be different from that involved in 
WKHDELOLW\WRUHPHPEHU³ZKDW- where-ZKHQ´ (Eacott and Norman, 2004, 
Langston and Wood, 2009). In this thesis both isolation rearing and 
subchronic PCP or PCP withdrawal models are tested in an episodic 
memory task the object-place-context recognition task (OPC 
recognition task) developed by Eacott and Norman (Eacott and 
Norman, 2004). 
 The table below briefly recapitulates the construct, face and 
predictive validity of the disease for both models (Table 1.4). Both 
models have been shown to be relevant model in schizophrenia and 
are widely used in this area of research. The table shows that on some 
aspects both models show strong construct validity and are similar on 
the face and predictive validities, both models are impaired in object 
recognition (Bianchi et al., 2006, Grayson et al., 2007), reversal 
learning (Abdul-Monim et al., 2007, Li et al., 2007), show hyperactivity 
(Gentsch et al., 1982) and respond positively with clozapine on PPI 
(Bakshi et al., 1994, Cilia et al., 2001). 
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Animal Model 
 
Phencyclidine (PCP) 
 
Isolation Rearing 
Protocol Subchronic injection 
(5 mg/kg i.p.) twice a 
day during 7 days 
Followed by 7 days of 
wash out 
Postnatal day 24 
isolated in a cage 
experiments started 5 
weeks after 
 
 
Construct 
validity 
Glutamatergic 
hypothesis 
NMDA receptor 
antagonist 
Glutamatergic 
hypofunction in the 
PFC 
(Melendez et al., 
2004) 
Dopaminergic 
hypothesis 
Direct and indirect 
effect on 
dopaminergic system 
(Marsden, 2006) 
Elevated dopamine 
level in the nucleus 
accumbens 
(Heidbreder et al., 
2000) 
 
 
 
Face 
validity 
Positive 
Symptoms 
Locomotor 
sensitisation following 
acute administration 
of 3.2 mg/kg PCP 
(Chapter 6) 
Ĺ/RFRPRWRUDFWLYLW\ 
 
(Gentsch et al., 1982) 
Negative 
symptoms 
Ļ5HYHUVDOOHDUQLQJ 
(Abdul-Monim et al., 
2007) 
Ļ5HYHUVDOOHDUQLQJ 
(Li et al., 2007) 
Cognitive 
dysfunction 
Ļ2EMHFWUHFRJQLWLRQ 
(Grayson et al., 2007) 
Ļ2EMHFWUHFRJQLWLRQ 
(Bianchi et al., 2006) 
Predictive 
validity 
Clozapine Ĺ33, 
(Bakshi et al., 1994) 
Ĺ33, 
(Cilia et al., 2001) 
Table 1.4: Brief comparative table of the subchronic PCP and isolation rearing 
model relevant to schizophrenia in rats. 
 
1.3 Treatment of schizophrenia 
 
Antipsychotics have been classified into the typical (oldest group, such 
as haloperidol) and the atypicals (such as clozapine Figure 1.5) 
categories based on their affinity for dopaminergic receptors (Figure 1.6 
and Table 1.5) (Meltzer et al., 1989). Both classes of drug are acting on 
the dopaminergic system with more or less affinity toward D2 receptors 
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(Table 1.5) compared to the typical antipsychotics, the atypical 
antipsychotics target a wider range of receptors. They are both efficient 
to treat the positive symptoms. However, they are far from impressive 
to treat the negative and cognitive symptoms even if some 
improvement have been noticed in attention for example after clozapine  
(Meltzer and McGurk, 1999, Gopal and Variend, 2005). Atypical 
antipsychotics appear to be more efficient to treat cognitive deficits than 
typicals  (Meltzer and McGurk, 1999, Gopal and Variend, 2005). 
 
Figure 1.5 Clozapine nomenclature 8-chloro-11-(4-methyl-1-piperazinyl)-
5Hdibenzo(b,e)(1,4)diazepine. 
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Table 1.5: Pharmacological profile of dopamine receptors  
(From Missale et al., 1998). 
 
 1.3.1 Antipsychotics 
 
Chlorpromazine, the first typical antipsychotic, was developed in 1950 
(Brand et al., 1954). This drug was one of the biggest advances in 
psychiatric treatment.  It truly changed the prognosis of patients with 
psychosis worldwide. Other antipsychotics such as haloperidol or 
chlorprothixene followed. These three different compounds are three 
different types of antipsychotics which derivate from different 
molecules: haloperidol is a butyrophenone, chlorpromazine a 
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phenothiazine and chlorprothixene a thioxanthenes. While typical 
antipsychotics are efficient against the positive symptoms of 
schizophrenia (e.g. hallucination and delusion), they appears to have a 
poor impact on the negative and the cognitive symptoms (Meltzer and 
McGurk, 1999, Gopal and Variend, 2005). The efficacy of the typical 
antipsychotics like chlorpromazine or haloperidol is correlated to their 
D2 receptor antagonist effect to reduce or abolish psychotic disorder. 
One of the major side effects of antipsychotics is that in the long-term 
antipsychotics induce at least some symptoms resembling those of 
3DUNLQVRQ¶VGLVHDVHFDOOHG ³H[WUDS\UDPLGDO VLGHHIIHFWV´ VORZQHVV LQ
movement, lack of facial expression and general weakness due to their 
high affinity with D2 receptors (Bishnoi et al., 2007). The phenothiazine 
seems to have the best antipsychotic potency and antiemetic effect but 
also strong extrapyramidal side effects (Feinberg and Snyder, 1975). 
 
 1.3.2 Atypical antipsychotics 
 
On the other hand, atypical antipsychotics, like clozapine or 
risperidone, possess less dopamine D2 receptor affinity with high 
affinity for the dopamine D4 receptor compared to antipsychotics and 
target the nucleus accumbens rather the neostriatum locus responsible 
IRU ³H[WUD S\UDPLGDO HIIHFW´ LQ 3DUNLQVRQ¶V GLVHDVH (Marsden, 2006). 
Another particular effect of these medications is their multiple 
antagonist effect on different subtypes of adrenergic, cholinergic, 
histaminergic and serotonergic receptors (Figure 1.6) (Millan, 2000, Ma 
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et al., 2006). The rich pharmacological profile of the atypical 
antipsychotics allows a reduction of positive symptoms with less extra 
pyramidal side effects compare to typical antipsychotics (Tandon and 
Jibson, 2002). In clinical trials, they also improve negative symptoms 
and cognitive function more than typical antipsychotics (Lublin et al., 
2005) but without successfully treating them (Marsden, 2006). As major 
side effects, Clozapine produces hypersalivation, weight gain, sedation, 
tachycardia and more dangerously can induce agranulocytosis and 
bone marrow toxicity (Buchanan, 1995, Pereira and Dean, 2006). 
Therefore, it is carefully used and is generally prescribed to patients 
who cannot tolerate typical antipsychotic drugs or non responders 
(Feldman et al., 1997). 
 
Figure 1.6: Radar representations of the binding profile of clozapine compared 
with haloperidol at multiple dopaminergic and serotonergic receptors. All data 
ZHUH JHQHUDWHG LQ WKH DXWKRU¶V ODERUDWRU\ DW FORQHG KXPDQ K UHFHSWRUV
cloned rat (r) (5-HT6 and 5-HT7), and cloned mouse (m) (5-HT3) receptors. Note 
the broad-EDVHG DQG ³HTXLOLEUDWHG´ LQWHUDFWLRQ RI FOR]DSLQH DW GLYHUVH
dopaminergic and serotonergic sites, whereas haloperidol shows pronounced 
affinity for hD2 (hD3 and hD4) receptors versus modest or weak affinity at other 
sites (From Milan, 2000). 
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In rodents, clozapine appears to be more efficient than typical 
antipsychotics in behavioural tasks which were correlated to the 
negative and cognitive symptom deficits of schizophrenia in animals. 
Indeed, clozapine reversed the chronic PCP deficit in conditional 
discrimination performance, reversal-learning, and object recognition 
whereas haloperidol did not (Abdul-Monim et al., 2006, Dunn and 
Killcross, 2006, Grayson et al., 2007). However, these results do not 
truly reflect the current clinical profile as both categories of 
antipsychotics have a minor effect on negative and cognitive symptoms 
such as episodic memory deficit (Lublin et al., 2005, Mortimer, 2005, 
Marsden, 2006, Young et al., 2009) even if clozapine appears to have 
some beneficial effects on some aspects (Meltzer, 1994, Meltzer and 
McGurk, 1999). One impediment to the identification and evaluation of 
potential new drug treatments is the lack of reliable animal models 
specifically designed to simulate cognitive impairment in schizophrenia. 
This has been identified by recent research consortia e.g. 
Measurement and Treatment Research to Improve Cognition in 
Schizophrenia" (MATRICS) (Sarter, 2006, Young et al., 2009). The 
MATRICS program brings together representatives of academia, 
industry and government in a consensus process for addressing the 
improvement of available antipsychotic medication to treat cognitive 
impairment in schizophrenia.  
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1.4. Cognitive enhancers 
 
1.4.1 Cholinergic system 
 
The central cholinergic pathways which project to the cerebral cortex 
regulate various general functions which include motivation, attention, 
arousal, memory and consciousness (Woolf, 1991, 1996). 
Acetylcholine is one of the key chemical messengers in brain and is 
found in high concentrations in cortex and HPC (Jung et al., 1996). The 
majority of cholinergic neurons in the basal forebrain are distributed 
among three different nuclei: the medial septum (MS), the nucleus 
Basalis of Meynert (nBM) and the diagonal band of Broca (dBB) 
(Mesulam et al., 1983).  Projections of these nuclei innervate the 
cerebral cortex, as well as the HPC and amygdala (Mesulam et al., 
1983). The cholinergic and other excitatory inputs modulate the 
excitatory state of HPC and cortical neurons and are involved in cortical 
plasticity (Semba, 2000) (Figure 1.7). 
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Figure 1.7: The central projections of cholinergic cells are schematically 
represented on a parassagital section from rat brain. The entire cortical mantle 
is innervated by the basal forebrain subsystem and the subcortical mass is 
innervated by the pontomesencephale subsystem (From Woolf, 1991). 
 
Acetylcholine receptors are classified into two categories depending on 
their affinity for nicotine and muscarine. There are the nicotinic 
acetylcholine receptors (nACh receptors) and the muscarinic 
acetylcholine receptors (mACh receptors), the first type is ionotropic 
and the second type is metabotropic.  The nACh receptors are 
classified according to their distribution in muscles or in the brain 
(neuronal types) (Deneris et al., 1991). The neuronal nACh receptors 
VXEW\SHVDUHDFRPELQDWLRQRIGLIIHUHQWVVXEXQLWVĮWRĮDQGȕ
WRȕIn schizophrenic patient the mRNA level of ĮDQGĮUHFHSWRUV
are significantly lower than in healthy population (Perl et al., 2003). The 
mACh receptors belong to the superfamily of G-protein-coupled 
receptors. There are five identified mACh receptors: M1, M2, M3, M4 
and M5 which are classified by their relation with the G protein types 
they are linked to (Van der Zee and Luiten, 1999). 
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1.4.1.1 Donepezil 
 
The cholinergic system has been implicated in the regulation of 
attention, memory, processing speed and sensory gating processes 
(Cummings, 2000). ,Q $O]KHLPHU¶V GLVHDVH DFHW\OFKROLQHVWHUDVH
inhibitors (AChEi) such as galantamine or donepezil (Figure 1.8) 
improve cognitive deficit induced by the disease (Bullock and Dengiz, 
2005, Tsuno, 2009). 
 
Figure 1.8: Donepezil nomenclature, 2-[(1-Benzyl-4-piperidyl)methyl]-5,6-
dimethoxy-2,3-dihydroinden-1-one, C24 H29 N O3. 
 
In schizophrenia, anomalies in the cholinergic pathway have been 
reported such as lower numbers of muscarinic (Crook et al., 2001) and 
nicotinic receptors (Freedman et al., 1995) in the PFC and HPC 
(Raedler et al., 2006). Post mortem studies demonstrate the link 
between the alterations of Ach receptors subtypes such as muscarinic 
M1/M4 and nicotinic receptors and cognitive impairment observed in 
schizophrenia (Friedman et al., 2002).  Indeed, there is a decrease in 
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low affinity of nAch receptors in HPC, cortex, striatum and thalamus 
(Friedman, 2004) but also a reduction of M1/M4 mACh receptors in the 
HPC, PFC and striatum (Cummings, 2000, Crook et al., 2001). 
Furthermore, a significant correlation has been found between impaired 
cognition in schizophrenia and the reduced level of choline 
acetyltransferase which is implicated in acetylcholine synthesis. 
(Powchik et al.,1998). In SPECT studies in living unmedicated 
schizophrenic patients, it has been shown that there are fewer mACh 
receptors in frontal, temporal and occipital cortex and in the striatum 
and thalamus compared to control group (Raedler et al., 2003). 
 
Based on these results, donepezil and other acetylcholinesterase 
inhibitors AChEIs (Table 1.6) have been tested in initial clinical trials in 
schizophrenia. Controversial results has been published with some 
studies suggesting beneficial improvement in cognition (Howard et al., 
2002, Buchanan et al., 2003, Risch et al., 2007, Chung et al., 2009) 
while others did not )ULHGPDQHWDO7X÷DO2HWDO.HHIH
et al., 2007). 
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Target Action Drug 
 
Aceylcholinesterase 
Inhibition of 
acetylcholinesterase resulting 
in non-specific increase in 
synaptic acetylcholine at 
nicotinic and muscarinic 
recpetors 
Tacrin, donepezil, 
rivastigmine, 
galantamine 
Muscarinic receptor M1 agonist Xanomaline, CDD-
0102, CI 1017, YM 796 
Nicotinic receptor Nicotinic receptor agonist 
Nicotinic receptor potentiator 
GTS-21 
Galantamine 
Table 1.6: Potential cholinergic compounds for cognitive enhancement in 
schizophrenia (From Friedman, 2004). 
 
In rodent models donepezil reverses  scopolamine-induced deficits in 
different memory tasks  such as spontaneous alternation in the Y-
maze, delayed non-match to place in radial maze, passive avoidance 
task and object recognition which assess working and spatial memories 
(Ogura et al., 2000 , Bontempi et al., 2003, Sambeth et al., 2007). 
Donepezil also improve aged rats performance in the water maze 
(Hernandez et al., 2006). However, few studies have investigated the 
cognitive effect of donepezil relevant to schizophrenia in rodents. 
Donepezil reverses the MK-801 and PCP-induced deficits in spatial 
reversal learning, contextual and cued memory, and one-trial object 
recognition (Csernansky et al., 2005, Kunitachi et al., 2009). In middle-
aged mice, Béracochéa (2007) demonstrated that donepezil given 
alone improves contextual memory (Béracochéa et al., 2007). 
Furthermore human studies have also revealed episodic memory 
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improvement after donepezil administration in healthy young adult 
(Grön et al., 2005).  
 
1.5 Cognitive impairment in schizophrenia 
 
1.5.1 Generality 
 
As reported E\ D UHFHQW UHVHDUFK FRQVRUWLXP ³0$75,&6´ cognitive 
deficits in schizophrenia include wide impairments in areas such as 
attention, executive function and memory (Green et al., 2004). They are 
good predictors of long±term disability of the disease. Unfortunately, 
there is currently no appropriate medication to treat the cognitive 
deficits, but some areas of research such as acetylcholinesterase 
inhibitors,(Erickson et al., 2005, Grön et al., 2005, Chung et al., 2009). 
Attention and executive function have been shown to be impaired in 
schizophrenia (Brazo et al., 2005). There are three categories of 
attentional deficits: sustained, selective attention and shift attention 
(Hagh-Shenas et al., 2002). Diverse studies show attentional deficit in 
schizophrenia in selective attention in auditory task (Hagh-Shenas et 
al., 2002, Mulet et al., 2007), spatial selective attention, in sustained 
attention (Mulet et al., 2007). In rats different task are used to measure 
attentional deficit and respond to dopamine agonists such as latent 
inhibition (Bay-Richter et al., 2009)or overshadowing (O'Tuathaigh and 
Moran, 2004).  
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 This thesis is focusing on the memory deficit observed in 
schizophrenia with particular attention on episodic memory deficits 
(Clare et al., 1993, Gold and Weinberger, 1995, Rushe et al., 1999, 
Danion et al., 2001, Achim and Lepage, 2003, Riutort et al., 2003, 
Toulopoulou et al., 2003, Al-Uzri et al., 2006). 
 
1.5.2 Memory 
 
For a long time, psychologists and philosophers have thought that 
memory was not one single entity. For example, Maine de Biran in 
1804, made the differentiation between mechanical memory, sensitive 
memory, and representative memory. In 1948, Tolman wrote at length 
on the proposition that there is more than one kind of memory (Tolman, 
1948, Squire, 1992). 
 In the middle of the 20th century, the exploration of memory in 
patients with brain injury or disease that affects mental function showed 
that the multiple memory systems have their own localization in brain. 
Studies on brain lesions in monkeys and human patients have divided 
memory into two principal categories: the implicit or nondeclarative 
memory, characterised by knowledge of motor skills and habits, and 
explicit or declarative memory defins as knowledge of fact and events 
(Squire, 1992, Milner et al., 1998) (Figure 1.9). 
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Figure 1.9: A memory taxonomy. (Declarative memory includes memory for 
facts and events and depends on the integrity of the HPC and related 
structures. Nondeclarative memory refers to a heterogeneous collection of 
distinct learning and memory abilities where performance changes but without 
affording access to the experience or experiences that caused the change 
(From Squire, 1992). 
 
1.5.2.1 Distinction between memories: explicit memory 
 
Explicit memory involves a specialized anatomical system in the medial 
temporal lobe, and particularly the HPC. This hypothesis comes mainly 
from three sources: human studies, brain lesions in primates and in 
studies amnesia and memory impairment in rats (Squire, 1992). 
 Brenda Milner (1998) described patient H.M. who had sustained 
a bilateral resection of the medial structures of the temporal lobe 
including HPC. H.M. had a very profound impairment of recent memory 
without other intellectual loss; this defends the hypothesis of the 
essential role of the HPC in the learning of new facts and events 
(Milner et al., 1998). 
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 Using a monkey model of human amnesia has confirmed this 
idea. A medial temporal lobe lesion in monkeys, including the HPC, 
produces deficits in tasks which require the utilisation of explicit 
memory like delayed nonmatching to sample (DNMS), a task that 
directly assessed responses related to object repetition (Squire, 1992). 
 In rodents, HPC lesion causes impairment of tasks which are 
used to explore explicit memory like water maze or radial maze (Morris 
et al., 1982, Kesner et al., 1993). Contextual information was shown to 
be impaired after HPC lesion in contextual fear conditioning (Kim et al., 
1993, Young et al., 1994, Maren and Fanselow, 1997). Furthermore, 
other studies seem to confirm the role of HPC for episodic memory in 
tasks that involved object, places and context recognition paradigm 
(two samples phase) (Eacott and Norman, 2004, Kart-Teke et al., 2006, 
Good et al., 2007a). However, in the one trial object recognition test 
(one sample phase) results are contradictory: some did not find any 
impairment (Aggleton and Brown, 1999, Mumby et al., 2002) while 
other did (Clark et al., 2001) (Table 1.6). 
 
Table 1.6: Effects of Lesions of the Hippocampal System or the Amygdala on 
Memory Tasks in the Rats (From Squire, 1992). 
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1.6. Episodic memory 
 
1.6.1 Definition 
 
In 1972, Endel Tulving defined explicit memory as having two different 
aspects, semantic memory and episodic memory (Tulving, 1972, 
Tulving, 1986). 
 According to Tulving¶V definition, episodic memory is the 
capacity to recollect an event in time and location. It refers to critical the 
WULDG ³:KDW-Where-:KHQ´ EXW ZLWK WKH FDSDFLW\ WR VHH RQHVHOI DV DQ
actor of the action (Tulving, 1972, Tulving, 1983, Tulving, 1985, 2002). 
For example, you can remember where you were, when you heard the 
news about the 11 September of 2001. Furthermore, just the evocation 
of this date (when) is a key memory of this particular event and helps 
you to recollect it: what (attack in New-York) and where (you heard the 
information). People see themselves in the situation: they are reliving it. 
Thus, episodic memory is the capacity to mentally travel in time which 
LV FDOOHG ³PHQWDO WLPH WUDYHO´ (Tulving, 1985). Mental time travel 
requires a notion of the concept of self. The person who mentally time 
travels is fully conscious of himself as an actor in a past situation and 
therefore is defined as autonoetic awareness. Autonoetic awareness is 
required for remembering (Tulving, 1985, Suddendorf and Corballis, 
1997). By contrast the semantic memory refers to the noetic awareness 
which characterised our ability to be aware about our environment 
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without any remembering but by knowing it based on familiarity. 
Semantic memory is the memory of facts and knowledge. These two 
states of awareness are interconnected and dependent from each other 
(Table 1.7) (Tulving, 1985). While, episodic memory is PFC and 
temporal lobe dependent (Vargha-Khadem et al., 1997, Tulving and 
Markowitsch, 1998), semantic memory belongs to a wider set of 
neocortical area which included frontal, temporal and occipital cortices. 
 However, when people are asked to recognise previously encountered 
LWHPVEDVHGRQ³UHPHPEHU´RU³NQRZ´MXGJPHQWVUHVXOWVGHPRQVWUDte 
that both judgments were not based on a degree of confidence and 
support the dissociation between two forms of recognition: one based 
on familiarity and one based on remembering (Rajaram, 1993). 
Therefore, people can have access to their personal past in terms of 
both autonoetic awareness (remembering) and in terms of noetic 
awareness too (knowing). 
 
Table 1.7: A schematic diagram of the relations between memory systems and 
varieties of consciousness (From Tulving, 1985). 
   59 | 
 
 
In order to understand better the origin of episodic memory, it is 
important to anatomically identify the brain region involved. Episodic 
memory reveals a large and complex interaction which involving the 
temporal lobe (perirhinal cortex, entorhinal cortex, postrhinal cortex and 
HPC) and the PFC. 
 
1.6.2 Brain structures involved in episodic memory 
 
1.6.2.1 Temporal lobe 
 
The perirhinal cortex seems to have a role in object familiarity or 
³NQRZLQJ´DQGLVimportant in object recognition performance but not to 
discriminate between context such as in the object-in-context task 
(Norman and Eacott, 2005). Furthermore perirhinal neurons respond 
maximally in the first presentation of visual stimuli, but less to the 
second presentaWLRQ³ZKDW´7KHLQWHJUDWLRQRIWKHREMHFWLQFRQWH[WLV
postrhinal cortex (or parahipocampal cortex in mammal) dependent 
(Aggleton and Brown, 1999). Indeed, c-Fos studies have found 
postrhinal cortex activation in spatial task which is not the case for 
perirhinal cortex. Postrhinal lesion in rats impairs the encoding of 
egocentric spatial relations between objects, but not the object 
perception itself (Norman and Eacott, 2005). 
 Network information encoded in perirhinal/postrhinal cortex is 
directly linked to entorhinal cortex which is responsible for a mental 
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PDS LQDVSDWLDOHQYLURQPHQW ³ZKHUH´7KHSUHVHQFHRI ³JULGFHOO´ LQ
this cortex is responsible for spatial representation. It is shown that 
entorhinal cortex receives many inputs from every sensory modality 
such as the eye and ears while damage to this area lead to a sensory 
integration deficit and spatial learning impairment (Hafting et al., 2005).  
 Furthermore entorhinal cortex possesses a main input in HPC, where 
the information is treated +3& E\ WKH LQWHUPHGLDWH RI ³SODFH FHOO´
allows a perfect orientation in space. This activity combines with the 
³HQFRGLQJ PDS´ and is responsible for spatial contextual recognition 
and allows free movement into a specific context toward a position 
(Davis et al., 2001, Hafting et al., 2005, Smith and Mizumori, 2006).  
All the information of OPC is carried to other brain structures via 
the fornix from the HPC. The Fornix is involved in combination of 
object, place and context rather than any of these elements alone or in 
pairs. Indeed, fornix or HPC lesion induces memory impairment only in 
OPC recognition task but not in object or/and place or/and context 
recognition task (Eacott and Norman, 2004, Norman and Eacott, 2005, 
Dere et al., 2007, Langston and Wood, 2009, Ergorul and Eichenbaum, 
2004).  
 
1.6.2.2 Prefrontal Cortex 
 
7KH WHPSRUDO UHODWLRQ RI DQ HYHQW ³ZKHQ´ LV UHODWHG WR WKH 3)&
Indeed, the PFC and more specifically the mPFC  have been reported 
to play an important role in recency discriminations for objects or their 
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spatial locations in time (Wheeler et al., 1997, Barker et al., 2007). 
These findings were confirmed with lesion of mPFC in humans, non-
human primates and rodents which were impaired in relative recency 
stimuli discriminations but not in recognition of novel and familiar stimuli 
(Dere et al., 2006).  
 
Neural systems are interconnected, the rhinal cortex (perirhinal, 
postrhinal and entorhinal cortex) is connected to the HPC and via the 
fornix connect to the PFC, itself also connected to the rhinal cortex. 
This hippocampal cortical loop, is directly involved in episodic memory 
(Bachevalier et al., 1997, Aggleton and Brown, 1999, Gurden et al., 
2000) (Figure 1.10).  
 
Neurobiological studies confirm the link between temporal cortex and 
PFC. In vivo in rats, infusion of the dopamine D1 receptor agonist 
(SKF81297) or D1 receptor antagonist (SCH23390) in PFC, produces 
respectively an excitatory or inhibitory effect on hippocampal and PFC 
long term potentiation (LTP) (Gurden et al., 2000). These data 
combined with the cortical dopaminergic hypoactivity and glutamatergic 
hypofunction could highlight the episodic memory deficit in 
schizophrenia (Figure 1.10). 
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Figure 1.10: Episodic memory process and relationship to glutamatergic and 
dopaminergic hypoactivity in prefrontal cortex. 
 
1.7 Episodic memory deficit in schizophrenia 
 
People with schizophrenia have shown impairments in episodic 
memory in a variety of tasks (e.g. Rivermead Behavioural Memory Test 
(RBMT), The Autobiographical Memory Inventory (Kunitachi et al.) or 
Remember/Know paradigm) (Clare et al., 1993, Gold and Weinberger, 
1995, Rushe et al., 1999, Danion et al., 2001, Achim and Lepage, 
2003, Riutort et al., 2003, Toulopoulou et al., 2003, Al-Uzri et al., 2006). 
There is some evidence for dissociable impairments in autonoetic and 
noetic awareness. Indeed, schizophrenic people are impaired in 
autonoetic awareness (remembering) but not in noetic awareness 
(knowing) (Wheeler et al., 1997, Danion et al., 1999, Keefe et al., 2002, 
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Riutort et al., 2003, Sonntag et al., 2003, Neumann et al., 2006). 
Schizophrenic patients appear to not be able to link different elements 
of an event into a cohesive and memorable whole (Danion et al., 1999).  
 Some studies using ketamine in humans (Hetem et al., 2000, Honey et 
al., 2005) have shown episodic memory deficit and they were able to 
distinguish between the two states of awarenesses. In the literature it is 
well established that NMDA receptor antagonist such as PCP or 
ketamine exacerbates and mimics schizophrenic-like symptoms in 
schizophrenic people and healthy volunteers (Luby et al., 1959, Javitt 
and Zukin, 1991, Krystal et al., 1994, Lahti et al., 1995, Jentsch and 
Roth, 1999, Curran and Morgan, 2000, Hetem et al., 2000, Javitt, 
2007). NMDA antagonist receptor disrupts memory in human (Ghoneim 
et al., 1985, Krystal et al., 1994, Malhotra et al., 1996, Curran and 
Morgan, 2000, Hetem et al., 2000, Morgan and Curran, 2006, Javitt, 
2007, Chrobak et al., 2008) without any difference between tasks:  
including recognition tasks (Ghoneim et al., 1985, Hetem et al., 2000, 
Honey et al., 2005); recall of passages of prose (Newcomer et al., 
1999); recall of high and low-frequency word lists (Ghoneim et al., 
1985, Malhotra et al., 1996, Hetem et al., 2000) and source memory 
tasks (Honey et al., 2003, Morgan et al., 2003).They also established 
that ketamine impairs encoding (i.e. capacity to encode the memory) 
but not the retrieval (i.e. capacity to recall the information into memory) 
part of memory (Hetem et al., 2000, Honey et al., 2005). Few studies 
investigated the effect of ketamine on conscious awareness in healthy 
volunteers (Hetem et al., 2000, Honey et al., 2005). Both studies 
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demonstrate an overall impairment of episodic memory but with some 
difference in how ketamine impairs the two awarenesses.  Hetem 
(Hetem et al., 2000) established that ketamine does not selectively 
impair the two awarenesses as it is typically seen in patients with 
schizophrenia and it induces an overall deficit in episodic memory. 
Honey (Honey et al., 2005) suggests that ketamine only impaired the 
remembering but not the knowing part of the memory and that under 
ketamine participants had a tendency to guess source judgements. 
Both studies are contradictory and therefore, it is not clear what the 
effects of NMDAR antagonist are on both types of awarenesses. 
 
Episodic memory impairment is of particular importance in 
schizophrenia as it is more closely associated with poor outcome than 
other symptoms in the disease such as hallucinations or delusions 
(Herlitz and Forsell, 1996, Green et al., 2004, Lepage et al., 2007, 
Berenbaum et al., 2008). Episodic memory impairment is also generally 
accompanied by other cognitive dysfunctions such as working memory, 
attention and executive functions (Mohamed et al., 1999, Nestor et al., 
2007). Therefore, episodic memory is a key cognitive deficit in 
schizophrenia and as previously mentioned there is currently no 
treatment.  
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1.8 Episodic memory paradigms  
 
1.8.1 Measuring episodic memory in humans 
 
Different tasks are used to assess episodic memory. It is possible to 
distinguish three types of test: one which assesses every day situations 
such as the Rivermead Behavioural Memory Test (RBMT), one which 
asses the general form of autonoetic awareness by asking the subject 
to remember specific events from their life such as The 
Autobiographical Memory Inventory (AMI), and one which discriminates 
the two forms of awareness based on remember and know paradigm 
such as the Remember/Know procedure. 
 
The RBMT is used to asses every day memory by assessing every 
days situations that could be troublesome for people with different 
memory impairments. The task was firstly designed by Wilson  (Wilson 
et al., 1985). Since now three different updates were made 
successively in 1999 with the RBMT-E, in 2003 with the RBMT-2 and 
now with the RBMT-3. Every update was created to restrict the memory 
deficit that could be assess but also to simplify and standardise the 
test. The task is based on 12 questions (14 for the RBMT-3) such as 
picture recognition, route: delayed or immediate recall, appointments: 
delayed recall and the score varies from 0 to 24 with 24 excellent 
memories and 0 no memory. People with schizophrenia have been 
shown to be impaired in this task in a numbered of studies (Cloud et al., 
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1994, Doody et al., 1997, Al-Uzri et al., 2006). One criticism of the task 
it is not specific for episodic memory as it also addresses items that 
assess working or spatial memory (e.g. picture recognition). 
 
The AMI is generally used to assess the ability or inability to remember 
information that preceds the onset of an illness or an accident. In 
schizophrenia, the task is an adaptation of Borrini (Borrini et al., 1989) 
version which was used to assess autobiographical memory in patients 
with Alzheimer's disease. The adaptation uses specific 
autobiographical questions which are more appropriate for the young 
schizophrenic population (e.g. question about retirement or work were 
changed). Typically people are asked to quote many personal events 
and name of friends of five different periods of their life in a short period 
of time (the preschool period; the period from ages 5 to 10; the period 
from age 11 to the onset of symptoms; the period from onset to 1 year 
before testing; and the current year). Respectively the score measures 
the episodic and semantic memory of the subject (Riutort et al., 2003). 
The AMI is generally modified through studies but generally assesses 
the same kinds of autobiographical questions. This type of task clearly 
reveals that Schizophrenic people are impaired in their capacity to 
remember events that occured in their past (Feinstein et al., 1998, 
Elvevag et al., 2003, Riutort et al., 2003, Piolino et al., 2009). 
Interestingly, schizophrenic people tend to report over general 
memories instead of specific, or events  that last more than a day (e.g. 
during the week end) (Riutort et al., 2003, Harrison and Fowler, 2004). 
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Furthermore, they remember more pleasant than negative 
autobiographical memories or pictures, which is the opposite pattern of 
control group (Neumann et al., 2006). 
 
The Remember/Know (R/K) paradigm is based on the capacity to 
remember or know if an item or word was paired with another item or 
object or belongs to a specific list in where it appears. A remember 
response is reflecting the capacity to be aware that an item or word has 
been encountered. A know answer is based on familiarity with the item 
or the object. In order to dissociate familiarity from guessing, a guess 
response is often introduced (Gardiner, 1988, Hetem et al., 2000, 
Sonntag et al., 2003, Honey et al., 2005). Previous studies showed that 
subjects used the know response when they were in fact guessing 
(Gardiner et al., 1997). The R/K paradigm is assumed to dissociate 
episodic memory (R) from semantic memory (K). This paradigm can 
also be analysed by Receiver Operating Curve (ROC) which shows 
dissociation between knowing and remembering (Yonelinas, 1994; 
Yonelinas, 1997; Heathcote et al., 2006) (Figure 1.11). A ROC is a 
function that associates the rate of correct answers (Y axis) and the 
rates of incorrect answers (X axis). It shows the trade-off between the 
two rates, the diagonal is the chance performance and how a curve is 
above it reflects more hit (correct answers) than false alarms (incorrect 
answers).   
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Figure 1.11: ROCs for recognition performance of humans in verbal recognition 
(adapted from Yonelinas et al., 1997) (Fortin et al., 2004). On the X axis it is the 
number of hits (correct answers) and on the Y axis it is the number of false 
alarms. ROC curve distinguishes between familiarity and remembering (From 
Fortin et al., 2004). 
 
 
1.8.2 Measuring episodic memory in animals 
 
Until quite recently it was considered that animals did not exhibit 
episodic memory in a similar way to humans, as it was believed to be 
intrinsically associated with language and its development (Mitchell, 
1993, Suddendorf and Corballis, 1997), in particular mental time travel 
aspects were thought to be particularly problematic in animals  with 
several suggestions that animals do not have the notion of time 
(Roberts, 2002, Zentall, 2006). Nowadays,  this idea has been 
challenged and with increasing behavioural sophistication of testing 
techniques it is clear that animals including rodents can encode events 
ZLWK VSHFLILF ³ZKDW´ ³ZKHQ´´ZKHUH´ FRPSRQHQWV (Clayton and 
Dickinson, 1998, Aggleton and Pearce, 2001, Roberts, 2002, Eacott 
and Norman, 2004, Babb and Crystal, 2006, Dere et al., 2006, Kart-
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Teke et al., 2006, Zentall, 2006, Eacott and Easton, 2007, Good et al., 
2007b, Pillay et al., 2008). 
 
Clayton (Clayton and Dickinson, 1998) was the first to report evidence 
of episodic-like memory in the food storing bird, the scrub jay. She 
demonstrates that scrub jays are able to remember where and when 
the storage of different types of food took place. This finding is 
GHVFULEHG DV ³HSLVRGLF-OLNH´ EHFDXVH WKH TXHVWLRQ RI DZDUHQHVV RU
autonoetic consciousness cannot be addressed (Clayton and 
Dickinson, 1998). This discovery is the trigger of other experiments 
which have been revealed conclusive in animal capacity to integrate 
WKH ³:KDW´ ³ZKHUH´ DQG ³ZKHQ´ FRPSRQHQW RI HSLVRGLF PHPRU\ DV
defined by Tulving (Tulving, 1983). Below there is a recapitulation of 
some studies which suggest episodic-like memory in animals (Table 
1.8). For example, rats show the same capacity to remember what food 
they encountered (chocolate or pellets), in which arms (where) and 
when (delays between sample and test phase) (Babb and Crystal, 
2006) 2WKHU VWXGLHV GHPRQVWUDWH URGHQW¶V FDSDFLW\ WR GLVFULPLQDWH D
new object in time (or context) and place (Eacott and Norman, 2004, 
Dere et al., 2006, Kart-Teke et al., 2006) which is based on the object 
recognition paradigm which stipulates that rodents explore more a new 
object compared to a familiar one (Ennaceur and Delacour, 1988). 
These tasks are discussed in detail in the next section, and especially 
the OPC recognition task developed by Eacott and Norman (2004) 
which is used in the entire thesis. 
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Table 1.85HFHQWVWXGLHVVXJJHVWLQJNQRZOHGJHRIGLIIHUHQW³Z´LQIRUPDWLRQLQ
YDULRXV VSHFLHV WKDW IRUP SDUW RI ³HSLVRGLF-OLNH´ PHPRU\ From Suddendorf 
and Corballis, 2007). 
 
1.9 The Object-Place-Context recognition task as a 
model of episodic memory in rodent? 
 
Many studies demonstrate a rat¶V preference for items it sees which is 
dependent on what it saw, where it saw it and when it saw it in a time 
dependent manner (delay) (Dere et al., 2005a, Dere et al., 2005b, Kart-
Teke et al., 2006, Good et al., 2007b). Eacott and Norman (2004) have 
shown that rats can remember what they saw and where depending on 
which past situation (context) they are being asked to remember. 
These stuGLHVH[SORLWD UDW¶V WHQGHQF\ WRH[SORUHDQRYHOREMHFWPRUH
than a familiar one. This tendency was first observed by Berlyne in 
1950 (Berlyne, 1950) and then developed by Ennaceur (Ennaceur and 
Delacour, 1988) as the novel object recognition task (NOR). This task 
does not involve any food reinforcement which avoids confounding 
affects on palatability and does not involve any specific motivation for 
the rodent. Furthermore, it is relatively easy to set up (Ennaceur and 
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Delacour, 1988). This paradigm is widely used and has different 
variants such as the object in place recognition, the place recognition, 
context recognition or temporal recognition (Table 1.9). This task can 
be used to discriminate the effect of drugs in the acquisition (before 
sample phase) or retention phase (after sample phase) which can last 
up to 24 hours (Dere et al., 2005a). Lesion studies performed in the 
NOR task allowed the research to investigate the role of different 
subcortical (such as the entorhinal, postrhinal, HPC and perirhinal) or 
cortical (such as the PFC) unit into recognition (See Figure 1.10). 
 
  
7
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Table 1.9:  The different object paradigms based on UDW¶VWHQGHQF\WRH[SORUHDnovelty compared to familiarity
Novelty preference 
paradigm 
Protocol What does it 
test? 
 
Type of memory tested 
 
 
Object recognition 
 
 
Object (What?) 
 
Working memory.  
Animals explore more the new object 
compared to the old one. 
 
Object in place 
recognition 
 
 
Object (What?) 
 
Place (Where?) 
 
Working memory. 
Animals explore more the object in a new 
place but based on the novelty effect of the 
object and place combination. 
 
 
 
Place recognition 
 
 
 
Place (Where?) 
 
 
Spatial memory. 
Animals explore more the object in the new 
place compared to the old place. 
 
 
Context recognition 
 
 
 
Object (What?) 
 
Context (When-
Which?) 
 
Context discrimination. 
Animals explore more the object not seen in 
the previously visited context. 
 
 
Temporal recognition 
 
 
 
Object (What?) 
 
Recency (When?) 
 
Temporal memory recency versus primacy. 
 Animals explore more the object primarily 
seen compared to the object recently seen. 
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Compared to others episodic memory task previously used (Table 
1.10), in the OPC recognition, the temporal (delay) information is 
secondary compared to the context in which rats first saw the objects. 
7KH FRQWH[W E\ LWVHOI DFWV DV DQ ³RFFDVLRQ VSHFLILHU´ DQG LV XVHG WR
discriminate between the two events (context 1 versus context 2). 
Similarly than in human, rats use contextual information, which is time 
related, to differentiate events that have occurred in the past (Smith et 
al., 2008). Indeed, based on the snapshot idea, episodic memory is an 
integration of cues (temporal or non-temporal cues) that will allow us to 
remember the past by reliving it: we are re-OLYLQJD³VSHFLILFRFFDVLRQ´
as a snapshot (Easton et al., 2008). In order to distinguish similar 
events between each other, the context specificity of the event will be 
used to differentiate them, such as for example:  the day you met this 
specific person for the first time at this conference, you have to 
remember at which conference you met them from amongst all of the 
conferences you have been to. Therefore, the contextual cues of that 
unique moment (such as conference location, where at the 
FRQIHUHQFH«ZLOO EH WKH NH\ WR UHPHPEHU WKH HYHQW DQG to relive it.  
Based on that Eacott and Norman (Eacott and Norman, 2004, Eacott 
and Easton, 2007, Easton et al., 2008) propose to redefine episodic 
memory as the recollection of an event in location depending on a 
VSHFLILF RFFDVLRQ  VXFK DV ³ZKDW´-³ZKHUH´-³ZKLFK´ DV ZKLFK WKH
occasion or the scene memory define by the context. Therefore, the 
context (which) may be temporal (Clayton and Dickinson, 1998, Dix 
and Aggleton, 1999, Dere et al., 2005a, Dere et al., 2005b, Babb and 
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Crystal, 2006, Kart-Teke et al., 2006, Good et al., 2007a) or 
nontemporal (Gaffan, 1994, Eacott and Norman, 2004, Eacott and 
Easton, 2007). The OPC recognition developed by Eacott and Norman 
(2004) is investigating rats episodic memory using their capacity to 
discriminate object in place (what-where) between two contexts (or 
events, which) and therefore is a valid assessment of episodic memory 
in animal. Furthermore, after HPC or fornix lesion rats were not able to 
discriminate the new configuration of object, place and context (Eacott 
and Norman, 2004, Langston and Wood, 2009) which are consistent 
with previous studies which demonstrate an association episodic 
memory and fornix-HPC structure (Kennedy and Shapiro, 2004, Nestor 
et al., 2007). Eacott and Norman (2004) have also shown a task 
specificity of the OPC recognition compared to the object in place 
recognition task (what-where) in which none of the rats with any type of 
lesions (postrhinal, perirhinal and fornix lesion) were impaired after a 
similar delay (Eacott and Norman, 2004). Complementarily, it was 
shown that fornix leVLRQGLGQRW LPSDLU UDWV¶ FDSDFLW\ WR UHFRJQL]H WKH
new object in context task (what-when) which confirm the task 
specificity of OPC recognition (Norman and Eacott, 2005). In object or 
object in place recognition they only have to refer to one context (one 
event) whereas in the OPC recognition task rats have to discriminate 
objects in place between two contexts (events discrimination) which 
reflect the criteria of episodic memory definition in humans as the 
capacity to distinguish events depending of a specific context used as 
³VFHQHPHPRU\´(Gaffan, 1994). 
  
7
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Table 1.10: Episodic-like memory task in rodents based on object recognition paradigm. The OPC recognition task and the E-maze are based 
on contextual discrimination while he other task are based in temporal discrimination. 
Rodent Episodic-like memory task What-Where-
When/which 
Explanation Reference 
 
Male C57BL/6 
mice 
 
 
- Object 
- Place 
- Time 
 
One object (NE) is in different place 
compared to when they previously 
saw them in sample 1 
 
Dere et al., 
2005a 
 
Male C57BL/6 
mice 
 
 
- Object 
- Place 
- Time 
 
Objects A and D swap their place in 
the test. Object A is older than D 
Which should induce more 
exploration. 
 
Good et 
al.,2007 
 
Male Wistar rats 
 
 
- Object 
- Place 
- Time 
 
Two objects (A2-B2) are in different 
place compared to when they 
previously saw them in sample 1. 
 
Kart-Teke 
et al., 2006 
 
Male dark Agouti 
 
 
- Object 
- Place 
- Context 
 
One object (right one) is in a new 
position only depending of the 
context (event discrimination). 
 
Eacott and 
Norman, 
2004 
 
Male dark Agouti 
 
 
- Object 
- Place 
- Context 
R/K paradigm: 
Remember: rats turn into the arm 
with the non habituated object 
(holding cage) 
Know: ratio of exploration between 
habituated and non habituated 
object 
 
Eacott and 
Easton, 
2007 
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1.10 The aims of the thesis 
 
My studies attempt to establish an animal model of the episodic 
memory deficit in schizophrenia. NMDA antagonists have been shown 
to be psychotomimetic and induce episodic memory deficits in human 
studies. NMDA antagonists such as PCP induce behavioural deficits 
including memory that are selectively reversed by antipsychotic drugs 
(Grayson et al., 2007, McLean et al., 2009). Rearing rats in isolation 
produces behavioural (PPI, object recognition deficits) (Bianchi et al., 
2006, McLean et al., 2008) and neurochemical alterations (elevated 
dopamine levels in the nucleus accumbens) similar to those observed 
in schizophrenia.  Both models produce deficits in simple memory tasks 
in rats but have not been tested in tasks that simultaneously address 
WKH³ZKDW´³ZKHQ´DQG³ZKHUH´DVSHFWRIHSLVRGLFPHPRU\ 
 The following studies investigated whether PCP and/or social 
isolation can induce memory deficits in episodic memory tasks that 
caSLWXODWH WKH ³ZKDW´ ³ZKHUH´ ³ZKHQ´ triad. Results are compared to a 
WDVNZKLFKRQO\UHFDSLWXODWHGWKH³ZKDW´DQG³ZKHUH´DVSHFWRIZRUNLQJ
memory. The tasks used are the OPC and the object in place (OP) 
recognition task which have been demonstrated and replicated 
previously in rats (Eacott and Norman, 2004). Having established that 
PCP disrupted the task, it had been investigated whether the 
antipsychotic drug clozapine or the promnesic cholinesterase inhibitor 
donepezil affected PCP-withdrawal induced disruption of episodic 
memory in rats.  
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- CHAPTER 2 - 
 
ESTABLISHEMENT OF THE OBJECT-PLACE-
CONTEXT RECOGNITION TASK 
 
 
2.1 Introduction 
 
There is a considerable interest in animal models of episodic memory 
that might be relevant to schizophrenia, both as systems to test 
potential new treatments and as model systems to investigate its 
biological aetiology in the disease. This objective is clearly established 
E\DFRQVRUWLXPRIUHVHDUFKHUVWKH³&RJQLWLYH1HXURVFLHQFH7UHDWPHQW
Research to Improve Cognition in Schizophrenia: CNTRICS. One of 
their aims is to improve the behavioural cognitive animal models in 
schizophrenia. In an attempt to develop episodic memory models in 
animals, many studies develop different tasks which assess an 
DQLPDO¶V FDSDFLW\ WR HQFRGH HYHQWV ZLWK VSHFLILF ³ZKDW´ ³ZKHQ´ DQG
´ZKHUH´ FRPSRQHQWV (Clayton and Dickinson, 1998, Aggleton and 
Pearce, 2001, Roberts, 2002, Eacott and Norman, 2004, Dere et al., 
2005a, Babb and Crystal, 2006, Kart-Teke et al., 2006, Eacott and 
Easton, 2007, Good et al., 2007a, Pillay et al., 2008). 
 As previously mentioned in the introduction, a study by Eacott and 
Norman (2004), using the OPC recognition task, demonstrated that rats 
   78 | 
 
are able to remember what they saw and where, depending in which 
context they were in (Eacott and Norman, 2004). The OPC recognition 
task uses rats tendency to explore novelty (Ennaceur and Delacour, 
1988) and their ability to differentiate events in term of context 
(context1 versus context 2) rather than time (recency versus primacy) 
(Eacott and Norman, 2004, Kart-Teke et al., 2006, Good et al., 2007a). 
Eacott and Norman (2004) also showed that the OPC recognition task 
is fornix dependent but that the one trial object in place recognition task 
(OP recognition task) is not. Recently another study using the OPC 
recognition task confirmed the HPC role in this task but not in one 
sample trial tasks that did not assess what-where-when simultaneously 
(Langston and Wood, 2009). These results clearly dissociated the two 
types of task and also corroborated previous findings showing the 
importance of HPC-fornix in episodic memory (Kennedy and Shapiro, 
2004, Nestor et al., 2007).  
 
In this chapter, the aim of the experiment was to replicate the OPC 
recognition task originally developed by Eacott and Norman (2004). 
However, based on previous studies on recency versus primacy 
(temporal) memory in rats, which showed that rats tend to explore more 
an object/place seen first than most recently (e.g. better memory for the 
last event compared to the first one) (Mumby et al., 2002, Dere et al., 
2005a, Dere et al., 2005b, Barker et al., 2007), the OPC task was 
slightly adapted to eliminate this recency natural preference which 
could occur in the original task. In this thesis, rats were only tested in 
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sample phase 1 context (primacy), instead of the sample phase 1 and 2 
context as tested in Eacott and Norman (2004) study. 
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2.2 Materials and Methods 
 
2.2.1 Animals 
 
12 adult male Lister Hooded rats (Biomedical Services Unit, University 
of Nottingham Medical School, UK 150-200g, 300-350g at start of 
behavioural testing) were used.  Animals received 1-2 minutes daily (9 
am) handling the day after arrival at the unit and ending the day before 
the experiment. Animals were exposed to the test room one day before 
habituation. Animals for all experiments were kept in a temperature 
(21±2ºC) and humidity (40-60%) controlled environment on a 12 hour 
light/dark cycle (lights on 07:00-19:00). Food (standard animal chow, 
Harlan, US) and water were available ad libitium. Experiments were 
carried out in accordance with the Animals (Scientific Procedures) Act, 
1986 and approved by a local ethical committee (PPL 40/2715). 
 
2.2.2 Behavioural Testing 
 
2.2.2.1 Apparatus 
 
All testing was carried out in two different clear Perspex chambers (30 
x 30 x 30 cm). A clear Perspex lid was placed on top of each chamber 
to prevent rats escaping but which allowed circulation of air. A video 
tracking was fixed to the lid to record each trial. One chamber (context 
1) had a white plastic floor and the walls were covered in black and 
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white squares (3 cm2). The second chamber (context 2) had a black 
plastic floor with wire mesh and four natural wood walls. Both chambers 
had crosses marked at the 2 locations where objects were presented. 
These locations were in the lower right and upper left corners 5cm from 
the walls of the chamber. The chambers stayed in the same position 
throughout the experiment. The room was lit by a single, centrally 
placed overhead fluorescent light (640 lux). Objects were chosen to 
fulfil the criteria of being easily cleaned and not easily gnawed by the 
rats. They were of a similar size and shape with different textures (e.g. 
glass, glass bottles surrounded by white tape), or colours (e.g. black 
and white), and heavy enough such that the rats could not push them 
over. Four copies of the objects were used during test trials to eliminate 
the use of odour cues. Objects and contexts were the same during all 
the experiment (Figure 2.1).  
Figure 2.1: Picture of the apparatus and the objects used in the OPC task. 
  
   82 | 
 
2.2.2.2 Habituation 
 
Each rat received one habituation session per day for eight days. A 
habituation session consisted of placement of the rat in the behavioural 
chamber for 10 minutes with an object at the centre of the arena. Four 
of these habituation sessions were carried out in context 1 and four 
habituation sessions in context 2, the order of which was 
counterbalanced. The objects used during habituation were different 
from those used during the rest of the procedure. Objects had different 
shapes and sizes (Figure 2.2). 
 
Figure 2.2: Picture of the objects used during the habituation phase only and 
both contexts with an object in the middle. There was only one habituation 
session per day.  
 
2.2.2.3 Object-Place-Context recognition task 
 
Trials consisted of two sample phases and a test phase separated by a 
delay. For all phases the rat started from the same point in the arena. 
Different copies of objects were used in each phase of the trial 
(sample1, sample 2 and test phase) to prevent the use of odour cues. 
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SAMPLE PHASE1: The first sample phase was carried out in context 1 
with object A in the lower left corner and object B in the upper right 
corner (see Figures 2.3 and 2.4). Rats were allowed to explore freely 
for 4 minutes. Rats were then placed in their holding cage for one 
minute while the arena was cleaned using 70% alcohol.  
SAMPLE PHASE 2: The second sample phase was carried out in 
context 2 with the locations of the objects switch (B now in lower left 
corner and A in upper right corner). Rats were allowed to explore freely 
for 4 minutes, after which they were placed in their holding cage for a 
delay period (2, 5, 10, 15, 30 or 120 minutes) before the test phase 
(see Figures 2.3 and 2.4).  
TEST PHASE: The test phase was carried out in context 1 with two 
copies of the same object placed in lower left and upper right corners 
(either two copies of A or two copies of B). Rats were allowed to 
explore freely for 3 minutes. Each object, location and context was 
familiar to the rat, however one of the objects had never been seen 
before in this specific location in this specific context (see Figures 2.3 
and 2.4). 
 Seven different delays were used: 2, 5, 10, 15, 30, 60, and 120 
minutes. For each delay each rat underwent 4 different trials, one per 
day, comprising sample 1, sample 2 and test as described above 
according to the following schedule.  In test phase 2 trials used context 
1 and 2 trials use context 2. There were thus four possible 
combinations: context 1 or 2 with two objects A or two objects B 
(context 1 AA / BB and context 2 AA / BB). (See figure 2.4 for more 
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details on experimental design). The objects, places and contexts were 
counterbalanced and followed an irregularly sequence between 
animals and days. Time used between sample phase and test phase 
were also irregularly counterbalanced between animals and days. 
Figure 2.3: Picture of the OPC recognition task. There was one test per day with 
only one delay. The new object in this condition was the one on the upper right 
corner (red circle), as this object (what?) had never been seen in this position 
(where?) in this context (when/which?).  
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Figure 2.4: Representation of the OPC recognition task experimental design. 
After 8 habituation days, rats were tested at several delays in their capacity to 
recollect an object in place depending on a context.  Rats explored two 
contexts with two different objects in alternated places then, after 5 or 10 
minutes delay, they were tested in one of the context (first one encountered) 
ZLWK WZR VLPLODU REMHFWV 2QO\ RQH REMHFW ³ZKDW´ ZLOO EH RQ D QHZ SODFH
³ZKHUH´GHSHQGLQJRIWKHFRQWH[W³ZKLFK-ZKHQ´. 
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2.2.3 Data analysis 
 
Time spent (second: sec) exploring both objects during test was scored 
from a video recording of the test phase. A discrimination index (DI) 
was calculated as (time spent exploring the novel object - time 
exploring the old object) / (time spent exploring the novel object + time 
spent exploring the familiar object). A score of 0 indicated no 
discrimination between novel and familiar object. Note that the novel 
object in this procedure was the one that was in a new location for a 
specific context as the rat was already familiar with the object, location 
and context. The total amount of time spent exploring both objects was 
also added up and analysed separately. The video was independently 
scored twice and the Pearson correlation coefficient between two 
independent ratings of DI was r=0.8. 
 One sample t-test for individual delays was used to determine if 
the DI was significantly greater than zero according to Eacott and 
Norman (2004). During the test phase, DI and total time spent exploring 
objects was analysed using one way repeated measures ANOVA within 
delays. Total time spent on objects (total object exploration) was 
analysed by one way ANOVA with delay as within factor. ANOVA was 
followed by t-test between delays. Furthermore, in order to analysed 
the effect of a short term delay (<15 minutes) and a long term delay 
(>15 minutes), data were collapsed and analysed using a paired 
sample t-test.  All data were statistically analysed using SPSS software, 
version 16.1 (SPSS Inc., USA). 
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2.3 Results 
 
This experiment replicated that of Eacott and Norman (2004) 
establishing this model of episodic memory in rats as robust and 
reproducible (Figure 2.5 A). 5DW¶VFDSDFLW\WRGLVFULPLQDWHDQHZREMHFW
in place depending of a context was delay dependent. There was no 
overall effect of delays on DI (F(6,66)=1.97; p>0.05). Animals performed 
better than zero after 2, 5, 10 and 15 minute delays (respectively: 
t(11)=3.06, p<0.05; t(11)=3.28, p<0.05;  t(11)=4.76, p<0.005; t(11)=3.09 
p<0.005), but not after 30, 60 or 120 minutes of interval between the 
sample phase and the test (respectively: t(11)=0.08, p>0.05; t(11)=1.67, 
p>0.05;  t(11)=1.12, p>0.05). When data were collapsed (Figure 2.5 B) 
to analysed the difference between short term delay (<15 minutes) and 
long term delay (>15 minutes), statisticlally analysis revealed a 
significant difference between short and long term delay (t(35)=3.63, 
p<0.05). 
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Figure 2.5 (experiment 1): A/ The OPC task was delay dependent. Rats spent 
more time to explore the new object in place depending on the context after 2, 
5, 10 and 15 minutes (§p<0.05 and §§p<0.005) but not after 30, 60 or 120 
minutes. B/ When delays were collapsed between short term delays (<15 
minutes) and long term delays (>15 minutes), there was a significant difference 
(*p<0.05). Data expressed as mean values (n=12) and errors bars represented ± 
SEM. 
 
Figure 2.6: Results of the OPC recognition task from Eacott and Norman (2004). 
Data (n=12) expressed as mean values and errors bars represented ± SEM. 
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The total object exploration was found to be  delay dependent, with a 
decrease in exploration between 2 minutes and15 minutes delay , after 
which exploration increased again (Figure 2.7). There was no 
significant effect of delays on total object exploration (F(6,66)=1.64; 
p>0.05). However, as the delay increased, rats showed a tendency to 
reduce the exploration of the object with increasing delay. Indeed, rats 
spent more time exploring both objects at 2 minutes delay than after 15 
minutes delay (t(11)=2.54; p<0.05), with no other difference in total 
object exploration between delays. 
 
Figure 2.7 (experiment 1): Total object exploration during the OPC recognition 
task. There was no general effect of delay but total object exploration reduced 
between 2 and 15 minutes (*p<0.05). Data expressed as mean values (n=12) and 
errors bars represented ± SEM. 
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2.4 Discussion 
 
These data show that rats performance in the modified OPC task was 
very similar to that in (DFRWWDQG1RUPDQ¶V study (2004) (Figure 2.6). 
Rats demonstrated a clear preference for the object in the new place 
depending on a specific context compared with an object in a more 
familiar configuration. This preference appeared to reduce when the 
delay increased and after 30 minutes delay rats were not able to 
perform the task. These data indicate that the OPC recognition task is a 
robust and a replicable phenomenon in rats.  
 
$UDW¶VPHPRU\IRU23&WDVNGHWHULRUDWHGDIWHUDVKRUWGHOD\SHULRG
PLQXWHVFRPSDUHGWRUDW¶VPHPRU\ LQRQHWULDOREMHFW UHFRJQLWLRQ that 
can last over three weeks (Mumby et al., 2005, Nestor et al., 2007, 
Squire et al., 2007). Dix and Aggleton (Dix and Aggleton, 1999) showed 
that rats are sensitive to task difficulty, such that one trial object 
recognition is less complex than place recognition which is less 
complex than context recognition (Dix and Aggleton, 1999, Mumby et 
al., 2002) (Figure 2.8). Therefore, OPC task could be a more complex 
task for rats that lead to a faster decay of memory over time compared 
to other one trial object recognition tasks.  
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Figure 2.8: During the test phase of the object recognition task rats spent more 
time to explore the new object compared to the old one during the first two 
minutes, but only one minute for the place recognition task. D2 ratio was 
defined as the difference of exploration between the newest components 
(object-place or object) and the oldest one divided by the total of exploration 
Data expressed as mean values and errors bars represented ± SEM (From Dix 
and Aggleton, 1999).  
 
,Q WKH23&UHFRJQLWLRQ WDVNH[SHULPHQWD UDW¶V WHQGHQF\ WRGHFUHDVH
exploration while the delay increased was observed. Rats tended to 
explore more the objects after 2 minute delay compared with 15 minute 
delay. +RZHYHU UDW¶V WRWDO REMHFW H[SORUDWLRQ VHHPHG WR VORZO\ UH-
LQFUHDVH DIWHU  PLQXWHV GHOD\ 5DW¶V WHQGHQF\ WR GHFUHDVH
exploration after a longer delay cannot be due to a habituation effect 
and therefore could be interesting to investigate further. Habituation is 
defined as the waning of a behavioural response due to the repetition 
of a stimulus. There are two forms of habituation, the long-term and the 
short-term form (Hinde, 1954, 1970, van der Staak, 1977). Long-term 
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habituation induces a decrease of exploration due to every days task 
repetition (rats explore more the objects on the first day than on the last 
day of the task) and short-term habituation is the decrease of 
exploration within the task (rats explore more during the first exposure 
into the context and less during the test phase). Therefore, the faster 
the rats are re-exposed to a context, the bigger the effect of short term 
habituation will be (less objects exploration). However, when the delay 
increases between the sample and test phase, there should be a 
dishabituation to the context and the objects and the object exploration 
should re-increase (Hinde, 1970, van der Staak, 1977). Unfortunately 
the sample phase was not recorded in the present experiment. 
However, in this experiment, when the delay increased, from 2 to 15 
minutes, rats tended to reduce their exploration of the objects, which 
was the opposite pattern to that expected. Therefore, the decrease of 
object exploration was not due to short term habituation. 
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2.4.1 Conclusion 
 
In this experiment, rats performed the modified OPC task controlling for 
recency confound, similarly to those reported in Eacott and Norman 
(2004) task. 
 Thus, it was concluded that the task was suitable to use to 
assess episodic memory in rats. The next aim of these studies was to 
examine whether treatments that induce memory deficits in animals 
and humans or that mimic some of the symptoms of schizophrenia 
induce impairment in the task.  
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- CHAPTER 3 - 
 
PCP WITHDRAWAL RELEVANT MODEL TO 
SCHIZOPHRENIA IN OPC AND OP RECOGNITION 
TASKS 
 
 
3.1 Introduction 
 
This chapter investigated the effect of withdrawal of subchronic PCP in 
episodic memory measured using the OPC task and a newly developed 
object-in-place (OP) task. As discussed previously (See chapter 1: 
page 31) withdrawal from subchronic PCP model is widely used as 
animal model relevant to schizophrenia in order to investigate the 
aetiology of the disease. This model demonstrates good construct, face 
and predictive validities of the disease (Jentsch and Roth, 1999, 
Enomoto et al., 2007, Mouri et al., 2007, Seillier and Giuffrida, 2009) 
(see Table 1.2 and 1.4). 
 
Withdrawal from subchronic PCP induces impairment in simple object 
recognition task that assess the ³ZKDW´ :KDW LV WKH QHZ REMHFW"
dimension (Grayson et al., 2007, Karasawa et al., 2008, McLean et al., 
2009) and had been defined as working memory (Ennaceur and 
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Delacour, 1988) but had never been tested in a task that capitulates the 
³ZKDW´³ZKHUH´³ZKHQ´WULDGDVGHILQHLQHpisodic memory in humans. In 
this chapter, withdrawal from subchronic PCP was tested in OPC 
recognition task. In order to further characterise the pattern of object 
exploration found in that experiment, an identical task addressing 
object in place only, without the contextual element was tested 
following the same withdrawal from subchronic PCP procedure. The 
OP recognition task was a similar task in term of number of days of 
habituation and conditions per delays to the OPC task; however, in this 
task there was only one sample phase instead of two. Therefore during 
the OP task rats had to remember the following event but did not have 
to discriminate between events.  
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3.2 Materials and Methods 
 
3.2.1 Animals 
 
20 adult male per experiment (Experiment 2 and 3) Lister Hooded rats 
(Biomedical Services Unit, University of Nottingham Medical School, 
UK 150-200g, 300-350g at start of behavioural testing) were used.  
Animals received 1-2 minutes daily (9 am) handling the day after arrival 
at the unit and ending the day before the experiment. Animals were 
exposed to the test room one day before habituation. Animals for all 
experiments were kept in a temperature (21±2ºC) and humidity (40-
60%) controlled environment on a 12 hour light/dark cycle (lights on 
07:00-19:00). Food (standard animal chow, Harlan, US) and water 
were available ad libitium. Experiments were carried out in accordance 
with the Animals (Scientific Procedures) Act, 1986 and approved by a 
local ethical committee (PPL 40/2715). 
 
3.2.2 Drug administration 
 
3.2.2.1 Subchronic PCP treatment 
 
Phencyclidine hydrochloride (PCP) was obtained from Sigma-Aldrich 
(Gillingham, UK) and dissolved in saline (0.9% w/v NaCl). PCP (5 
mg/kg/ml in saline) was injected intraperitoneally (i.p.) to half the rats 
(n=10) twice daily (8 am and 6 pm) for 7 days followed by a 7 day drug 
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free period. The control group (n=10) received the same treatment 
regimen with sodium chloride 0.9% w/v (1ml/kg i.p.) The subchronic 
3&3 UHJLPHQ ZDV HVWDEOLVKHG DFFRUGLQJ WR -HQWVFK¶V VWXG\ LQ ZKLFK
they demonstrated cognitive impairment and reduction of the 
dopaminergic mPFC activity (Jentsch et al., 1997a). 
 
3.2.3 Experiment 2: PCP withdrawal model relevant to 
schizophrenia in OPC recognition task  
 
3.2.3.1 Behavioural testing 
 
The OPC recognition followed the same procedure than used in 
chapter 2 (See page 82). Except that only delays of 5 and 10 minutes 
were used (Figures 3.1 and 3.2). Also, some modifications were made 
on context 2 (removed the wire mesh) and one of the object set had 
been changed (sand blasted glass replaced the glass surrounded by 
tape) (Figure 3.3). These modifications of context and objects were 
made because in previous experiments (not mentioned here) some rats 
were distracted by the wire mesh and the tape around the objects. 
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Figure 3.1: Representation of the OPC recognition task experimental design. 
After 8 habituation days, rats were tested at 5 or 10 minutes delay in their 
capacity to recollect an object in place depending on a context.  Rats explored 
two contexts with two different objects in alternated places then, after 5 or 10 
minutes delay, they were tested in one of the context (first one encountered) 
ZLWKWZRVLPLODUREMHFWV2QO\RQHREMHFW³ZKDW´ZDVRQDQHZSODFH³ZKHUH´
GHSHQGLQJRIWKHFRQWH[W³ZKLFK-ZKHQ´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Figure 3.2: Picture of the OPC recognition task. There was one test per day with 
only one delay. The new object in this condition was the one on the lower right 
corner (red circle), as this object (what?) was never seen in this position 
(where?) in this context (when/which?). 
 
Figure 3.3: Picture of the apparatus and the objects used during the OPC and 
OP task. 
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3.2.4 Experiment 3: PCP withdrawal model relevant to 
schizophrenia in OP recognition task  
 
3.2.4.1 Behavioural testing   
 
The OP recognition followed the same procedure than used in OPC 
recognition task, except that there was only one sample phase (no 
sample phase 2). The test phase was directly preceded by one sample 
phase and a delay of 5 or 10 minutes in between. The OP task took 
place in the same apparatus with similar objects than the previous OPC 
tasks. 
 
3.2.4.1.1 Habituation 
 
The habituation was similar to the OPC task 
 
  3.2.4.1.2 OP recognition task 
 
Trials consisted of one sample phase and a test phase separated by a 
delay. For all phases the rats started from the same point in the arena 
(upper left corner, face to the wall). Different copies of objects were 
used in each trial (sample 1, sample 2 and test phase) to prevent the 
use of odour cues. 
SAMPLE PHASE: The first sample phase was carried out in the context 
(context 1 or 2) with object A in the lower left corner and object B in the 
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upper right corner. Rats were allowed to explore freely for 4 minutes. 
Rats were then placed in their holding cage for 5 or 10 minutes delay 
while the arena was cleaned using 70% alcohol (see Figures 3.4 and 
3.5).  
TEST PHASE: The test phase was carried out in the same context than 
in sample phase (context 1 or 2) with two copies of the same object 
placed in lower left and upper right corners (two copies of A or two 
copies of B). Rats were allowed to explore freely for 3 minutes. Each 
objects and locations was familiar to the rat, however one of the objects 
had never been seen before in this specific location (see Figures 3.4 
and 3.5). 
 
Two delays were used (5 and 10 minutes), being selected on the basis 
the previous OPC task (not presented here).  For each delay each rat 
underwent 4 different trials, one per day, comprising sample and test 
phase as described above according to the following schedule.  2 trials 
use context 1 and 2 trials used context 2 in test phase. There were thus 
four possible combinations: context 1 or 2 with two objects A or two 
objects B (context 1 AA / BB and context 2 AA / BB). (See figure 3.4 for 
PRUH GHWDLOV RQ H[SHULPHQWDO GHVLJQ 7KH REMHFW¶V SODFHV GXULQJ WKH
sample phase were counterbalanced between delays and animals. 
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Figure 3.4: Representation of the OP recognition task experimental design. 
After 8 habituation days, rats were tested at 5 or 10 minutes delay in their 
capacity to recollect an object in place.  Rats explored only one of the two 
contexts with two different objects (A and B) then, after 5 or 10 minutes delay, 
they were tested in the same context with two similar objects (A-A or B-B). Only 
RQHREMHFW³ZKDW´ZDVEHRQDQHZSODFH³ZKHUH´EXWLn this task it did not 
depend on the context. 
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Figure 3.5: Picture of the OP recognition task. There was one test per day with 
only one delay. The new object in this condition was the one on the lower right 
corner (red circle), as this object (what?) was never seen in this position 
(where). 
 
3.2.5 Data analysis 
 
Time spent (second: sec) exploring both objects during test was scored 
from a video recording of the test phase. A discrimination index (DI) 
was calculated as (time spent exploring the novel object - time 
exploring the old object)/ (time spent exploring the novel object + time 
spent exploring the familiar object). A score of 0 indicated no 
discrimination between novel and familiar object. Note that the novel 
object in this procedure was the one that was in a new location for a 
specific context as the rat was already familiar with the object, location 
and context. The total amount of time spent exploring both objects is 
also added up and analysed separately. 
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 For the sample phase a split-plot ANOVA was used with 
exploration time (in seconds) as dependent variable and treatment and 
experimental day as factors. 
 For the test phase, one-way ANOVA for each delay was 
performed with DI as dependent variable with treatment as factor 
followed by planned post-hoc t-tests where appropriate. Two-way 
ANOVA was performed with exploration time (sec) as dependent 
variable between treatments and within delays followed by planned 
post-hoc t-tests where appropriate. One sample t-test for individual 
treatment groups was used to determine if the DI was significantly 
greater than zero as reported in Eacott and Norman (2004). All data 
were statistically analysed using SPSS software, version 16.1 (SPSS 
Inc., USA). 
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3.3 Results 
 
3.3.1 Experiment 2: PCP withdrawal rats in OPC recognition task 
 
In the sample phase (Figure 3.6), there was a significant decrease in 
total object exploration over the 8 days of the procedure. There was a 
significant effect of days on total object exploration (F(7,126)=46.16, 
p<0.01) but no effect of treatments (F(1,18)=0.23, p>0.05) nor interaction 
between treatments and days (F(7,126)=0.28, p>0.05).  
 
Figure 3.6 (experiment 2): In the sample phase both saline and PCP withdrawal 
groups explored the two objects the same amounts of time (time in second: 
sec). Data expressed as mean values (n=10 per group) and errors bars 
represented ± SEM. 
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In the test phase (Figure 3.7), at 5 minutes delay there was  a 
significant effect of treatments on DI (F(1,19)=8.01, p<0.05). Saline group 
DI was significantly greater than PCP group DI (t(18)=2.83, p<0.05). 
Saline treated rats DI was significantly greater than zero at the 5 
minutes delay (t(9)=2.62, p<0.05) but not 10 minutes delay (t(9)=1.45, 
p>0.05). PCP rats were impaired on the task at both delays; the DI was 
not significantly greater than 0 at either the 5 minutes (t(9)=-1.32, 
p>0.05) or 10 minutes delay (t(9)=0.63, p>0.05). 
 
Figure 3.7 (experiment 2): PCP withdrawal induced OPC recognition deficit in 
rats. After 5 minutes delay, only saline group performed above zero (§p>0.05) 
with a significant difference between scores compared to PCP group (*p>0.05). 
Data expressed as mean values (n=10 per group) and errors bars represented ± 
SEM. 
 
  
   107 | 
 
Total object exploration during the test phase (Figure 3.8) was delay 
dependent for the saline group but not for the PCP withdrawal group. 
There was a significant effect of delays on total object exploration 
(F(1,18)=10.51, p<0.05) but not of treatments (F(1,18)=0.87, p>0.05) nor 
interaction between treatments and delays (F(1,18)=2.40, p>0.05). Saline 
group explored the two objects more after 5 minutes delay than after 10 
minutes (t(9)=3.07, p<0.05) which was not the case for PCP withdrawal 
group for which total object exploration was not affected by delay 
(t(9)=1.35, p>0.05). 
 
Figure 3.8 (experiment 2): In the test phase, total object exploration reduced 
with increasing delay in the saline group but not for the PCP withdrawal group. 
Saline group after 5 minutes delay compared to 10 minutes delay (*p<0.05). 
Data expressed as mean values (n=10 per group) and errors bars represented ± 
SEM. 
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3.3.2 Experiment 3: PCP withdrawal rats in OP recognition task 
 
Total object exploration was not affected by treatment. There was a 
significant effect of days on total object exploration (F(7,126)=63.84; 
p<0.001) but not of treatments (F(1,18)=0.37; p>0.05) (Figure 3.9). This 
diminution of total object exploration by days can be explained by 
habituation to the task. 
 
Figure 3.9 (experiment 3): In the sample phase both saline and PCP withdrawal 
groups explored the two objects the same amounts of time (time in second: 
sec).  Data expressed as mean values (n=10 per group) and errors bars 
represented ± SEM. 
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In the test phase (Figure 3.10), There was a significant effect of 
treatments (F(1,18)=6.12, p<0.05) and delays (F(1,18)=5.38, p<0.05) on DI 
with an interaction between treatments and delays (F(1,18)=8.01, 
p<0.05). PCP group DI after 10 minutes delay was significantly different 
from saline group at the same delay (t(18)=2.71, p<0.05) and also from 
PCP group after 5 minutes delay (t(9)=2.23, p=0.05). Saline group DI 
was significantly greater than zero after 5 and 10 minutes delay 
(t(9)=3.79, p<0.05 and t(9)=5.23, p<0.05). Also PCP group DI was 
significantly greater than zero after 5 minutes delays (t(9)=4.34, p<0.05) 
but not after 10 minutes delay (t(9)=-0.35, p>0.05). 
.  
Figure 3.10 (experiment 3): PCP withdrawal induced OP recognition deficit in 
rats. After 5 minutes delay, both groups were able to discriminate the new 
object in place (§p<0.05). However, after 10 minutes delay, only the saline group 
spent more time exploring the object in a new place (§p<0.05). There was a 
significant difference between PCP group at 10 minutes delay compared to PCP 
group after 5 minutes delay and saline group after 10 minutes delay S
Data expressed as mean values (n=10 per group) and errors bars represented ± 
SEM. 
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Total object exploration in the test phase of the OP task (Figure 3.11) 
was neither treatment nor delay dependent. There was no significant 
effect  of delays on total object exploration (F(1,18)=0.30, p>0.05), nor 
treatments (F(1,18)=0.43, p>0.05) nor interaction between treatments 
and delays (F(1,18)=0.47, p>0.05). 
 
Figure 3.11 (experiment 3): In the test phase, total object exploration was 
neither affected by PCP withdrawal nor delay. Data expressed as mean values 
(n=10 per group) and errors bars represented ± SEM. 
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3.4 Discussion 
 
These data indicate that PCP withdrawal induces a deficit in recognition 
memory that UHTXLUHVVLPXOWDQHRXVPHPRU\IRUWKH³ZKDW´³ZKHQ´DQG
³ZKHUH´ DVSHFWV. Reduced memory was seen at 10 minutes delay in 
saline controls confirming the sensitivity of the task to delay between 
acquisition and recall (Eacott and Norman, 2004), while PCP 
withdrawal rats showed a deficit at both 5 and 10 minute delays. 
Secondly, it was found unexpectedly that saline treated rats showed a 
delay dependent decrease in total object exploration which was not 
seen in PCP withdrawal rats. Thirdly, these results demonstrated that in 
the OP task that does not contain an explicitly contextual element, PCP 
withdrawal did induce a deficit in OP recognition. However, the delay 
induced total object exploration decrease identified in the previous 
experiment, in the OPC task, was not seen in controls. A direct 
comparison between the two tasks showed in control rats that after 10 
minutes delay recognition was not affected in the OP recognition task 
but was in the OPC recognition task and also that after 5 minutes delay 
PCP-treated rats were able to recognise an object in a new place but 
not an object in a new place depending on the context. Finally, object 
exploration in the test phase was not affected by treatment and/or delay 
when the recognition task did not involve context discrimination. These 
results clearly demonstrated specific difference between the OPC 
recognition task and the OP recognition task which did not involve 
contextual discrimination. Therefore, the OPC recognition task may be 
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a useful model to assess episodic memory deficits consequent to 
treatments relevant to schizophrenia. 
 
3.4.1 New component discrimination 
 
As shown in chapter 2, OPC recognition task assesses episodic 
memory in rats as the capacity to discriminate between two events. 
PCP withdrawal rats were unable to distinguish the newest object place 
and context combination. These results demonstrate a cognitive deficit 
in episodic memory after a subchronic PCP treatment in rats (5 mg/kg 
twice daily during 7 days). These data reinforce the cognitive list of 
impairment induced by subchronic PCP treatment in rodents (Castellani 
and Adams, 1981, Jentsch et al., 1997b, Hashimoto et al., 2005, 
Rodefer et al., 2005, Abdul-Monim et al., 2006, Grayson et al., 2007, 
Javitt, 2007, Hashimoto et al., 2008) and are consistent with human 
studies showing that acute non-competitive NMDA receptor antagonists 
disrupt episodic memory performance (Hetem et al., 2000) more 
specifically for the PCP-withdrawal model that these deficits are 
persistent after drug discontinuation (Malhotra et al., 1996). Subchronic 
PCP treatment in rats is reminiscent of the episodic memory deficit 
described in schizophrenic patients (Herlitz and Forsell, 1996, Rushe et 
al., 1999, Toulopoulou et al., 2003, Lepage et al., 2007, Nestor et al., 
2007). Combined with the neuropathological changes induced by the 
PCP treatment (Olney et al., 1989), this study confirms the utility of the 
subchronic PCP model  as a model relevant to schizophrenia and 
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confirms the importance of the NMDA glutamatergic systems in 
memory and more specifically in episodic memory.  
 As this model involves withdrawal from PCP rats are not tested 
under the acute influence of the drug and thus it is unlikely that results 
are mediated by extraneous effects of PCP on general performance in 
the rats. There were no significant differences in object exploration 
between PCP and control rats in the sample phases confirming that 
withdrawal from PCP had no effect on general exploration pattern. 
)XUWKHUPRUH3&3ZLWKGUDZDOGLGQRWDIIHFW UDWV¶ memory in the OPC 
task after 5 minutes delay, but did in the OPC task. The control group, 
after 5 minutes but not after 10, recognised the object in a new place 
DQG FRQWH[W LQ D WDVN WKDW LQYROYHG ³ZKDW´ ³ZKHUH´ ³ZKHQ´ +RZHYHU
when the task did not involve a context discrimination rats were able to 
perform the task after 10 minutes delay. These results clearly 
established a task difference between the OPC recognition and the OP 
recognition task. To some extent, it is possible to postulate that the 
OPC recognition task assesses episodic memory which recapitulates 
the what-where-when (Eacott and Norman, 2004, Langston and Wood, 
2009) and the OP recognition task assesses working memory as it had 
been originally postulated by Ennaceur and Delacour, (Ennaceur and 
Delacour, 1988). Therefore, the OP recognition task is a clearly distinct 
task which involves different types of memory as it has been previously 
demonstrated in the literature (Eacott and Norman, 2004, Langston and 
Wood, 2009). Indeed, the OPC recognition task is HPC/fornix 
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dependent which is not the case of the OP recognition task (Eacott and 
Norman, 2004, Langston and Wood, 2009).  
 
There are a number of possible underlying mechanisms that could 
mediate PCP-induced deficit in episodic memory. Subchronic PCP 
reduces parvalbumin-immunoreactive (parvalbumin-IR) neurons in the 
CA2/3 sub-region of the HPC and reduces prefrontal cortical 
dopaminergic activity (Jentsch et al., 1997b, Abdul-Monim et al., 2007). 
Given that prior studies have demonstrated a role of both the HPC 
(Eichenbaum, 2003) and frontal cortical networks in the temporal 
discrimination of events and episodic memory (Lee and Kesner, 2003, 
Barker et al., 2007) these are possible mechanisms that could be 
explored in future studies.   
 
3.4.2 Total object exploration 
 
In the sample phase, total object exploration for saline/PCP rats 
showed a long term habituation effect of days (reduction of the 
exploration by days). This effect was constant for all the groups in both 
experiments.  
 
In the OPC recognition task, in the test phase, total object exploration 
was delay dependent for saline-treated rats. The Control group 
explored the two objects after a 5 minutes delay more than after a 10 
minutes delay. This effect was abolished either by PCP withdrawal or 
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when the task is not context dependent. In the OP recognition task 
VDOLQHJURXS¶VREMHFWH[SORUDWLRQZDVQRWDIIHFWHGE\GHOD\7KLVHIIHFW
on total object exploration, as previously explained in chapter 2, cannot 
be due to a short term habituation to the context-object. Also, this effect 
was task dependent and seemed to be related to context 
discrimination. These results plus those in subsequent experiments 
have suggested that this measure may be representative of 
remembering (autonoetic awareness) in rats which could be distinct 
from rats capacity to discriminate the newest combination of object-
place-context based on familiarity (noetic awareness) (Tulving, 1985, 
Fortin et al., 2004, Eacott and Easton, 2007) (see chapter 8:  page: 
189). 
 
 
3.4.3 Conclusion 
 
These experiments established that PCP withdrawal DEROLVKHG UDW¶V
memory in a task that simultaneously assessed the what-where-when. 
7KLVGHILFLWZDVQRWGXH WR UDW¶V LQFDSDFLW\ WRGLVFULPLQDWHQRYHOW\DV
after 5 minutes delay, PCP-treated rats were able to recognise an 
object in a new place in the OP recognition task. Therefore, results 
showed that both tasks did not assess the same type of memory 
(Eacott and Norman, 2004, Dere et al., 2007, Easton et al., 2008, 
Langston and Wood, 2009)  and that one task was more complex than 
the other one, as control rats performed better into the OP task than in 
the OPC task. Furthermore, a delay dependent effect on total object 
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exploration in control group was noticed in the test phase of the OPC 
task but not in the OP task. This total object exploration seemed to be 
induced by the context and cannot be due to habituation effect as in the 
sample phase both groups explored the objects at the same extent. 
 
The next step was to test another animal model relevant of 
schizophrenia, the isolated rearing model, in the OPC and OP 
recognition task, in order to correlate the findings with the subchronic 
PCP model. 
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- CHAPTER 4 - 
  
ISOLATION REARING MODEL RELEVANT TO 
SCHIZOPHRENIA IN OPC AND OP RECOGNITION 
TASKS  
 
 
4.1 Introduction 
 
This chapter investigated the effect rearing rats pups from weaning in 
isolation on episodic memory in adulthood. Isolation rearing model is 
used as a model relevant to neurodevelopmental aspects of 
schizophrenia (see Figure 1.4 and Table 1.6). As with the subchronic 
PCP model, the isolation rearing model induces a robust increase in 
natural forgetting in the simple non-spatial object recognition task 
(Bianchi et al., 2006, McLean et al., 2008) (See chapter 1: page 26 for 
fuller treatment effects of isolation rearing). However, the effect of 
isolation rearing has not been previously examined in an episodic 
memory task. The following chapter describes the effects of isolation 
rearing on both OPC recognition (Eacott and Norman, 2004, Langston 
and Wood, 2009) and OP recognition using the same tasks established 
in chapter 3.  
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4.2 Materials and Methods 
 
4.2.1 Animals 
 
For each experiment (experiment 4 and 5), 20 experimentally naïve 
male Lister Hooded rats (Biomedical Services Unit, university of 
Nottingham Medical School, UK) weighing 50-100g were obtained 
immediately after weaning on postnatal day (PND) 24. Animals were 
pseudo-randomly assigned (counter-balanced by weight and litter) into 
two rearing groups, housed either singly (socially isolated) or in groups 
of 4 (group housed) per cage. For the duration of the experiment, all 
rats were reared for at least 5 weeks, with minimal handling, in plastic 
cages with sawdust lined, solid bases and no additional environmental 
enrichment prior to experimental testing. Animals were housed in the 
same temperature (21±2ºC) and humidity (40-60%) controlled holding 
room on a reversed 12 hour light/dark cycle (lights on 07:00-19:00) and 
received the same auditory, olfactory and visual cues but only group-
housed rats were able to make physical contact with littermates. All 
experiments were carried out during the light phase. Food (standard 
animal chow, Harlam, US) and water were available ad libitium. 
Experiments were carried out in accordance with the Animals (Scientific 
Procedures) Act, 1986 and approved by a local ethical committee. 
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4.2.2 Behavioural tasks before the OPC or the OP recognition task 
 
 
Rats were tested in the OPC or the OP recognition task eight weeks 
after their isolation (post natal day (PND) 79). On PND 58, rats were 
tested in a locomotor activity task in a novel arena which was followed 
twenty four hours later by a two trial non-spatial object recognition with 
an inter trial interval of 2 hours (PND 59). On PND 65 rats performed a 
PPI task and then a conditioned emotional response task (CER) on 
PND 72 (Figure 4.1). This part of the protocol was not performed by me 
but has been utilised previously to assess behavioural alterations that 
are thought to have translational relevance to some of the core positive, 
negative and cognitive defects seen in schizophrenia (Fone and 
Porkess, 2008) and the resultant data from the these test is therefore 
only given in the appendix to validate the successful development of 
the neurodevelopment alterations in this experiment. 
 
 
Figure 4.1: Summary of experimental procedures undergone by the isolated 
rats before the OPC or the OP task. 
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4.2.3 Experiment 4 and 5: Isolation rearing model relevant to 
schizophrenia in OPC recognition task  
 
4.2.3.1 Behavioural testing 
 
The OPC and OP recognition followed the same procedure used in 
chapter 3 (See page 97 and 100). Results were analysed following the 
same procedure than in chapter 3 (Seee page: 103).  
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4.3 Results 
 
4.3.1 Experiment 4: Isolated rats in OPC recognition task 
 
In the sample phase, overall, isolated rats spent more time exploring 
the two different objects (Figure 4.2). There was a significant effect of 
treatments (F(1,18)=4.69; p<0.05) and days (F(7,126)=22.16; p<0.001) on 
total object exploration but no interaction between treatments and days 
(F(7,126)=1.70; p>0.05). 
 
Figure 4.2 (experiment 2): In the sample phase isolated group explored more 
the two objects compared to grouped group (time in second: sec). Data are 
expressed as mean values (n=10 per group) and errors bars represented ± SEM. 
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In the test phase (Figure 4.3), there was a significant effect of delays on 
DI (F(1,18)=6.24; p<0.05) but no effect of treatments (F(1,18)=0.08; 
p>0.05) nor interaction between treatments and delays (F(1,18)=0.12; 
p>0.05). At the 5 minutes delay both isolated and group housed rats 
spent more time exploring the object in new location depending on 
context (group-housed rats: t(9)=2.40; p<0.05 and isolated rats: 
t(9)=2.74; p<0.05 compared to zero). At 10 minutes delay neither group 
did (group-housed rats: t(9)=0.22; p>0.05 and isolated rats: t(9)=0.71; 
p>0.05 compared to zero).  
 
Figure 4.3 (experiment 4):  Isolation reared and group housed rats were not 
impaired in the OPC task. Both groups of rats recognised the object in the new 
place depending on the context after 5 minutes delay (§p<0.05) but not after 10 
minutes delay (*p<0.05 isolated rats within delays). Data are expressed as mean 
values  (n=10 per group) and errors bars represented ± SEM. 
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In the test phase, the total object exploration was affected by delay for 
the group-housed rats but not the isolated littermates (Figure 4.4). 
There was no significant effect of treatments (F(1,18)=0.73; p>0.05) nor 
delays (F(1,18)=3.69; p>0.05) on total object exploration but there was 
an interaction between delays and treatments (F(1,18)=5.11; p<0.05). 
Group-housed rats spent significantly more time exploring the two 
objects after 5 minutes delay than after 10 minutes delay (t(9)=2.95; 
p<0.05). 
 
 
Figure 4.4 (experiment 4): In the test phase, total object exploration was 
affected by isolation rearing and delay. Grouped rats after 5 minutes delay 
compared to 10 minutes delay (*p<0.05). .Data are expressed as mean values 
(n=10 per group) and errors bars represented ± SEM. 
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4.4.2 Experiment 5: Isolated rats in OP recognition task 
 
In the sample phase, isolated rats explored more the two objects than 
the grouped one (Figure 4.5). There was a significant effect of 
treatments (F(1,18)=4.91; p<0.05) and days (F(7,126)=30.99; p<0.001) on 
total object exploration but no interaction between treatments and days 
(F(7,126)=0.63; p>0.05). 
 
Figure 4.5 (experiment 5): In the sample phase isolated group explored more 
the two objects compared to grouped group (time in second: sec). Data are 
expressed as mean values (n=10 per group) and errors bars represented ± SEM. 
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In the test phase, there was no effect of treatmeQWRQUDW¶VFDSDFLW\WR
distinguish the familiar from the novel object (Figure 4.6). There was  
no effect of treatments (F(1,18)=0.25; p>0.05) nor delays (F(1,18)=0.12; 
p>0.05) nor interaction between treatments and delays (F(1,18)=0.37; 
p>0.05) on DI. DI compared to zero highlighted that both groups 
performed the task at both delays (group-housed rats:  at 5 minutes 
t(9)=3.52; p<0.05; at 10 minutes t(9)=3.36; p<0.05 and isolated rats: at 5 
minutes t(9)=4.04; p<0.05; at 10 minutes t(9)=2.89; p<0.05).  
 
Figure 4.6 (experiment 5): Isolation reared and group housed rats were not 
impaired in the OP task. Both groups of rats recognised the object in the new 
place after 5 and 10 minutes delay (§p<0.05 compared to 0). Data are expressed 
as mean values  and errors bars represented ± SEM. 
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Total object exploration in the test phase of the OP task (Figure 4.7) 
was neither treatment nor delay dependent. There was no significant 
effect of treatments on total object exploration (F(1,18)=0.61; p>0.05) nor 
delays (F(1,18)=0.94; p>0.05) nor interaction between treatments and 
delays (F(1,18)=1.50; p>0.05). 
 
Figure 4.7 (experiment 5): In the test phase, total object exploration was neither 
affected by isolation rearing nor delay. Data are expressed as mean values  
(n=10 per group) and errors bars represented ± SEM. 
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4.4 Discussion 
 
These experiments showed that rats which were housed in social 
isolation from weaning were able to discriminate the newest 
combination of what-where-when compared to a most familiar 
combination. This suggests they do not have a deficit in episodic 
memory-like memory. There was no difference in DI between group-
housed and isolated group. After 10 minutes delay, both groups 
showed a delay dependent decrease and did not perform the OPC task 
.Furthermore in the OP task, there was also no difference between the 
two groups at either delay tested, however in this task both groups 
were able to distinguish an object in a new place after 10 minutes 
delay. On the other hand, in the test phase, the total object exploration 
in the grouped housed but not isolated group decreased with delay. 
 
4.4.1 New component discrimination 
 
These results in the OP and OPC task combined with the results in 
object recognition demonstrated that isolated rats were able to 
discriminate a new object (for at least 1 hour) (Bianchi et al., 2006, 
McLean et al., 2008), an object in a new place and also an object in a 
new place depending on context. However, memory for one trial 
recognition task (OP task, >10 minutes) seems to last much longer 
than for two trials object recognition (OPC task, <10 minutes).   
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 Isolation reared rats were not impaired in either of the OPC and 
OP recognition tasks. However, delays used in these experiments were 
extremely short compared with the 1 hour used by other studies in 
object recognition task (Bianchi et al., 2006, McLean et al., 2008) 
(Appendix 1.2) and may account for the inability to show any deficit. 
 Four weeks before the OPC or the OP recognition task, isolated 
rats showed a deficit in one trial object recognition task after two hours 
delay (Appendix 1.2) which confirmed that isolated rats were impaired 
in the cognitive task which assessed object recognition. Therefore, in 
the OPC task, one possibility was that the short delay between the 
sample and the test phase (5 and 10 minutes) may have been 
insufficient to expose the relatively mild impairment in memory which 
might be produced by isolation compared with that associated with 
chronic PCP. Indeed, it may have narrowed the possibility of detection 
of a deficit between the control and the experimental group. In the OPC 
task, only animals which cannot discriminat the newest combination 
after 5 minutes delay are identified as being impaired in episodic 
memory.  
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Appendix 1.2. Animals reared in social isolation (SI) demonstrated NOR deficits. 
The time spent exploring two identical objects in the familiarisation trial (A) and 
a novel and familiar object in the choice trial (B) are presented as mean sec ± 
s.e.m. (n=10 per group). Each trial was separated by an ITI of 2 hours. The 
ability to discriminate between the novel and familiar object was calculated as 
discrimination ratios D1 and D2 (mean ± s.e.m.; C and D). * = S   
SE\SDLUHG6WXGHQW¶VW-test from Group housed (GH) control. 
 
These results demonstrate a task specificity of the OPC recognition 
task compared to a task which does not involve context discrimination. 
Indeed, both groups performed the OP task after 10 minutes delay but 
not the OPC task at similar delay. 
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4.4.2 Total object exploration  
 
Total object exploration in the test phase, in isolated groups remained 
constant and was not delay dependent in both OPC and OP tasks. 
However in controls, total object exploration decreased with increasing 
delay in controls in the OPC task but not in the OP task. In the OP 
version of the task in which contextual information was kept constant 
and therefore not necessary for object recognition the delay-induced 
decrease in total object exploration was not seen. These results 
corroborate the results found with PCP-withdrawal model, which 
suggested that total object exploration differences seen in isolated rats 
and PCP-treated rats may reflect an abnormality in processing 
contextual information that was common to both models was and as 
also reported in schizophrenia (Cohen and Servan-Schreiber, 1992, 
Bazin et al., 2000, Waters et al., 2004). However impairment in the 
explicit recall of contextual information was not seen as socially isolated 
rats were able to perform the OPC task (which requires contextual 
information too) just as well as controls (at least at the time intervals 
used herein). It may be possible that rats can therefore use two 
potential strategies to solve the task, one based on familiarity toward 
one or more of the components in the test phase and the other based 
on remembering the general recognition of the context and the object 
previously seen in the sample phase (context-object association) 
(Tulving, 1985, Fortin et al., 2004, Eacott and Easton, 2007). Therefore, 
The OPC and OP recognition task demonstrate that the capacity to 
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discriminate an object in a new place in a context using familiarity was 
generally not impaired in isolated rats but remembering the context-
object association previously seen in the sample phase was disrupted, 
but only when the task involved contextual discrimination (comparing 
events). 
 
4.4.3 Conclusion 
 
In view of the robust effect of PCP withdrawal but not isolation rearing 
to impair OPC recognition, it was decided to use PCP withdrawal model 
to evaluate pharmacological treatment in the model. In the next 
chapter, this OPC task with the subchronic PCP model relevant to 
schizophrenia was used to investigate the effect of the atypical 
antipsychotic clozapine.   
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- CHAPTER 5 ± 
 
THE EFFECT OF ANTIPSYCHOTIC CLOZAPINE 
ON PCP WITHDRAWAL-INDUCED EPISODIC 
MEMORY DEFICIT IN RATS 
 
 
5.1 Introduction  
 
As discussed, in Chapter 1 (See page 37) , PCP-induced learning and 
memory deficit is widely used as an animal model of abnormalities in 
memory and other cognitive functions in schizophrenia (Jentsch and 
Roth, 1999, Wong and Van Tol, 2003). However tasks currently used to 
assess episodic memory such as novel object recognition may be 
limited for two reasons; first, PCP induces object recognition deficits in 
rodents that are reversed by antipsychotic drugs (Hashimoto et al., 
2005, Grayson et al., 2007). However,  antipsychotic drugs do not 
generally (Meltzer, 1994) reverse memory impairments in patients 
(Goldberg et al., 1993) (See chapter 1 page: 45); second, there is 
evidence that the brain circuitries that underpin performance in tasks 
thaWDVVHVVPHPRU\IRU³ZKDW´GLIIHUIURPWKRVHWKDWXQGHUSLQWKHDELOLW\
WR UHPHPEHU ³ZKDW´ ³ZKHQ´ DQG ³ZKHUH´ (Eacott and Norman, 2004, 
Dere et al., 2007, Langston and Wood, 2009) (chapter 3 and 4) which 
suggests a memory dissociation between the two tasks 
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In chapter 3, it has been shown that PCP withdrawal disrupted memory 
LQUDWVLQDWDVNWKDWVLPXOWDQHRXVO\LQFOXGHVWKH³ZKDW´³ZKHUH´³ZKHQ´
aspects that characterise human episodic memory. In the present 
study, it was examined whether the antipsychotic drug clozapine known 
to reverse PCP withdrawal impairment in one trial object recognition 
(Hashimoto et al., 2005, Grayson et al., 2007) affects impairment in 
OPC recognition.  
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5.2 Materials and Methods 
 
 
Figure 5.1: Time line of the experimental procedure of the experiment 6. 19 rats 
received subchronic PCP treatment and 20 received saline injections. Half of 
each group were then injected, 40 minutes prior the OPC task, with clozapine 5 
mg/kg or saline. 
 
5.2.1 Animals 
 
39 adult male Lister Hooded rats (Biomedical Services Unit, University 
of Nottingham Medical School, UK 150-200g, 300-350g at start of 
behavioural testing) were used.  Animals received 1-2 minutes daily (9 
am) handling the day after arrival at the unit and ending the day before 
the experiment. Animals were exposed to the test room one day before 
habituation. Animals for all experiments were kept in a temperature 
(21±2ºC) and humidity (40-60%) controlled environment on a 12 hour 
light/dark cycle (lights on 07:00-19:00). Food (standard animal chow, 
Harlan, US) and water were available ad libitium. Experiments were 
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carried out in accordance with the Animals (Scientific Procedures) Act, 
1986 and approved by a local ethical committee (PPL 40/2715). 
 
5.2.2 Subchronic PCP treatment 
 
PCP treatment schedule was as described previously (See chapter 3 
page 96) 
 
5.2.3 Experiment 6: Effect of clozapine on PCP withdrawal rats in 
OPC recognition task 
 
5.2.3.1 Clozapine 
 
Clozapine was obtained from Sigma-Aldrich (Gillingham, UK). 
Clozapine was dissolved in a minimum volume of acetic acid, pH was 
adjusted to 5.5 with 1 M sodium hydroxide (NaOH) and saline (0.9% 
w/v NaCl) was added to adjust the volume. Rats received 5 mg/kg i.p. 
clozapine or saline (0.9% w/v NaCl) (1ml/kg, i.p., n=20) 40 minutes 
prior the task for 8 consecutive days. This regimen has previously been 
shown to reverse object recognition deficits in rats treated with NMDAR 
antagonists PCP and MK801 (Grayson et al., 2007, Karasawa et al., 
2008). One PCP-treated rat died after two days of treatment for 
unknown reasons (leaving n=9 for PCP-saline group). 
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5.2.4 Behavioural testing: OPC recognition 
 
The OPC recognition followed the same procedure used in chapter 3 
and 4 (See chapter 3 page 97) 
 
 5.2.5 Data analysis 
 
Statistical analysis were similar than in previous chapters (See chapter 
3 page 103 for more detail). However in this case, treatment levels 
were:  saline-saline, PCP-saline; saline-clozapine, PCP-clozapine.  
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5.3 Results 
 
Clozapine reduced total object exploration during the sample phase 
(Figure 5.2). There was a significant effect of days (F(7,245)=57.53, 
p<0.01) and treatments (F(3,35)=307.28, p<0.01) on total object 
exploration and interaction between treatments and days (F(21,245)=8.66, 
p<0.01).  
 
Figure 5.2 (experiment 6): In the sample phase all groups explored the two 
objects the same amounts of time (time in second: sec). Data are expressed as 
mean values  (n=10 for saline-saline/saline-clozapine and PCP-clozapine groups 
and n=9 for PCP-saline group) and errors bars represented ± SEM. 
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In the test phase (Figure 5.3), at 5 minutes delay there was a significant 
effect of treatment on the DI (F(3,35)=3.08, p<0.05). Clozapine did not 
impair VDOLQH WUHDWHG UDW¶V FDSDFLW\ WR SHUIRUP WKH WDVN ', ZDV
significantly better than chance, t(9)=2.33, p<0.05), also clozapine did 
not restore the PCP-induced deficit after the same delay (t(9)=-0.81, 
S!7KHUHIRUHFOR]DSLQHDIIHFWHGUDW¶VJHQHUDOH[SORUDWLRQEXWQRW
their capacity to discriminate object in place and context. A table 
showing time spent exploring each objects (new combination versus 
familiar one) is presented in appendix 2.1. Saline-saline treated rats 
were able to perform the task after 5 minutes delay (DI significantly 
better than zero, t(9)=3.82, p<0.01). None of the PCP or saline treated 
rats were able to recognise the correct new triad of object, place and 
context at any delay (p>0.05). Similarly to in experiment 2 there was a 
difference between saline-saline DI and PCP-saline DI (t(17)=2.25, 
p<0.05) and also between PCP-clozapine DI (t(18)=2.51, p<0.05). 
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Figure 5.3 (experiment 6): Clozapine did not reverse the PCP withdrawal-
induced deficit in OPC task in rats. After 5 minutes delay, both saline-saline and 
saline-clozapine group performed above zero S&OR]DSLQHDIIHFWHGUDW¶V
exploration but not their capacity to discriminate new object in place and 
context. Data are expressed as mean values  (n=10 for saline-saline/saline-
clozapine and PCP-clozapine groups and n=9 for PCP-saline group) and errors 
bars represented ± SEM. 
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As noticed in the sample phase, clozapine reduced rats object 
exploration (Figure 5.4).There was a significant effect of treatments on 
total object exploration (F(3,35)=20.32, p<0.001) and an interaction 
between treatments and delays (F(3,35)=4.40, p<0.01). Clozapine-
treated rats independently of their first treatment (saline or PCP) were 
impaired in exploration at both delays (saline-saline compared to 
saline-clozapine group after 5 minutes delay: t(18)=4.32, p<0.001 and 
after 10 minutes t(18)=2.58, p<0.05; PCP-saline compared to PCP-
clozapine group after 5 minutes delay: t(17)=4.93, p<0.001 and after 10 
minutes delays compared to saline-saline group after 10 minutes delay: 
t(17)=5.31, p<0.001.). Also, total object exploration in the control group 
was higher at 5 minutes delay compared to 10 minutes delay (t(9)=4.04, 
p<0.05) but that was not the case for the  other groups (Saline-
clozapine group: t(9)=0.08, p>0.05; PCP-saline group: t(8)=-0.25, p>0.05 
and PCP-clozapine group: t(9)=-1.06, p>0.05). Furthermore total object 
exploration, after 5 minutes delay, in the control group was higher 
compared to the PCP-saline group (t(17)=2.44, p<0.05) but not after 10 
minutes delay.  
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Figure 5.4 (experiment 6): In the test phase, total object exploration was 
affected by delays in control group (*p<0.05) but not in PCP-saline group and by 
clozapine (*p<0.05 and **P<0.001). Data are expressed as mean values (n=10 for 
saline-saline/saline-clozapine and PCP-clozapine groups and n=9 for PCP-
saline group) and errors bars represented ± SEM.  
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5.4 Discussion 
 
Clozapine (5 mg/kg) did not affect PCP-induced episodic memory 
deficit in OPC recognition nor did it affect reduced delay induced 
reduction in total object exploration. The dose used produced 
significant sedation which was reflected in reduced exploration times 
during the sample phase of the task. Clozapine has known sedative 
effects in both humans and in experimental animals (Kumra et al., 
2008, Wiley, 2008). However, there was no disruption in DI in clozapine 
treated rats suggesting that in this model a degree of sedation was not 
confound to memory performance. It is possible that clozapine may 
have an influence on memory performance at higher doses than the 
dose used in this study test here. However, same dose has been 
shown to reverse PCP withdrawal effects in one-trial object recognition 
in rats (Grayson et al., 2007, Karasawa et al., 2008) which addresses 
³ZKDW´ZKLFKREMHct is new?) which only refer to a previous event, and 
refers to working memory task (Ennaceur and Delacour, 1988). This is 
in contrast to the OPC recognition task in the present study which 
requires a comparison between events (Eacott and Norman, 2004, 
Dere et al., 2007, Langston and Wood, 2009) (see chapter 3 and 4). In 
the present study clozapine did not improve the PCP withdrawal 
induced-deficit in OPC recognition which suggest that this reversal 
does not extend to episodic memory defined as memory for what-
where-when.  
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The sedative effect of clozapine (Kumra et al., 2008, Wiley, 2008), 
reduced the reliability of investigating the effects on total object 
exploration in the test phase. 
 
5.4.4 Conclusion 
 
These data indicate that in contrast to prior studies using tasks that do 
not require recognition of both context and component clozapine does 
not reverse PCP withdrawal disruption of memory (Hashimoto et al., 
2005, Grayson et al., 2007, Karasawa et al., 2008). These data suggest 
that it is possible to pharmacologically distinguish between memory for 
³what-where-ZKHQ´ (OPC recognition) which do not respond to atpical 
antipsychotic DQG³ZKDW´RQH-trial object recognition) which is improved 
by typical antipsychotic.  
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- CHAPTER 6 - 
 
THE EFFECT OF DONEPEZIL ON PCP 
WTHDRAWAL-INDUCED EPISODIC MEMORY 
DEFICIT IN RATS 
 
 
6.1 Introduction  
 
In chapter 5, it was shown that clozapine did not reverse the PCP 
withdrawal-induced episodic memory deficit in the OPC task. It was 
important to demonstrate that PCP withdrawal induced deficit in OPC 
recognition could be reversed if this model is to have utility for detecting 
novel memory enhancing drugs. Thus, it was postulated that consistent 
with data suggesting a cholinergic substrate to episodic memory and 
with prior reports of enhancement of episodic memory in humans (Grön 
et al., 2005) and rodents (Béracochéa et al., 2007) that this impairment 
would be reversible by the acetylcholinesterase drug donepezil (See 
chapter 1 page 50).  
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6.2 Materials and Methods 
 
Figure 6.1: Time line of the experimental procedure of the experiment 6. 20 rats 
received subchronic PCP or saline treatment. Half of each group were then 
injected, 40 minutes prior the OPC task, with donepezil 0.3 mg/kg or saline. 
 
6.2.1 Animals 
 
40 adult male Lister Hooded rats (Biomedical Services Unit, University 
of Nottingham Medical School, UK 150-200g, 300-350g at start of 
behavioural testing) were used.  Animals received 1-2 minutes daily (9 
am) handling the day after arrival at the unit and ending the day before 
the experiment. Animals were exposed to the test room one day before 
habituation. Animals for all experiments were kept in a temperature 
(21±2ºC) and humidity (40-60%) controlled environment on a 12 hour 
light/dark cycle (lights on 07:00-19:00). Food (standard animal chow, 
Harlan, US) and water were available ad libitium. Experiments were 
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carried out in accordance with the Animals (Scientific Procedures) Act, 
1986 and approved by a local ethical committee (PPL 40/2715). 
 
6.2.2 Subchronic PCP treatment 
 
PCP treatment schedule was as described previously (See chapter 3 
page 96) 
 
 
6.2.3 Experiment 7: Effect of donepezil on PCP withdrawal rats in 
OPC recognition task 
 
6.2.3.1 Donepezil 
 
Donepezil was obtained from The National Institute of Mental Health: 
NIMH (Bethesda, USA). Donepezil was dissolved in saline (0.9% w/v 
NaCl). Rats received 0.3 mg/kg i.p. donepezil or saline (0.9% w/v NaCl) 
(1ml/kg, i.p., n=20) 40 minutes prior the task during 8 days. This 
regimen has been shown to improve memory in other behavioural tasks 
in rodents such as object recognition (Prickaerts et al., 2005). 
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6.2.4 Behavioural testing: OPC recognition 
 
The OPC recognition followed the same procedure used in chapter 3, 4 
and 5 (See chapter 3 page 97) 
 
6.2.5 Data analysis 
 
Statistical analysis were similar than in previous chapters (see chapter 
3 page 104 for more detail). However in this case, treatment levels 
were:  saline-saline, PCP-saline; saline-donepezil, PCP-donepezil.  
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6.3 Results 
 
As previously observed, in the sample phase (Figure 6.2) there was a 
significant decrease on total object exploration over the 8 days of 
procedure, but neither doQHSH]LO QRU 3&3 DIIHFWHG UDW¶V H[SORUDWLRQ. 
There was a significant effect of days on total object exploration 
(F(7,252)=83.24, p<0.01), but no effect of treatment (F(3,36) =0.56, p>0.05) 
and nor interaction between treatment and days (F(21,252)=0.75, p<0.01).  
 
Figure 6.2 (experiment 7): In the sample phase all groups explored the two 
objects the same amounts of time (time in second: sec). Data are expressed as 
mean values (n=10 per group) and errors bars represented ± SEM. 
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In the test phase (Figure 6.3), At 5 minutes delay there was a 
significant effect of treatments on DI (F(3,36)=2.81, p=0.05). After 5 
minutes delay, PCP-saline group DI was significantly lower than saline-
saline, saline-donepezil and PCP-donepezil group DI (respectively: 
t(18)=2.43, p<0.01; t(18)=2.50, p<0.05 and t(18)=2.21, p<0.05  ). Donepezil 
reversed PCP-induced episodic memory deficit in OPC task after 5 
minutes delay (DI significantly better than zero: t(9)=2.74, p<0.05) but 
not after 10 minutes (DI not significantly better than zero t(9)=1.21, 
p>0.05). Donepezil improved saline treated rats memory after 10 
minutes delay (DI after 10 minutes delay is significantly better than zero 
(saline-donepezil group DI t(9)=2.45, p<0.05 and saline-saline group DI 
t(9)=-0.083, p>0.05). Both saline-saline and saline-donepezil treated 
rats performed the task after 5 minutes delay (DI significantly better 
than zero after 5 minutes delay: saline-saline group t(9)=3.71, p<0.05 
and saline-donepezil group t(9)=3.58, p<0.05). 
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Figure 6.3 (experiment 7): Donepezil reversed the PCP withdrawal-induced 
deficit in OPC task in rats. After 5 minutes delay, only PCP-saline group did not 
perform above chance (§p<0.05) and there were a significant difference 
between DI from PCP-saline group with every other groups was revealed 
(*p<0.05). After 10 minutes delay, saline-donepezil treated rats still performed 
the task (§p<0.05) but not the other groups. Data are expressed as mean values  
(n=10 per group) and errors bars represented ± SEM. 
 
  
   151 | 
 
Total object exploration in the test phase was delay and treatment 
dependent (Figure 6.4). There was a significant effect of delays on total 
object exploration (F(3,36)=28.05, p<0.001) and an interaction between 
treatments and delays (F(3,36)=6.62, p<0.001). Both saline-saline and 
saline-donepezil groups showed more total object exploration after the 
short delay compared to the longer one (respectively: t(9)=5.44, p<0.001 
and t(9)=6.54, p<0.001), which was not the case for PCP-saline and PC-
donepezil (t(9)=-0.69, p>0.05 and t(9)=1.71, p>0.05). After 5 minutes 
delay, there was no significant effect of treatment on total object 
exploration (F(3,36)=0.92, p>0.05), however after 10 minutes delay, there 
was a significant effect of treatment on total object exploration 
(F(3,36)=7.30, p<0.001). Indeed, after 10 minutes delay, PCP-saline 
group explored more the object compared to all the other groups 
(saline-saline group: t(18)=-3.81, p<0.05; saline-donepezil group: t(18)=-
3.73, p<0.05 and PCP-donepezil group: t(18)=-3.18, p<0.05). 
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Figure 6.4 (experiment 7): In the test phase, total object exploration was 
affected by PCP withdrawal nor delay, donepezil did not reverse these PCP 
withdrawal/delay-induced deficit. Total object exploration was delay dependent 
for the saline-saline (**p<0.001) and saline-donepezil (**p<0.001) group but not 
for PCP-saline (p>0.05) and PCP-donepezil (p>0.05) group. Data are expressed 
as mean values  (n=10 per group) and errors bars represented ± SEM. 
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6.4 Discussion 
 
Donepezil (0.3 mg/kg) increased performance in saline-treated rats and 
reversed the PCP-induced deficit in the episodic memory task of OPC 
recognition but did not affect PCP withdrawal disruption of delay 
dependent reduction of total object exploration. Donepezil is known to 
have a beneficial effect RQOHDUQLQJDQGPHPRU\LQ$O]KHLPHU¶VGLVHDVH
(Bullock and Dengiz, 2005, Tsuno, 2009). In schizophrenia, anomalies 
in the cholinergic pathway have been reported such as lower numbers 
of both muscarinic and nicotinic receptors in the PFC and HPC 
(Raedler et al., 2006, Crook et al., 2001, Freedman et al., 1995). Few 
studies have investigated the cognitive effect of donepezil in rat models 
relevant to schizophrenia.  Studies in mice have shown donepezil 
reversal of MK-801 and PCP-induced deficits in spatial reversal 
learning, contextual and cued memory, and one-trial object recognition 
(Csernansky et al., 2005, Kunitachi et al., 2009). In middle-aged mice, 
Béracochéa (Béracochéa et al., 2007) demonstrates that donepezil 
given alone improves contextual memory. Furthermore human studies 
have also revealed episodic memory improvement after donepezil 
administration (Grön et al., 2005). In human studies, some studies 
show a beneficial effect of AChEIs in general cognitive impairment in 
schizophrenia in task such as Rey Auditory Verbal Learning Test 
(RAVLT), Wisconsin Card Sorting Test (WCST) and selective attention 
Digit Span Distraction Test (DSPT), howver others studies do not found 
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any improvement or a minimal benefits (Friedman et al., 2002, Howard 
HWDO/LGGOH%XFKDQDQHWDO7X÷DO2HWDO
Keefe et al., 2007, Risch et al., 2007, Chung et al., 2009). The studies 
performed to date have however used general cognitive assessment 
batteries typically measuring executive function and attention and do 
not include specific tests of episodic memory. 
 
 Donepezil alone did not improve delay-induced total object exploration 
deficit after 10 minutes delay and nor improved the PCP withdrawal-
induced deficit in total object exploration after 5 minutes. In the light of 
my suggestion that total object exploration reduction after delay may 
reflect autonoetic awareness while OPC performance (DI) reflects 
noetic awareness, these results suggest that donepezil might improve 
UDWV¶ FDSDcity to discriminate OPC based on familiarity (noetic 
DZDUHQHVV EXW QRW UDWV¶ FDSDFLW\ WR UHPHPEHU WKH SUHYLRXV YLVLWHG
context and objects (autonoetic awareness) (see chapter 8 page 189 
for more details).  
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5.4.4 Conclusion 
 
This suggests that PCP withdrawal disruption of OPC is potentially 
reversible and it may be a new sensitive preclinical model for to study 
the episodic memory impairments in schizophrenia. Furthermore, these 
data suggest that the ACh(,¶VPD\EHXVHIXODVWUHDWPHQWIRUPHPRU\
impairment in schizophrenia. 
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- CHAPTER 7 - 
 
LOCOMOTOR ACTIVITY TASKS IN PCP-
WITHDRAWAL RATS 
 
 
7.1 Introduction 
 
This chapter investigated locomotor activity in subchronic PCP treated 
rats given either acute PCP (3.2 mg/kg) challenge, clozapine (5 mg/kg), 
and with donepezil (0.3 mg/kg). The PCP challenge was performed to 
validate and to analyse the long term effect of the subchronic PCP 
treatment; but also to investigate if the potential chronic effect of 
clozapine and donepezil treatment received during the OPC task could 
reverse PCP sensitization on LMA task. Clozapine and donepezil 
injections were tested in order to analyse their effects on locomotor 
activity.  
 
In rats, PCP challenge after repeated PCP administration increases 
locomotor activity (Xu and Domino, 1994, Johnson et al., 1998). This 
specifiFSKHQRPHQRQLVFDOOHG³UHYHUVHWROHUDQFH´RUVHQVLWL]DWLRQDQGLW
is correlated with apoptotic neuronal degeneration in different parts of 
the brain including the anteterior cingulate, parietalcingulate, temporal, 
piriform, entorhinal cortices, HPC and amygdala (Olney et al., 1989, 
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Phillips et al., 2001). Increased locomotor activity induced by PCP 
sensitization is associated with dopamaniergic hyperactivity and is 
supposed to be related to clinical manifestations of schizophrenia 
(Steinpreis et al., 1994, Adams and Moghaddam, 1998). Dysfunctions 
in the dopaminergic and glutamatergic systems are the origin of 
behavioural sensitization due to neural adaptations in the 
mesocorticolimbic regions (Pierce and Kalivas, 1997, Cornish and 
Kalivas, 2001). Clozapine prevents apoptotic degeneration of cortical 
neurons and reduced locomotor sensitization after chronic PCP 
treatment (Johnson et al., 1998, Phillips et al., 2001). On the other 
hand, the effect of donepezil on behavioural locomotor sensitization 
after PCP challenge had never been investigated. 
 
While donepezil does not affect general locomotor activity (Sonkusare 
et al., 2005), clozapine is known to induce sedative effects in patients 
and in experimental animals (Kumra et al., 2008, Wiley, 2008). The 
sedative effects were observed during the OPC recognition task and 
affected object exploration during the sample and the test phases.  
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7.2 Materials and Methods 
 
7.2.1 Animals 
  
Animals were the same as those used in chapter 6 and 7 (See chapter 
5 and 6: page 134 and 145) 
 
7.2.2 Apparatus 
  
All locomotor experiments take place in the same open fields. Each 
activity monitor consist of a clear Perspex box (40 x 20 x 25 cm), 
surrounded by SDI photobeam Activity System frame with 4x8 
photobeams (spaced between them: 1 15/16´FURVVLQJWKHDUHQDWRWUDFN
WKHDQLPDO¶VVSHFLILFSDWK All photocells are interfaced to a Windows 
XP computer and the number of beam breaks relayed as counts in 5 
minute time bins using SDI Photobeam Activity software. 
 
7.2.3 Drug administration 
 
7.2.3.1 PCP 
 
PCP preparation was previously described (See chapter 3 page 97). 
Rats received 3.2 mg/kg i.p. PCP or saline (0.9% w/v NaCl) (1ml/kg, 
i.p., n=20) after 40 minutes of habituation to the LMA boxes. This 
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regimen has been shown to induce PCP sensitization in LMA (Philip et 
al. 2001). 
 
7.2.3.2 Clozapine 
  
Clozapine preparation was previously described (See chapter 5 page 
135) 
 
7.2.3.3 Donepezil 
 
Donepezil preparation was previously described (See chapter 6 page 
146) 
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7.2.4 Behavioural testing 
 
 
Figure 7.1: Summary of experimental procedures. Chronic PCP treatment was 
followed by a 7 day withdrawal period and then animals were tested in the OPC 
task.  LMA with clozapine (5 mg/kg, experiment 8) or donepezil (0.3 mg/kg 
experiment 9) was carried out two days after the OPC task and seven days after 
rats were tested on LMA with PCP challenge (3.2 mg/kg experiment 10 and 11).  
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7.2.4.1 Experiment 8 and 9: PCP (3.2 mg/kg) challenge after OPC 
task with clozapine and with donepezil  
 
The LMA task was carried out 9 days after the last OPC t ask or 31 
days after the last PCP injections. Each animal (n=40) received 40 
minutes of habituation in the activity monitor box, before an acute 
injection of PCP (3.2 mg/kg i.p.) and then were allowed to move freely 
in the box for 40 minutes. Their behaviour was monitored throughout 
the experiment by SDI Photobeam Activity soft (see Figure 7.2). 
 
 
Figure 7.2: Experimental design of the LMA task. Rats had 40 minutes of 
habituation into the open field, followed by PCP (3.2 mg/kg) injection (i.e. 
experiment 8 and 9) and then they came back in the open field for 40 minutes. 
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7.2.4.2 Experiment 10-11: LMA after clozapine (5 mg/kg) and 
donepezil 0.3 mg/kg 
 
LMA task was carried out two days after the last day of the OPC task. 
Each group of rats previously treated in experiment 6 (n=39) such as: 
saline-saline, saline-clozapine, PCP-saline and PCP-clozapine and in 
experiment 7 (n=40) such as: saline-saline, saline-donepezil, PCP-
saline and PCP-donepezil were divided in two subgroups. Half of them 
received the clozapine (5 mg/kg i.p.) injection and half of them the 
saline injection (See Appendix 3.1 for diagram). Prior to injection, 
animals received 20 minutes of habituation in the activity monitor box 
(see Figure 7.2). Then, they were kept in their holding cage (post 
injection) for 40 minutes before replacement in the activity monitor box 
for 70 minutes. They were allowed to move freely in the box and their 
behaviour was monitored throughout the experiment by SDI 
Photobeam Activity soft (see Figure 7.3). 
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Figure 7.3: Experimental design of the LMA task after clozapine (5 mg/kg) or 
donepezil (0.3 mg/kg) which was carried out two days after the OPC task (See 
Figure 7.1). Rats had 20 minutes of habituation into the open field, followed by 
clozapine (5 mg/kg) (experiment 10) or donepezil (0.3 mg/kg) (experiment 11) or 
saline injection. After 40 minutes delay in their holding cage, they came back 
into the open field for 70 minutes. 
 
7.2.5 Data analysis 
 
LMA was calculated as mean ± SEM activity per 5 minutes for each 
group. Two-way ANOVA was performed with beam break (counts) as 
dependent variable between treatments and within delays followed by 
planned post-hoc LSD where appropriate. All data were statistically 
analysed using SPSS software, version 16.1 (SPSS Inc., USA). 
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7.3 Results 
 
7.3.1 Experiment 8: PCP (3.2 mg/kg) challenge after OPC task 
under  clozapine  
 
Results showed that there was a PCP sensitisation of the rats which 
received subchronic PCP treatment (Figure 7.6). Previous clozapine 
treatment during the OPC recognition task did not reverse PCP 
sensitisation. There was a significant effect of treatments (F(3,35)=5.03; 
p<0.001) and time (F(6,210)=25.85; p<0.001) on LMA but no interaction 
between treatments and time (F(18,210)=1.10; p>0.05). There was a 
significant difference between saline-saline group and PCP-saline 
group (p<0.05), saline-clozapine group and PCP-clozapine (p<0.05) but 
not between saline-saline group and saline-clozapine group (p>0.05) or 
PCP-saline group and PCP-clozapine (p>0.05). In the habituation 
phase, there was no difference of LMA between groups. There was a 
significant effect of time on LMA (F(7,245)=86.94; p<0.001) but not of 
treatment (F(3,35)=2.05; p>0.05) and no interaction between treatment 
and time (F(21,245)=1.54; p>0.05). 
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Figure 7.4 (experiment 8): There was PCP sensitization after a PCP challenge 
(3.2 mg/kg) even 31 days after the last PCP injection. Clozapine (5 mg/kg) 
received during the OPC recognition task did not reverse the PCP sensitization. 
There was a significant difference of LMA between saline-saline (sal-sal) group 
and PCP-saline (pcp-sal) group (p<0.05) and between saline-clozapine (sal-clo) 
group and PCP-clozapine (pcp-clo) group (p<0.05). Data are expressed as mean 
values  (n=10 for saline-saline/saline-clozapine and PCP-clozapine groups and 
n=9 for PCP-saline group) and errors bars represented ± SEM. 
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7.3.2 Experiment 9: PCP (3.2 mg/kg) challenge after OPC task 
under donepezil 
 
Rats PCP sensitisation was observed in PCP withdrawal rats (Figure 
7.7). Donepezil did not restore the hyperlocomotor activity induced by 
the PCP treatment. There was a significant effect of treatments 
(F(3,36)=3.71; p<0.05) and times (F(6,216)=27.98; p<0.001) on LMA 
without any interaction between treatments and times (F(18,216)=1.91; 
p>0.05). There was a significant difference between saline-saline group 
and saline-donepezil group (p<0.05), saline-donepezil group and PCP-
donepezil (p<0.05) but not between saline-saline group and saline-
donepezil group (p>0.05) or PCP-saline group and PCP-donepzil 
(p>0.05). In the habituation phase, there was no difference on LMA 
between groups. There was a significant effect of times on LMA 
(F(7,252)=104.02; p<0.001) but not of treatments (F(3,36)=0.90; p>0.05) 
and nor interaction between treatments and times (F(21,252)=0.70; 
p>0.05). 
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Figure 7.5 (experiment 9): 31 days after the last injection of the chronic PCP 
treatment, there was PCP sensitization after a PCP challenge (3.2 mg/kg). 
Donepezil (0.3 mg/kg) received during the OPC recognition task did not reverse 
the PCP sensitization. There was a significant difference on LMA between 
saline-saline (sal-sal) group and PCP-saline (pcp-sal) group (p<0.05) and 
between saline-donepezil (sal-donep) group and PCP-donepezil (pcp-donep) 
group (p<0.05). Data are expressed as mean values  (n=10 per group) and errors 
bars represented ± SEM. 
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7.3.3 Experiment 10: LMA after Clozapine (5 mg/kg) 
 
40 minutes after the 5 mg/kg clozapine injection, rats locomotor activity 
was reduced compared to rats which received saline injection (Figure 
7.4). There was a significant effect of treatments (F(3,35)=34.53; p<0.05) 
and times (F(13,455)=36.01; p<0.05) on LMA but no interaction between 
treatments and times (F(39,455)=1.46; p>0.05). There was a significant 
difference between groups which had been injected with clozapine and 
those which had been injected with saline (p<0.05), but there was no 
difference between groups previously treated with saline and PCP 
(p>0.05). In habituation, there was a significant effect of times on LMA 
(F(3,105)=87.82; p<0.05) but not of treatments (F(3,35)=0.60; p>0.05) and 
no interaction between treatments and times (F(9,105)=0.66; p>0.05).  
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Figure 7.6 (experiment 10): Clozapine (5 mg/kg) 40 minutes after injection 
LPSDLUHG UDW¶V ORFRPRWRU DFWLYLW\ There was a significant difference on LMA 
between saline-saline (sal-sal) group and saline-clozapine (sal-clo) group 
(p<0.05) and between PCP-saline (pcp-sal) group and PCP-clozapine (pcp-clo) 
group (p<0.05). Data are expressed as mean values  (n=10 for saline-
saline/saline-clozapine and PCP-clozapine groups and n=9 for PCP-saline 
group) and errors bars represented ± SEM. 
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7.3.4 Experiment 11: LMA after donepezil (0.3 mg/kg) 
 
Donepezil (0.3 mg/kg) did not affect raW¶VORFRPRWRUDFWLYLW\)LJXUH.5). 
There was a significant effect of times on LMA (F(13,468)=48.94; p<0.05) 
but not of treatments (F(3,36)=0.03; p>0.05) no interaction (F(39,468)=0.92; 
p>0.05). In the habituation phase there was also no difference in 
locomotor activity between groups. There was a significant effect of 
time (F(3,108)=206.03; p<0.05) but not of treatment (F(3,36)=0.03; p>0.05) 
nor interaction between treatments and times (F(9,108)=0.58; p>0.05). 
 
Figure 7.7 (experiment 11): Donepezil (0.3 mg/kg) 40 minutes after injection did 
QRWDIIHFWUDW¶VORFRPRWRUDFWLYLW\There was no significant difference between 
groups on LMA (saline-saline (sal-sal); saline-clozapine (sal-donep); PCP-saline 
(pcp-sal); PCP-clozapine (pcp-donep)). Data expressed as mean (n=10 per 
group) values and errors bars represented ± SEM. 
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7.4 Discussion 
 
PCP (3.2 mg/kg) challenge showed PCP ZLWKGUDZDOUDWV¶VHQVLWLVDWLRQ
This result demonstrated that the subchronic PCP treatment has 
persisted for at least over 31 days after the last PCP injection the PCP 
withdrawal effect during the OPC and OP tasks recognition. Also, 
chronic clozapine and chronic donepezil treatment received during the 
OPC task and LMA task did not reverse the PCP-induced hyperactivity 
after acute PCP challenge 7 days later. 
 
Clozapine (5 mg/kg) but not donepezil (0.3 mg/kg) had a sedative effect 
that reduced locomotor activity (experiment 8 and 9: Figure 7.5 Figure 
7.6) and objects exploration (experiment 6: Figure 5.2). This sedative 
effect is well established in the literature (Kumra et al., 2008, Wiley, 
2008). However, in VDOLQH WUHDWHG UDWV FOR]DSLQH GLG QRW LPSDLU UDW¶V
capacity to discriminate between the newest combination of object, 
place and context (See chapter 5 for more detail). 
 
 Overall these data confirmed the sedative effect induced by clozapine 
but not by donepezil. Also, they showed a long lasting effect of 
subchronic PCP treatment certainly induced by apoptotic neuronal 
degeneration in different brain regions (Phillips et al., 2001). Chronic 
clozapine treatment (8 days) did not last 7 days after the last injection 
and was not able to reverse the PCP-induced sensitization, this effect 
has been interpreted as clozapine withdrawal effect which induced 
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dopaminergic hypersensitivity and psychosis relapse in human (Borison 
et al., 1988, Shore et al., 1995) (See chapte 8: page 192). 
 
7.4.1 Conclusion 
 
The LMA tasks establish a long term effect of PCP withdrawal in the 
subchronic PCP model of rats and also that clozapine but not donepezil 
induce sedation in rats that could interfere with the total object 
exploration in the OPC task.  However clozapine sedative effect did not 
affect rats¶ capacity to discriminate the object in place depending on the 
context (See chapter 5 Figure 5.3 and 5.4). 
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- CHAPTER 8 ± 
 
GENERAL DISCUSSION 
 
 
The results, presented in this thesis 1) established a modified OPC 
recognition task in our laboratory 2) demonstrated that withdrawal from 
subchronic PCP induced a deficit in OPC recognition 3) found that 
donepezil but not clozapine restored this PCP-induced deficit, 4) 
established that isolation reared rats did not show a deficit in OPC 
recognition after a short delay but did after 1h in standard object 
recognition paradigm, 5) found that both PCP and isolation rearing 
abolished delay sensitive decrease in total object exploration at test 6) 
confirmed that reduction of exploration is associated with context as OP 
recognition does not show total object exploration decrease at delay 
and 7) confirmed that OP recognition is disrupted by PCP withdrawal  
8) PCP sensitisation of the locomotor response was shown after acute 
PCP (3.2 mg/kg) injection 31 days after the last PCP injection 
confirming persistent changes induced by withdrawal from subchronic 
PCP 9) showed that neither PCP hyperactivity nor abolition of delay 
sensitive in reduction in total object exploration was clozapine or 
donepezil treatment. 
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8.1 Differentiation between the effects of PCP withdrawal 
and isolation rearing in the OPC and OP recognition task 
 
The OPC recognition task recapitulates the human episodic memory 
definition defined by Tulving as the capacity to recollect an event in 
time and place (what-where-when) (Tulving, 1983). On the other hand, 
the OP recognition task is a one trial object recognition task and only 
assesses what-where, therefore this task is more associated with 
working memory and the capacity to remember the previous situation 
(Ennaceur and Delacour, 1988, Dere et al., 2007). Both tasks were 
matched for the number of days of the procedure and the number of 
conditions by delays, only the number of sample phases was different 
(i.e. two sample phases for the OPC task and one sample phase for the 
OP task).The choice of this protocol has been decided in order to 
investigate further the effect of the second trial (context dependent 
task) on total object exploration deficit seen in the OPC task after a 
longer delay. 
 
PCP withdrawal and isolation rearing models demonstrated different 
patterns of results in OPC and OP tasks. Indeed, in the OPC task but 
not in the OP task after 5 minutes, PCP withdrawal rats were impaired 
in their capacity to discriminate the new object (experiment 2 and 3: 
Figure 3.7 and Figure 3.10). On the other hand, in both tasks, isolated 
rats did not show any impairment compared to the control group and 
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were impaired after 10 minutes delay in the OPC task (experiment 4: 
Figure 4.3) and not impaired in the OP task after 10 minutes delay 
(experiment 5: Figure 4.6). Interestingly, it is important to note that 
before the OPC and the OP recognition task the isolated rats have 
been previously tested and have been shown to be impaired on a one 
trial object recognition task with a delay of 1 hour between sample and 
test, replicating results from previous studies (Appendix 1.2) (Bianchi et 
al., 2006, McLean et al., 2008). Therefore, it cannot be argued that 
isolated rats were not impaired due to incomplete isolation during 
rearing or an other procedural problem. One possible explanation for a 
lack of effect of isolation rearing is the short delay interval between the 
two samples and the test phase (5 and 10 minutes).  The likelihood of 
identifying a deficit between the control and the experimental group is 
necessarily short and only animals which cannot discriminate the 
newest combination after 5 minutes delay can be identified as impaired 
in episodic memory. Also, isolated rats show a much more robust 
memory in object recognition task compared to PCP withdrawal rats. In 
prior studies in female rats PCP withdrawal rats were impaired after a 1 
minute delay (Grayson et al., 2007, McLean et al., 2009) and male after 
10 minutes delay in object in place (i.e. chapter 4, OP recognition task), 
while isolated rats were impaired in the object recognition task after 1 
hour (Appendix 1.2) (Bianchi et al., 2006, McLean et al., 2008). Thus, 
isolation rearing induces a general milder impairment in memory 
compared with that associated with withdrawal from subchronic PCP 
administration. 
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 On the other hand during the OP task, PCP treated rats showed 
a deficit at 10 minutes but not 5 minutes delay (experiment 3: Figure 
3.10). Previous studies found that PCP-treated rats were not able to 
discriminate the familiar object from the new one even after 1 minute 
delay (Grayson et al., 2007, McLean et al., 2009). The OP recognition 
task developed in this chapter assessed spatial-working memory as 
only the combination of object and place created the newest 
environment and not the object or the place on their own, therefore 
there was no purely spatial orientation involved in this task. Thus, the 
task specificity of the OP recognition may have influenced PCP-treated 
UDWV¶ FDSDFLW\ WR UHPHPEHU WKH FRPELQDWLRQ RI WKH REMHFW DW D QHYHU
encountered place after 5 minute delay. Also, as PCP-treated rats were 
not impaired after 5 minutes delay in the OP task, it suggests that PCP-
treated rats have a general tendency to explore a new environment and 
that their impairment after 10 minutes delay or in the OPC task was 
only due to a longer retention delay or task difficulty and not to their 
lack of interest in novelty. 
 
These results clearly established a robust impairment in both OPC and 
OP tasks induced by PCP withdrawal which was not the case for 
isolation rearing.  Therefore, withdrawal from subchronic PCP model 
appears to be a better model to investigate the episodic memory deficit 
in this OPC task. It also support previous suggestions that the OPC 
task and the OP task investigate different types of memory (different 
delays of retention between the OPC and the OP tasks) as previously 
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demonstrated in other studies (Eacott and Norman, 2004, Langston 
and Wood, 2009).  
 
8.2 Differentiation between OPC recognition task and OP 
recognition task 
 
A direct comparison of results, between the OPC and the OP tasks 
clearly suggests that both tasks investigated different types of memory 
and lower DI, after 10 minutes delay, in the OPC task suggests that it is 
a more complex task than the OP task. Control and isolated/group 
housed rats performed better in the OP task (memory not impaired 
after 10 minutes delay) than in the OPC task (memory impaired after 10 
minutes delay).  This was also the case for PCP withdrawalrats which 
showed memory impairment after 5 minutes delay in the OPC task but 
not in the OP task. Previous studies using both tasks also clearly 
established a differentiation between the two tasks (Eacott and 
Norman, 2004, Langston and Wood, 2009). Indeed, after fornix (Eacott 
and Norman, 2004) or HPC (Langston and Wood, 2009) lesion both 
studies showed that animals were able to perform the OP task but not 
the OPC task after 2 minutes delay. In both studies, they concluded 
that both tasks assess different types of memory such that OPC is 
investigating episodic memory and OP investigating working memory 
(Eacott and Norman, 2004, Langston and Wood, 2009).  
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PCP-treated rats were relatively more impaired into their capacity to 
integrate the context as a part of the information of a coherent memory 
(OPC task) compared to when the memory did not involve context 
specificity (OP task). In the OPC task, PCP withdrawal rats did not 
integrate the context as part of the information and, in the test phase, 
cannot differentiate the two objects as both of the objects had been 
previously seen in those places but in different contexts (sample phase 
1 and 2). On the other hand, when the task does not involve context 
discrimination (OP task), PCP-treated rats were able to distinguish the 
newest combination of place and object, at least after 5 minutes.  
These results are reminiscent of human studies in schizophrenia which 
highlighted a context memory deficit which demonstrated difficulties for 
schizophrenic patients to bind different memory components such as 
the context of the information in episodic memory (Cohen and Servan-
Schreiber, 1992, Bazin et al., 2000, Waters et al., 2004). Therefore, in 
the OPC task, the context appeared to be crucial and characteristic of 
episodic memory definition which refOHFWV UDWV¶ FDSDFLW\ WR LQWHJUDWH
different features (place and object) within a specific context in which 
event has co-occurred. 
 
Furthermore, it has been found that in the OPC task but not in OP task, 
there was a delay dependent reduction in total object exploration in 
controls that was not seen in PCP withdrawal or isolated rats. 
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8.3 Total object exploration time is delay dependent in 
the OPC task but not in the OP task  
 
In all experiments (experiment 1, 2, 4, 6 and 7), in control groups, delay 
induced D GHFUHDVH RI UDW¶V H[SORUDWLRQ during the test phase. Rats 
spent less time exploring both objects at 5 min delay compared to 10 
minutes delay.  
 Multiple exposures to a context will lead to a diminution of 
exploration because rats will learn that there is no novelty present and 
therefore they will explore the open field less during the second 
exposure (Broadbent et al., 2009). Rats will be habituated to the 
context. Habituation is defined as the waning of a behavioural response 
due to the repetition of a stimulus. Two forms of habituation can be 
distinguished, the long-term and the short-term forms (Hinde, 1954, 
1970, van der Staak, 1977).  In the OPC recognition task the long term 
habituation is the repetition of the task, more a task is repeated more 
the rats will be habituated to the contexts and the objects, therefore, the 
less they will explore them the next time they will encounter them 
(Broadbent et al., 2009). Thus, exploration should decrease day by 
day, which was the case as shown in sample phase (experiments 2, 3, 
4, 5, 6 and 7: Figure 3.6, 3.9, 4.2, 4.5, 5.2 and 6.2). The short term 
habituation is within the task itself, rats should explore more during the 
test phase compared to the sample phase as the objects and context 
will appear more familiar. Also, when the delay is increased between 
the sample phase and the test phase rats should explore more as there 
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is a dishabituation of the context and the objects (they become less 
familiar). The faster the rats are re-exposed to a context the greater the 
habituation will be (Hinde, 1970, van der Staak, 1977). In the OPC task 
in experiments 2, 4, 6 and 7, when the delay increased, from 5 to 10 
minutes, there was a reduction rather than an increase in time spent 
exploring the objects, therefore short term habituation is unlikely to 
explain the effect obtained.   
 
If the postulate is that rats explore the familiar less (Powel et al., 2004; 
Broadbent et al., 2009), it is possible that after 10 minutes delay the 
environment, which is the association of the context and the objects 
(context-object association) seems more familiar than after 5 minutes 
delay. One of the possible reasons for this diminution of objects 
exploration could therefore be that rats after 10 minutes delay were 
more confused than after 5 minutes delay by the similarity of the 
context-object association during the test phase compared to the 
context-object association during the sample phases 1 and 2. Total 
object exploration time is reduced after a longer delay because rats are 
more confused, they do not fully remember the previous context-object 
association seen during the sample phase 1 (context-object association 
look similar). Rats did not remember that the context-object association 
was different between the test and the sample phase 1. In other words, 
after a short delay rats remembered the sample context-objects 
association but not after a longer delay which was leading to less 
exploration.  
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 In the OP task in which contextual information had been kept 
constant and therefore not necessary for object recognition, the delay-
induced decrease in total object exploration was not seen (experiments 
3 and 5: Figure 3.11 and 4.7). This might suggest that total object 
exploration differences seen in PCP-treated rats and isolated rats may 
reflect an abnormality in processing contextual information that was 
common to both models. Contextual processing deficits have been 
widely reported in schizophrenia (Cohen and Servan-Schreiber, 1992, 
Bazin et al., 2000, Waters et al., 2004). However, it cannot be 
concluded that isolated rats have impairment in the explicit recall of 
contextual information as they successfully performed the OPC task 
(which requires contextual information) as well as controls. One 
potential explanation might be that rats can use two potential strategies 
to solve the task, one based on familiarity with one or more of the 
components (object, place, context) encountered during the test phase 
and one based on remembering the context-object association 
previously seen. It has been recently shown that rats can use 
familiarity/recall strategies in task that involved odour discrimination 
associated with reward (Fortin et al., 2004) and also in the E-shape 
recognition task based on rats spontaneous tendency to explore 
novelty (Table 1.10) (Eacott and Easton, 2007). Scrub jays are also 
able to remember a past situation in order to act at a present time 
which suggests that animals can mentally travel in time and can 
remember previous events (Clayton and Emery, 2009). This 
interpretation of the results might suggest that knowing (DI) and 
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remembering (delay-induced total object exploration reduction) are 
dissociable within the OPC task but not within the OP task. PCP but not 
isolation rearing disrupts knowing (experiments 2 and 4) while both 
PCP and isolation disrupt remembering (experiments 2 and 4). 
 
 This capacity to remember the context-object association as indexed 
by reduced delay-induced total object exploration may be analogous to 
autonoetic awareness or remembering the past situation, which is 
distinguishable from noetic awareness or knowing which will be in this 
case the capacity to discriminate the most familiar object at the present 
time (test phase). To remember the context-object association of both 
sample phases and test phase is the capacity to compare events in 
time, and to be able to refer to a past situation in order to behave in a 
present situation (e.g. increase or decrease exploration). This 
LQWHUSUHWDWLRQRIWRWDOREMHFWH[SORUDWLRQFRUUHVSRQGVWR7XOYLQJ¶VZKDW-
where-where definition of episodic memory (Tulving, 1983).  In this 
FDVH WKH ³ZKDW´ZLOOEH WKHFRQWH[W-REMHFWDVVRFLDWLRQ WKH ³ZKHQ´ZLOO
be during the first exposure of the sample phase (first event: sample 
phase 1 compared to the second event: sample phase 2) and the 
³ZKHUH´ZLOOEHWKHFRQWH[WRIWKHILUVWH[SRVXUH 
 However, in experiment 1, which looked at a number of different 
delays at 15 minutes delay, rats were still able to discriminate the new 
object in place and context (experiment 1: Figure 2.5), even if rats did 
not fully remember the difference between context-object associations 
from the sample compared to the test phase. That was not the case in 
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other experiments (experiment 2, 4, 6 and 7) in which, for control 
group, lRZHUH[SORUDWLRQZDVDOZD\VDVVRFLDWHGZLWKUDWV¶LQFDSDFLW\WR
discriminate the new object in place and context. This result does not 
contradict the previous statement, as the capacity to discriminate the 
newest object configuration is based on familiarity and refers to 
knowing or to the noetic awareness and this is distinct from autonoetic 
awareness which refers to remembering the context-object association 
(Tulving, 1985, 1986, 2002, Tulving, 2005). Therefore, rats could 
potentially recognise the new object in place and context only based on 
which object shares the most familiar aspects in term of place and 
context. This discrimination of the newest object configuration refers to 
7XOYLQJ¶V GHILQLWLRQ RI HSLVRGLF Pemory (Tulving, 1983) as the 
recollection of an object in place and context (what, where and 
which/when), however, it does not necessarily refer to rats capacity to 
remember the previous events as the task could be potentially solved 
with familiarity toward one or more of the three dimensions (objects, 
places and contexts).  
 
Mumby et al., (2002) studied the effect of HPC lesion in rats in object 
recognition, place recognition and context recognition task (Figure 8.1). 
They rank ordered object recognition tasks according to complexity with 
object recognition being easier than place or context recognition. While 
these authors were explicitly studying lesion effects and do not discuss 
this effect, examination of figure 2 (see figure 8.1) below shows that 
increasing  complexity is associated with decreasing total object 
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exploration  at test, in the absence of differences in exploration times in 
the sample phase. It is possible therefore that a new object could be 
more salient than a new place or context.  
 
Figure 8.1: Time engaged in object exploration during the familiarisation and 
test phases for each trial type (Object recognition, place recognition and 
context recognition). For context trials data are shown separately for the first 
(1) and second (2) familiarization phases. Error bars represent SEM. (From 
Mumby et al., 2002). 
 
Good et al., (2007a) also studied the effect of HPC lesion in rats in 
different object recognition paradigms (e.g. object recognition, temporal 
and spatial context recognition, and spatio-temporal context 
recognition).  Examination of total time spent exploring object 
(approximate time spent in second on the new object + time spent on 
the familiar object)  according to the results presented in figure 2 (see 
figure 8.2) highlights similar results to those in Mumby¶VVWXG\ (Mumby 
et al., 2002) with a decrease of total object exploration depending of the 
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task complexity, with higher exploration when the object-context 
association in the test phase shared less similarity than in the sample 
phase (e.g. spatio-temporal context recognition as less similarity than 
spatial recognition). However, in this study, they did not report 
exploration time of the sample phase. 
 
Figure 8.2: Approximate summation of the time spent exploring objects in the 
test phase during the novelty, temporal, spatial context and spatio-temporal 
context tests in sham rats and rats with hippocampal lesions (From Good et al., 
2007a). 
 
These results are reminiscent of the findings in the present thesis. This 
could suggest that the more a task is complex the less the rats 
explored the objects. In the OPC task, total object exploration time is 
reduced after a longer delay, but not after a short delay, because 
context-object association in the test appeared more complicated to 
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distinguish from the context-object association seen in the sample 
phase 1. Sample phase 2 is interfering between sample phase 1 and 
test phase which makes the whole context-object association similar 
during the test phase and the sample phase 1. In both studies (Mumby 
et al., 2002, Good et al., 2007a), sham rats were able to discriminate 
the newest combination of objects compared to a more familiar one in 
every paradigms, which suggests that decrease in total object 
exploration is independent from rats ability to recall which object is new 
at test time. Thus, it could be  possible to postulate that, in the OPC 
task, rats can use two potential strategies to identify a new object in 
place and context, one based on simple recognition (does this look 
familiar?) and one based on contextual recognition of the objects (does 
it the same context and objects?). These two strategies may 
correspond to the current distinction between knowing/remembering in 
episodic memory (Tulving, 2002) 
 
 
The delay-induced deficit was abolished by both PCP withdrawal and 
social isolation (experiment 2, 4, 6 and 7: Figure 3.8, 4.4, 5.3 and 6.4). 
The delay effect on total object exploration could be interpreted as 
remembering or autoQRHWLF DZDUHQHVV GHILFLW DQG UDW¶V FDSDFLW\ WR
discriminate the familiar object in place depending of a context (DI) as 
knowing or noetic awareness.  
 Isolation rearing abolished delay induced total object exploration 
(remembering) but not their capacity to distinguish the newest object 
combination (knowing) is consistent with studies showing that episodic 
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memory in schizophrenia was impaired in remembering but not in 
knowing (Wheeler et al., 1997, Danion et al., 1999, Keefe et al., 2002, 
Riutort et al., 2003, Sonntag et al., 2003, Neumann et al., 2006). As, 
the behavioural effects of PCP in humans have been shown to persist 
for several weeks a (Jentsch and Roth, 1999, Enomoto et al., 2007, 
Seillier and Giuffrida, 2009), PCP withdrawal results in rats are 
consistent with human study using ketamine administration which 
showed impairment in both remembering and knowing (Hetem et al., 
2000), in this case is impairment in both total object exploration 
(remembering) and object recognition (knowing) (Table 8.1). 
Human 
Studies 
Autonoetic awareness 
(Remembering) 
noetic awareness 
(Knowing) 
Control group OK OK 
Schizophrenic 
patient* 
Ļ OK 
Ketamine/PCP 
human** 
Ļ Ļ 
OPC task 
(5 minutes delay) 
Total Object exploration 
(Remembering) 
Object-Place-
Context 
(Knowing) 
Control group OK OK 
Isolation rearing Ļ OK 
PCP withdrawal Ļ Ļ 
Table 8.1: Comparative study between human and animal showing a potential 
interpretation of the total object exploration and object-place-context 
recognition (DI) effect in PCP withdrawal and isolation rearing model of 
schizophrenia (*(Sonntag et al., 2003);**(Hetem et al., 2000)). 
 
It has been shown that people with schizophrenia have damage to the 
HPC which could be responsible for cognitive impairments including 
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episodic memory (Chambers et al., 1996, Shenton et al., 2001, 
Bergeron et al., 2005). Subchronic PCP administration, as well as 
isolation, induces some permanent disruption into the HPC such as 
dopaminergic hyperfunction (Jones et al., 1992, Pierce and Kalivas, 
1997, Hall, 1998, Cornish and Kalivas, 2001). On the other hand, HPC 
lesion in rats impairs performance in the OPC task. Similar deficit had 
been seen after PCP withdrawal but not isolation rearing (Eacott and 
Norman, 2004, Langston and Wood, 2009). Therefore, it can be 
suggested that subchronic PCP induces more damages into the HPC 
which provoke major memory impairment, such as in the OPC, OP and 
object recognition task, compared with that associated with isolation 
(only impaired in object recognition after 1h delay). Furthermore, in 
human, HPC damage or lesion impaired both recall and recognition 
(Wais et al., 2006). Thus, it will have been interesting to know if Eacott 
and Norman (2004) or Langston and Wood (2009) would have obtained 
similar delay-induced deficit as well as the impairment in recognition in 
their OPC task if they will have tested different delays with the HPC 
lesion in rats. 
 
Overall, these data suggest that the OPC task is sensitive to glutamate 
antagonists withdrawal and that it can identify highly specific memory 
impairments common to both PCP and social isolation rearing (total 
object exploration deficit). This suggests that this may prove to be a 
sensitive preclinical model for episodic memory impairments in 
schizophrenia. This model integrated contextual information which 
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provided dissociation between the noetic awareness 
(knowing/familiarity) and the autonoetic awareness 
(remembering/recall). Thus, PCP withdrawal model compared to 
isolation may be a relevant model to study a possible dissociative 
improvement induced by atypical antipsychotics such as clozapine or 
by cognitive enhancers such as donepezil in both the autonoetic and/or 
the noetic awareness aspect of the OPC task. 
 
8.4 Donepezil but not clozapine restore the PCP-induced 
deficit in episodic memory but not the delay-induced 
deficit in total object exploration 
 
Donepezil (0.3 mg/kg) has been shown to increase performance in 
saline-treated rats and to restore the PCP-induced deficit in the OPC 
recognition task (experiment 7: Figure 6.3). In rodents donepezil has 
been shown to restore the NMDA antagonist-induced deficit in spatial 
reversal learning, contextual and cued memory, and one-trial object 
recognition (Csernansky et al., 2005, Kunitachi et al., 2009) and 
improve episodic contextual memory in middle aged mice (Béracochéa 
et al., 2007). This finding corroborates previous human studies which 
have also revealed episodic memory improvement after donepezil 
administration (Grön et al., 2005). Results are consistent with these 
findings as in the present study at the 10 minutes delay donepezil rats 
showed clear object discrimination where controls did not, suggesting 
that it enhances basal memory performance. AChEIs have been tested 
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in initial clinical trials in schizophrenia some studies suggesting a 
beneficial effect in general cognitive impairment (e.g., Rey Auditory 
Verbal Learning Test (RAVLT); Wisconsin Card Sorting Test (WCST); 
selective attention Digit Span Distraction Test (DSPT)) in schizophrenia 
but others demonstrating minimal benefits (Friedman et al., 2002, 
+RZDUGHWDO/LGGOH%XFKDQDQHWDO7X÷DO2HW
al., 2004, Keefe et al., 2007, Risch et al., 2007, Chung et al., 2009). 
The studies performed to date have however used general cognitive 
assessment batteries typically measuring executive function and 
attention and do not include specific tests of episodic memory. While 
large scale double blind studies are required to fully assess the 
therapeutic potential of AChEIs, our study suggests that episodic 
memory impairment in particular might benefit from the effects of 
AChEIs in schizophrenia. 
 Delay-induced reduction in total object exploration time was 
abolished in PCP-saline group as in other experiments but donepezil 
failed to restore it (experiment 7: Figure 6.4). According to our 
interpretation of what total object exploration time reduction is 
measuring it could be that donepezil restored the noetic awareness 
(knowing, which object in place in this context is new?), but did not 
improve the PCP-induced deficit in autonoetic awareness 
(remembering, is it the same context-objects association?). 
 Therefore, it is possible to conclude a role of the cholinergic 
system in memory (Bontempi et al., 2003, Bullock and Dengiz, 2005, 
Seltzer, 2005) including episodic memory (Grön et al., 2005). In 
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animals, interactions between the cholinergic and glutamatergic 
systems have been established in some forms of memory such as 
spatial reversal learning, contextual and cued memory, and one-trial 
object recognition (Csernansky et al., 2005, Kunitachi et al., 2009). 
During episodic memory, acetylcholine may facilitate glutamate activity 
by coordinating states of acquisition and recall in the cortex and the 
HPC (Cox et al., 1994). Cholinergic projections modulates the 
glutamatergic pathway into the HPC and is responsible for encoding 
new information into different hippocampal subregions (Yun et al., 
2000).   In order to corroborate our findings, further analysis with 
donepezil in humans using specific tasks which investigate the 
knowing/remembering part in schizophrenia would be of future interest. 
 
Clozapine did not reverse the PCP-induced deficit in OPC task 
(experiment 6: Figure 5.3), and total object exploration could not have 
been investigated further as clozapine treated rats explored less than 
non clozapine treated rats due to a sedative effect (experiment 6: 
Figure 5.4) (Kumra et al., 2008, Wiley, 2008). However no disruption in 
DI in clozapine treated rats suggests that in this task this degree of 
sedation did not confound memory performance. The present findings 
confirm that this reversal does not extend to episodic memory defined 
as memory for what-where-when while the present findings suggest a 
reproduction of the lack of clinical effectiveness of antipsychotics such 
as clozapine to treat episodic memory deficits in schizophrenia seen in 
schizophrenia in RBMT or AMI test (Riutort et al., 2003, Al-Uzri et al., 
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2006). It is possible that clozapine may have an influence at a higher 
dose than that tested here. This is unlikely, as at this dose clozapine 
reverses PCP- and MK801 (a non-competitive NMDA receptor 
antagonist) induced deficits in one-trial object recognition (Hashimoto et 
al., 2005, Grayson et al., 2007, Karasawa et al., 2008). These studies 
used one-WULDOREMHFWUHFRJQLWLRQWDVNVDGGUHVVLQJ³ZKDW´ZKLFKREMHFW
is new?), that only refer to a previous event, and are considered as 
working memory tasks (Ennaceur and Delacour, 1988). This is in 
contrast to OPC recognition in the present study which requires a 
comparison between events. The possibility that these tasks may be 
dissociable is suggested by the finding that fornix/HPC lesion does not 
impair one-trial object recognition but does impair OPC recognition 
(Eacott and Norman, 2004, Langston and Wood, 2009). However, 
further studies using a variety of doses and antipsychotics including 
perhaps the putatively antipsychotic mGluR2/3 agonists, are warranted 
before such a conclusion could be definitively drawn (Gold and 
Weinberger, 1995, Harvey and Keefe, 2001, Riutort et al., 2003). 
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8.5 Long lasting impairment in locomotor activity 
induced by subchronic PCP treatment is not restored by 
chronic clozapine or donepezil injections  
 
 
These data demonstrated a robust hyperactivity in PCP withdrawal rats 
after acute PCP challenge. Sensitisation was observed 31 days after 
the last PCP injection when challenged with 3.2 mg/kg PCP. Neither 
donepezil nor clozapine administred chronically during the OPC task 7 
days before LMA reversed PCP sensitization. Also, data confirmed that 
clozapine (5 mg/kg) but not donepezil (0.3 mg/kg) induced sedation in 
rats which last for more than 110 minutes after injection. 
 
Subchronic PCP treatment produced a long lasting effect which was 
lasting for at least 31 days. Indeed, PCP-treated rats are hyperactive 
after an acute PCP (3.2 mg/kg) compared to saline-treated rats 
(experiment 8 and 9: Figure 7.4 and 7.5). This locomotor activity has 
been used to model psychosis in animals (Goldman-Rakic, 1996, 
Verma and Moghaddam, 1996). Also, subchronic PCP exposure 
attenuates the PFC dopaminergic release induced by a single PCP 
injection (Jentsch et al., 1997b) and after an acute PCP challenge, this 
attenuation of dopamine efflux is interpreted as a reduction of 
dopamine neurons in the PFC (Jentsch et al., 1997a, Jentsch et al., 
1997b, Easton et al., 2008). Chronic clozapine treatment (9 days 
treatment) received during the OPC task and LMA task 7 days earlier 
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did not reverse the PCP hyperlocomotion induced by PCP challenge in 
subchronic PCP rats (Figure 7.4). Previous studies in rats have shown 
that acute clozapine (10 mg/kg i.p.) reverses the PCP (3.2 mg/kg i.p.) 
challenge-induced effect on locomotor activity 48 hours after injection in 
chronic PCP-treated rats (20 mg/kg s.c. once a day for 5 days) (Phillips 
et al., 2001)and that chronic clozapine administration (10 mg/kg i.p. 
once a day for 14 days) reversed, 11 days after treatment, the acute 
PCP (7.5 mg/kg i.p.) -induced hyperlocomotor activity (Abekawa et al., 
2007). Thus, in LMA task, the long term effect of the chronic PCP 
treatment had never been investigated after such a long period of time 
and appeared to be robust. Also, chronic clozapine treatment did not 
restore the deficit which could be due to the delay (7 days) between the 
last clozapine injection and the PCP challenge task. Also, chronic 
donepezil (8 days treatment) did not reverse hyperlocomotor activity 
induced by NMDA antagonist (experiment 9: Figure 7.5) as it has been 
previously shown in other study (Csernansky et al., 2005). However, in 
humans, clozapine withdrawal induces abnormal behaviour, psychosis 
symptoms and dopaminergic supersensitivity (Borison et al., 1988, 
Shore et al., 1995, Stanilla et al., 1997), which could explain why PCP-
clozapine and saline-clozapine group had a tendency to be more 
hyperactive than PCP-saline and saline-saline group respectively 
(experiment 10:  Figure 7.5) after the acute PCP injection. 
 
The clozapine (5 mg/kg) dose used during the LMA task produced 
significant sedation which was clearly established by a reduction of 
   195 | 
 
locomotor activity 40 minutes after injection. This result confirmed 
previous finding about the sedative effect of clozapine in patients and 
rodents (Kumra et al., 2008, Wiley, 2008) and can explain the low 
object exploration observed during the OPC task. However, clozapine 
VHGDWLYH HIIHFW GLG QRW LPSDLU UDW¶V FDSDFLW\ WR GLVFULPLQDWH QHZ
environment. On the other hand, donepezil did not induce any 
difference in locomotor activity task compared to control group which is 
consistent with a previous study (Sonkusare et al., 2005). 
 
8.6 Conclusion 
 
 
- The OPC recognition task has been refined and previous results found 
in the original study by Eacott and Norman (2004) replicated. 
- It has been demonstrated that PCP withdrawal rats but not isolated rats 
are impaired in the OPC task, however they both demonstrate 
impairment into total object exploration during the test phase compared 
to control groups. These results could suggest that the task can 
differentiate between autonoetic awareness (total object exploration, is 
the context-object association familiar?) and the noetic awareness 
(capacity to discriminate the newest combination of object, place and 
context). If confirmed this would corroborate findings in human studies 
on episodic memory with NMDA antagonist and with schizophrenic 
persons. 
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- A task specificity has been shown between a two sample recognition 
task (the OPC recognition task) compared to a one-sample recognition 
task (OP recognition task). 
- It has been found that donepezil but not clozapine restore the PCP-
induced deficit in OPC recognition task as a model of episodic-like 
memory which suggests a role of AChEIs in cognitive deficit in 
schizophrenia. However neither clozapine nor donepezil restored the 
total object exploration noticed during the test phase which could reflect 
the limitation of AChEIs into autonoetic aspects of cognitive 
improvement in schizophrenia. 
- In summary these studies have shown that OPC recognition in rats 
may have some potential as a behavioural measure for animal models 
of episodic memory in schizophrenia. 
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- APPENDIX ± 
 
 
1.1 Material, method and results of the behavioural task 
that isolated rats performed before the OPC task and OP 
task (From Caitlin Jones: 1st Year Treansfert Report, July 
2008). 
 
 
 
Figure 4.1: Summary of experimental procedures underwent by the isolated rats 
before the OPC or the OP task. 
 
1.1.1 Appendix 1: Locomotion and Rearing Activity in a Novel 
Environment on PND 58 
 
Locomotion (LMA) and rearing activity was measured using 12 
automated infra-red activity monitors consisting of plexiglas cages 
(39cm x 23.5cm x 24.5cm) with wire mesh lids and exchangeable 
floors, fitted with 2 layers of 5 parallel horizontal photobeams (designed 
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by Dept. Medical Physics, University of Nottingham, Nottingham, UK). 
The consecutive breaking of 2 adjacent photobeams in the lowest set 
of beams, situated 9 cm from the bottom of the cage produce counts of 
ambulatory locomotor activity. The breaking of any individual beam 
located in the upper set (20 cm from the bottom of the cage) produced 
counts indicative of rearing activity. Cumulative beam break counts 
were automatically recorded by computer software (Activity Monitor 
Alias, Dept. Medical Physics, University of Nottingham, 
UK) in 5 min time epochs for a period of 60 min and store for 
subsequent off-line analysis. 
 
 1.1.1.1 Data Analysis 
 
LMA and rearing activity were calculated as mean ± SEM activity per 5 
min for each group. Mean ± s.e.m. total LMA and rears over 60 min 
were also calculated. 
 
A repeated measures analysis of variance (RM ANOVA) was used to 
analyse LMA datD+RXVLQJFRQGLWLRQZDVVHWDVWKH³EHWZHHQ´YDULDEOH
LQ DOO VWXGLHV ZKLOVW WLPH ZDV LGHQWLILHG DV ³ZLWKLQ JURXS´ YDULDEOHV
Post ± KRF DQDO\VHV ZHUH SHUIRUPHG E\ %RQIHUURQL¶V ZKHUH
DSSURSULDWH 6LJQLILFDQFH OHYHOV ZHUH VHW DW S DQG DOO DQDO\VHV
were performed using GraphPad Prism® v.4.0.3 (GraphPad Software 
Inc, San Diego, USA). Any raw data values which were ± 2 X standard 
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deviations (SD) away from the mean were deemed outliers and not 
included in subsequent data analyses. 
 
1.1.1.2 Result 
 
Housing animals in social isolation increased novelty-induced LMA 
(Appendix 1.1). A repeated measures analysis of variance (RM 
ANOVA) revealed a significant difference between the LMA of GH and 
SI animals (F(11,198)   S ZLWK D SRVW-hoc Bonferroni test 
indicating hyperactivity in SI compared to GH controls. LMA decreased 
over time in both groups of animals but this was significantly faster in 
GH controls (main effect ANOVA F(11,198)    S 7KHUH
was no interaction between Housing Condition X Time. Furthermore, 
DQXQSDLUHG6WXGHQW¶VW-test identified a significant greater total LMA in 
6,DQLPDOVS)LJXUHLQVHW 
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Appendix 1.1: Rearing Lister Hooded rats in social isolation from weaning 
increases their spontaneous locomotor activity in a novel area. Group housed 
(squares and GH in the inset) or socially isolated (triangles and SI in the inset) 
animals (n =10 per group) are placed in automated photobeam activity cages for 
60 min. LMA is represented as activity counts (beam breaks) per 5 min (main) or 
the total LMA over 60 min (inset). Data are presented as mean activity ± s.e.m. 
IRU HDFK UHDULQJ FRQGLWLRQ    S E\ XQSDLUHG 6WXGHQW¶V W-test vs. GH 
controls. 
 
1.1.2 Appendix 2: Recognition of a Novel Object in a Familiar 
Environment on PND 59 
 
The novel object recognition task was adapted from studies initially 
described by and based on those previously described by Marsden and 
colleagues (Bianchi et al., 2006; Lapiz et al., 2003). 24 h following the 
measurement of locomotion and rearing activity, animals were re-
habituated to the same infra-red activity monitor cages for a period of 3 
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min. Animals were then returned to their homecages for 1 min whilst 2 
identical objects (upturned 8 cm x 5 cm water-filled, plastic bottles 
covered with white masking tape) were placed securely in each activity 
cage. During this familiarisation trial (T1), animals were allowed to 
explore both objects for a total period of 3 min and the time (sec) spent 
exploring each object is recorded manually. Following an inter-trial 
interval (ITI) of 2 hours (based on previously published findings by 
(King et al., 2004) which was spent in their homecages, animals were 
reintroduced to the activity cage whereupon one of the familiar objects 
was replaced with a novel object (an upturned 8 cm x 5 cm waterfilled 
plastic bottle covered in white masking tape, with 3 additional 1.2 cm 
black stripes). During this choice trial (T2), exploration of either object 
was recorded as previously described for T1. Objects were located in 
the front left and back right of the cage, 5 cm from the side and 10 cm 
from the back of the cage. The location of the novel object varied in a 
pseudorandom order within groups and both objects and cages were 
cleaned with 20% w/v ethanol (EtOH) between trials to remove any 
olfactory cues. Exploratory behaviour was defined as sniffing, touching 
and direct attention to the object - indicated by moving vibrissae whilst 
the nose was within 1 cm of the object. Climbing on or chewing the 
object were not considered as exploratory behaviours and therefore not 
counted.  
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1.1.2.1 Data Analysis 
 
Data were calculated according to methods established by Ennaceur 
and Delacour (Ennaceur and Delacour, 1988) and previously described 
by (Bianchi et al., 2006). In order to discern mean total exploratory 
behaviour (± s.e.m.), the total time spent exploring both objects in the 
familiarisation (Object 1 (s) + Object 2 (s)) and choice 
(Novel (s) + Familiar (s)) trials were calculated for each animal. Data 
were presented as the mean exploration time (s) for each object ± 
s.e.m. for each group. In order to established the ability of either group 
to discriminate between the familiar and novel object in the choice trial, 
two discrimination ratios were calculated according to the following 
equations; 
D1 = Novel (sec) ± Familiar (sec) 
 
D2 =Novel (sec) ± Familiar (sec) 
       Novel (sec) + Familiar (sec)  
 
Data are presented as mean D1 and D2 ± s.e.m. for each treatment 
group. 
 
Statistical differences between groups both in the familiarisation and 
choice trials in the NOR task were identified using paired StuGHQW¶V W-
tests, whilst D1 and D2 ratios were analysed one-way ANOVA and post 
KRF %RQIHUURQL WHVWV 6LJQLILFDQFH OHYHOV ZHUH VHW DW S DQG DOO
analyses were performed using GraphPad Prism® v.4.0.3 (GraphPad 
Software Inc, San Diego, USA). Any raw data values which were ± 2 X 
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standard deviations (SD) away from the mean were deemed outliers 
and not included in subsequent data analyses. 
 
1.1.2.2 Result 
 
Social isolation induced recognition memory deficits in rats. During the 
familiarisation trial of the NOR task, both GH and SI rats spent an equal 
amount of time exploring both identical objects (Appendix 1.2; A) with 
no significant place preference for either object. During the choice trial 
(Appendix 1.%*+DQLPDOVVSHQWDVLJQLILFDQWO\ORQJHUSE\
6WXGHQW¶VSDLUHGW-test) time exploring the novel rather than the familiar 
object whist SI animals spent equal time exploring both objects. Failure 
to recognise the novel object was confirmed by statistical analyses of 
the D1 and D2 discrimination ratios (Appendix 1.2; C and D). In both 
cases, the indices of SI animals were significantly lower than those of 
WKH*+DQLPDOVSLQDOOFDVHV7RWDOREMHFW-directed exploration 
time significantly decreased between the familiarisation and choice 
WULDOV LQ ERWK JURXSV RI DQLPDOV S DQG S IRU *+ DQG 6,
DQLPDOVUHVSHFWLYHO\E\SDLUHG6WXGHQW¶VW-test). 
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Appendix 1.2: Animals reared in social isolation demonstrated NOR deficits. 
The time spent exploring two identical objects in the familiarisation trial (A) and 
a novel and familiar object in the choice trial (B) are presented as mean sec ± 
s.e.m. (n=10 per group). Each trial is separated by an ITI of 2 hours. The ability 
to discriminate between the novel and familiar object is calculated as 
GLVFULPLQDWLRQ UDWLRV ' DQG ' PHDQ  VHP & DQG '    S   
SE\SDLUHG6WXGHQW¶VW-test from GH control. 
 
1.1.3 Appendix 1.3: Prepulse Inhibition of the Acoustic Startle 
Response on PND 65 
 
All studies were carried out based on those previously reported by 
Geyer and colleagues (Geyer et al., 1993; Varty et al., 2000). Studies 
were conducted using four SR-Lab (San Diego Instruments, San Diego, 
USA) startle response systems. Each system consisted of a clear 
Plexiglas non-restrictive cylinder (8.8cm x 19.5cm) mounted on a solid 
perspex base situated inside a well lit (15W) and ventilated sound 
attenuating chamber (39cm x 38cm x 58cm). Background noise (65dB) 
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and acoustic stimuli ± 120dB startle response and 76dB, 80dB and 
84dB prepulse stimuli  produced by a noise generator controlled by SR-
Lab and administered through a microphone located 24cm above the 
restraint chamber. Individual whole body startle responses were 
transduced by a piezoelectric accelerometer attached to the base of the 
system and recorded as 100 x 1-msec readings by Startle Reflex 
Testing software (San Diego Instruments, San Diego, USA) starting 
from the initiation of the startle pulse. Each chamber was calibrated 
prior to experimental use to ensure consistent readings. animals were 
placed in the startle chambers receiving 65dB background noise for an 
acclimatisation period of 5 min. Animals were then exposed to a series 
of ten 120dB pulse alone (120PULSE) trials in order to familiarise each 
animal with the 120dB tone. Once completed, animals underwent 46 
pulse alone or prepulse + pulse trials consisting of a 120dB, 20 msec 
startle tone or a 40 msec 76dB (76PP120), 80dB (80PP120) or 84dB 
(84PP120) tone followed by a startle tone. The interval between the 
prepulse and pulse tones was set as 100 msec. All trials were 
administered in a pseudorandom, unpredicitive order with a variable 
inter-trial interval. Each animal received 15 x 120dB trials, and 7 trials 
of each prepulse intensity in total. 
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1.1.3.1 Data Analysis 
 
Initial and final startle responses for each group were calculated as a 
mean ± s.e.m. of the five 120dB tone trials preceding and following the 
series of 46 prepulse + pulse and pulse alone trials respectively. 
Prepulse inhibition for each prepulse intensity (xxPP) was calculated 
using a Microsoft Excel spreadsheet according to the following 
equation and expressed as a percentage. 
 
%PPI = (mean 120PULSE) ± (mean xxPP120) 
      (mean 120PULSE) 
 
A repeated measures analysis of variance (RM ANOVA) was used to 
DQDO\VH33,GDWD+RXVLQJFRQGLWLRQZDVVHWDVWKH³EHWZHHQ´YDULDEOH
ZKLOVWSUHSXOVHLQWHQVLW\ZDVLGHQWLILHGDV³ZLWKLQJURXS´YDULDEOHV3RVW
± KRFDQDO\VHVZHUHSHUIRUPHGE\%RQIHUURQL¶VWHVWZKHUHDSSURSULDWH 
6LJQLILFDQFHOHYHOVZHUHVHWDWSDQGDOODQDO\VHVZHUHSHUIRUPHG
using GraphPad Prism® v.4.0.3 (GraphPad Software Inc, San Diego, 
USA). Any raw data values which were ± 2 X standard deviations (SD) 
away from the mean were deemed outliers and not included in 
subsequent data analyses. 
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1.1.3.2 Result 
 
Post-weaning social isolation had no effect on prepulse inhibition 
(Béracochéa et al.) of acoustic startle responses (Appendix 1.3). A 
repeated measure ANOVA identified a significant effect of prepulse 
intensity on %PPI (F(2,36)   S KRZHYHU QR VLJQLILFDQW
differences between rearing conditions were seen. ANOVA showed 
that %PPI increased with increasing prepulse intensity for all treatment 
groups. No significant Housing Condition X Prepulse Intensity 
interaction was present. Social isolation had no effect on the magnitude 
of the initial startle response when compared to group housed 
littermates (mean startle amplitude GH = 348±5; SI = 389±5). 
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Appendix 1.3: Raising animals in post-weaning social isolation did not disrupt 
prepulse inhibition (Béracochéa et al.) of the acoustic startle response. Startle 
responses were induced by a 120dB pulse, inhibition of the startle response 
was induced by 76dB, 80db and 84dB prepulse tones. Values represent mean 
%PPI ± s.e.m. (n=10 per group). A significant effect of increasing prepulse 
LQWHQVLW\ZDVLGHQWLILHGSE\UHSHDWHGPHDVXUHV$129$ 
 
1.1.4 Appendix 4: Conditioned Emotional Response Paradigm on 
PND 72 
 
All studies were based on those previously described by Marsden and 
colleagues (Fulford and Marsden, 1997; Saulskaya and Marsden, 
1995). using a two-way rat shuttle box consisting of a light side and a 
dark side (25 x 25 x 27 cm) separated by an automated trap door (8 x 8 
cm) linked to a shuttle box control and automated shocker (Panlab 
SLab, Barcelona, Spain). Animals were placed in the light side of the 
   238 | 
 
box for 30 sec, where upon a door into the dark side was automatically 
opened. The latency time for all four paws of the animal to transfer to 
the dark side was automatically recorded using a floor sensor by the 
computer software (ShutAvoid software v.1.8.2., Panlab S.L, USA) and 
caused closure of the inter-chamber door. Animals were allowed to 
explore the dark side for 30 sec before a conditioned stimulus 
(Csernansky et al.) consisting of a concurrent light and tone (3kHz, 
89dB) were administered continuously for 5 sec. The unconditioned 
stimulus (US) consisted of a mild inescapable 0.4mA footshock 
administered through a grid floor and was given in the final 1 sec of the 
CS. Each animal underwent a total of three CS/US trials separated by a 
fixed ITI of 55 sec. Upon completion of the conditioning trial, animals 
returned immediately to their home cages and the shuttle box was 
cleaned thoroughly with 20% EtOH between animals. 24 h and 48 h 
post-conditioning animals returned to the dark side of the shuttle box 
however no light/tone or mild footshocks were applied. The time spent 
in a frozen position was recorded manually for a maximum of 300 sec 
in both the retention (24h post conditioning) and extinction trials (48 h 
post conditioning). Freezing behaviour was defined as the complete 
absence of movement except that essential for respiration (including 
moving vibrissae) and adoption of a hunched posture. During the 
extinction trial, the CS was re-administered to the animals after initial 
freezing time has been measured for 300 sec, for a period of 5 sec and 
(re)freezing behaviour was monitored as described previously.  
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1.1.4.1 Data Analysis 
 
Data are presented as the mean total freezing time (sec) ± s.e.m. for 
each trial/condition in both experiments. 
 
A repeated measures analysis of variance (RM ANOVA) was used to 
analyse CER data. Housing FRQGLWLRQ ZDV VHW DV WKH ³EHWZHHQ´
YDULDEOHZKLOVWWULDOW\SHZDVLGHQWLILHGDV³ZLWKLQJURXS´YDULDEOHV3RVW
± KRFDQDO\VHVZHUHSHUIRUPHGE\%RQIHUURQL¶VWHVWZKHUHDSSURSULDWH
6LJQLILFDQFHOHYHOVZHUHVHWDWSDQGDOODQDO\VHVZHUHSHUIRUPHG
using GraphPad Prism® v.4.0.3 (GraphPad Software Inc, San Diego, 
USA). Any raw data values which were ± 2 X standard deviations (SD) 
away from the mean were deemed outliers and not included in 
subsequent data analyses. 
 
1.1.4.2 Result 
 
The freezing behaviour of SI animals was significantly reduced 
compared to that of GH control animals (Appendix 1.4). Following a 
significant RM ANOVA (F(1,36)  SDSRVW-hoc Bonferroni 
test highlighted reduced freezing behaviour in SI animals following all 
trial types compared with GH controls. A significant effect of trial type 
was also highlighted (F(2,36)  SLQGLFDWLQJWKDWDQLPDOV
froze for a longer during the CS alone trial (48h post-cue) when 
compared to the retention (24h) and extinction trials (48h pre-cue). The 
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Trial Type X Housing interaction did not reach statistical significance 
(F(2,36) = 0.48, p=0.62). 
 
Appendix 1.4. Socially isolated rats display impaired conditioned emotional 
responses following non-aversive inescapable foot shocks. GH or SI rats (n=10 
per group) were administered 3 light/tone cues paired with a 0.4mA foot 
shocks. Freezing behaviour was scored 24h and 48h later in the same context, 
in the absence and presence (48h post cue) of light/tone cues. Data presented 
as mean IUHH]LQJVHFVHP Svs. *+9HK Svs. GH Veh 
calculated by repeated measures ANOVA and post-hoc Bonferroni test. 
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2.1 Table (appendix 2.1) showing the time spent 
exploring each objects during the 3 minutes test phase 
in experiment 6 (chapter 5): ³7KHHIIHFWRIDQWLSV\FKRWLF
clozapine on PCP withdrawal-induced episodic memory 
GHILFLWLQUDWV´ 
 
 
 
 
P
<
0 
 
 
  
*P<0.05 significant difference in time exploring the novel OPC 
compared with the familiar OPC. 
 
  
Delay 
 
 
 
Treatment 
 
Total 
exploration 
 
Novel 
OPC 
 
Familiar 
OPC 
 
p value 
 
 
saline-saline 16.1655 9.594 6.5715 *<0.05 
5 minute saline-clozapine 6.97175 4.1705 2.80125 *<0.05 
 
PCP-saline 11.66972 5.898333 5.771389 >0.05 
 
PCP-clozapine 5.00475 2.335 2.66975 >0.05 
      
 
saline-saline 10.58825 5.8645 4.72375 >0.05 
10 minute saline-clozapine 6.80725 3.4195 3.38775 >0.05 
 
PCP-saline 11.97972 5.637778 6.341944 >0.05 
 
PCP-clozapine 5.9485 2.90675 3.04175 >0.05 
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3.1 Drug treatments by rats received from the 
subchronic PCP treatment, the OPC task and LMA task 
after clozapine and donepezil 
 
 
 
Appendix 3.1: Diagram of treatment by rats adminstrated from the subchronic 
treatment, followed by the OPC task after clozapine (5 mg/kg) and donepezil 
(0.3 mg/kg), and LMA after clozapine (5 mg/kg) and donepezil (0.3 mg/kg) 
injection. 
 
 
